Existing Annotations Review

Core Functions

BRCA1-BARD1 heterodimer functions as RING-type E3 ubiquitin ligase catalyzing K6-linked polyubiquitin chains essential for homologous recombination repair. This enzymatic activity modifies histones and other substrates to facilitate DNA repair and chromatin remodeling.

Molecular Function:

ubiquitin-protein transferase activity

BRCA1 recognizes and binds damaged DNA at double-strand breaks through its BRCT domains recognizing phosphorylated proteins and through direct DNA interaction. This binding is essential for recruiting repair machinery to sites of DNA damage.

Molecular Function:

damaged DNA binding

BRCA1 interacts with p53 tumor suppressor to coordinate DNA damage response and apoptotic signaling. The central region of BRCA1 forms an intrinsically disordered scaffold for this and other protein interactions.

Molecular Function:

p53 binding

References

GO_REF:0000002

Gene Ontology annotation through association of InterPro records with GO terms.

GO_REF:0000033

Annotation inferences using phylogenetic trees

GO_REF:0000107

Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara.

GO_REF:0000120

Combined Automated Annotation using Multiple IEA Methods.

PMID:10477523

Functional interaction of BRCA1-associated BARD1 with polyadenylation factor CstF-50.

PMID:10518542

BRCA1-associated growth arrest is RB-dependent.

PMID:10855792

VCP, a weak ATPase involved in multiple cellular events, interacts physically with BRCA1 in the nucleus of living cells.

PMID:11090615

Sequence-specific transcriptional corepressor function for BRCA1 through a novel zinc finger protein, ZBRK1.

PMID:11301010

BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function.

PMID:11739404

BRCA1-induced large-scale chromatin unfolding and allele-specific effects of cancer-predisposing mutations.

PMID:11751867

The LIM domain protein LMO4 interacts with the cofactor CtIP and the tumor suppressor BRCA1 and inhibits BRCA1 activity.

PMID:11836499

BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage.

PMID:11877377

SMC1 is a downstream effector in the ATM/NBS1 branch of the human S-phase checkpoint.

PMID:12242698

Highlight: BRCA1 and BRCA2 proteins in breast cancer.

PMID:12354784

BRCA1 interacts directly with the Fanconi anemia protein FANCA.

PMID:12419185

NBS1 localizes to gamma-H2AX foci through interaction with the FHA/BRCT domain.

PMID:12419249

BRCA1 supports XIST RNA concentration on the inactive X chromosome.

PMID:12607005

MDC1 is a mediator of the mammalian DNA damage checkpoint.

PMID:12890688

The BRCA1/BARD1 heterodimer assembles polyubiquitin chains through an unconventional linkage involving lysine residue K6 of ubiquitin.

PMID:14550570

BRCA1 interacts with FHL2 and enhances FHL2 transactivation function.

PMID:14576433

The BRCT domain is a phospho-protein binding domain.

PMID:14654789

A member of the Pyrin family, IFI16, is a novel BRCA1-associated protein involved in the p53-mediated apoptosis pathway.

PMID:15107825

BRCA1 cooperates with NUFIP and P-TEFb to activate transcription by RNA polymerase II.

PMID:15125843

Structure of the BRCT repeats of BRCA1 bound to a BACH1 phosphopeptide: implications for signaling.

PMID:15133502

Structure and mechanism of BRCA1 BRCT domain recognition of phosphorylated BACH1 with implications for cancer.

PMID:15265711

BARD1 regulates BRCA1 apoptotic function by a mechanism involving nuclear retention.

PMID:15571721

Characterization of segments from the central region of BRCA1: an intrinsically disordered scaffold for multiple protein-protein and protein-DNA interactions?

PMID:15674350

Structural determinants of the BRCA1 : estrogen receptor interaction.

PMID:15965487

BRCA1 participates in DNA decatenation.

PMID:16101277

Structural basis for cell cycle checkpoint control by the BRCA1-CtIP complex.

PMID:16326698

BRCA1 affects lipid synthesis through its interaction with acetyl-CoA carboxylase.

PMID:16452482

ATM activation by ionizing radiation requires BRCA1-associated BAAT1.

PMID:17334399

Functional consequences of cyclin D1/BRCA1 interaction in breast cancer cells.

PMID:17349954

A critical role for the ubiquitin-conjugating enzyme Ubc13 in initiating homologous recombination.

PMID:17511879

The interaction of PP1 with BRCA1 and analysis of their expression in breast tumors.

PMID:17525332

ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.

PMID:17525340

Abraxas and RAP80 form a BRCA1 protein complex required for the DNA damage response.

PMID:17581638

The FANCJ/MutLalpha interaction is required for correction of the cross-link response in FA-J cells.

PMID:17643121

CCDC98 targets BRCA1 to DNA damage sites.

PMID:17873885

E2-BRCA1 RING interactions dictate synthesis of mono- or specific polyubiquitin chain linkages.

PMID:18001824

RNF8 ubiquitylates histones at DNA double-strand breaks and promotes assembly of repair proteins.

PMID:18001825

RNF8 transduces the DNA-damage signal via histone ubiquitylation and checkpoint protein assembly.

PMID:18285836

Pathogenicity of the BRCA1 missense variant M1775K is determined by the disruption of the BRCT phosphopeptide-binding pocket: a multi-modal approach.

PMID:18716619

CDK targets Sae2 to control DNA-end resection and homologous recombination.

PMID:19117993

BRCA1-associated protein 1 interferes with BRCA1/BARD1 RING heterodimer activity.

PMID:19261748

MERIT40 facilitates BRCA1 localization and DNA damage repair.

PMID:19369211

PALB2 is an integral component of the BRCA complex required for homologous recombination repair.

PMID:20016594

The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress.

PMID:20016603

Mammalian SUMO E3-ligases PIAS1 and PIAS4 promote responses to DNA double-strand breaks.

PMID:20160719

Identification of DBC1 as a transcriptional repressor for BRCA1.

PMID:20351172

The UBXN1 protein associates with autoubiquitinated forms of the BRCA1 tumor suppressor and inhibits its enzymatic function.

PMID:20820192

BRCA1 affects global DNA methylation through regulation of DNMT1.

PMID:21102443

Transcriptional regulation of BRCA1 expression by a metabolic switch.

PMID:21240188

Interaction between the helicases genetically linked to Fanconi anemia group J and Bloom's syndrome.

PMID:21407215

Multifunctional transcription factor TFII-I is an activator of BRCA1 function.

PMID:21673012

KIAA0101 interacts with BRCA1 and regulates centrosome number.

PMID:21951318

Ligand-dependent differences in estrogen receptor beta-interacting proteins identified in lung adenocarcinoma cells corresponds to estrogenic responses.

PMID:21988832

Toward an understanding of the protein interaction network of the human liver.

PMID:22110403

Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer.

PMID:22193777

ChAM, a novel motif that mediates PALB2 intrinsic chromatin binding and facilitates DNA repair.

PMID:9662397

BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase A.

Reactome:R-HSA-9701000

BRCA1:BARD1 heterodimer autoubiquitinates

PMID:10549283

Brca1 controls homology-directed DNA repair.

PMID:9789027

BRCA1 is associated with the centrosome during mitosis.

GO_REF:0000003

Gene Ontology annotation based on Enzyme Commission mapping

GO_REF:0000041

Gene Ontology annotation based on UniPathway vocabulary mapping.

GO_REF:0000043

Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping

PMID:10910365

Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response.

PMID:12080089

JunB potentiates function of BRCA1 activation domain 1 (AD1) through a coiled-coil-mediated interaction.

PMID:12214252

Roles of BRCA1 in centrosome duplication.

PMID:15159397

BRCA1-BARD1 complexes are required for p53Ser-15 phosphorylation and a G1/S arrest following ionizing radiation-induced DNA damage.

PMID:16288014

BRCA1 and c-Myc associate to transcriptionally repress psoriasin, a DNA damage-inducible gene.

PMID:16651405

DNA damage-induced BARD1 phosphorylation is critical for the inhibition of messenger RNA processing by BRCA1/BARD1 complex.

PMID:17505062

Growth factor signaling pathways modulate BRCA1 repression of estrogen receptor-alpha activity.

PMID:20656689

Differential regulation of JAMM domain deubiquitinating enzyme activity within the RAP80 complex.

PMID:22186889

BRCA1 is an essential regulator of heart function and survival following myocardial infarction.

PMID:22369660

BRCA1 tumor suppressor network: focusing on its tail.

PMID:22792074

FANCJ/BACH1 acetylation at lysine 1249 regulates the DNA damage response.

PMID:22884692

TRIP12 and UBR5 suppress spreading of chromatin ubiquitylation at damaged chromosomes.

PMID:23415688

BRCA1 is a novel target to improve endothelial dysfunction and retard atherosclerosis.

PMID:23624935

BRCA1 is a negative modulator of the PRC2 complex.

PMID:23680151

Function of BRCA1 in the DNA damage response is mediated by ADP-ribosylation.

PMID:24981860

Human-chromatin-related protein interactions identify a demethylase complex required for chromosome segregation.

PMID:26807646

EXD2 promotes homologous recombination by facilitating DNA end resection.

PMID:26833090

Non-catalytic Roles for XPG with BRCA1 and BRCA2 in Homologous Recombination and Genome Stability.

PMID:28319063

Compromised BRCA1-PALB2 interaction is associated with breast cancer risk.

PMID:28398198

Functional and mutational landscapes of BRCA1 for homology-directed repair and therapy resistance.

PMID:29656893

DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.

PMID:29899443

Structural basis for regulation of human acetyl-CoA carboxylase.

PMID:30657944

CtIP-BRCA1 complex and MRE11 maintain replication forks in the presence of chain terminating nucleoside analogs.

PMID:31527615

The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.

PMID:33961781

Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.

PMID:34552057

ZGRF1 promotes end resection of DNA homologous recombination via forming complex with BRCA1/EXO1.

PMID:34591612

A protein interaction landscape of breast cancer.

PMID:35351360

BRCA1/BARD1 is a nucleosome reader and writer.

PMID:8944023

Identification of a RING protein that can interact in vivo with the BRCA1 gene product.

PMID:9497340

Identification of a novel cytoplasmic protein that specifically binds to nuclear localization signal motifs.

PMID:9528852

BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression.

PMID:9774970

Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells.

PMID:9811458

Characterization of a carboxy-terminal BRCA1 interacting protein.

Reactome:R-HSA-5693606

DNA Double Strand Break Response

GO_REF:0000024

Manual transfer of experimentally-verified manual GO annotation data to orthologs by curator judgment of sequence similarity.

GO_REF:0000052

Gene Ontology annotation based on curation of immunofluorescence data

GO_REF:0000117

Electronic Gene Ontology annotations created by ARBA machine learning models

PMID:10868478

Suppression of breast cancer invasion and migration by indole-3-carbinol: associated with up-regulation of BRCA1 and E-cadherin/catenin complexes.

PMID:11573085

Structure of a BRCA1-BARD1 heterodimeric RING-RING complex.

PMID:14636569

Regulation of BRCC, a holoenzyme complex containing BRCA1 and BRCA2, by a signalosome-like subunit and its role in DNA repair.

PMID:14976165

BRCA1 : BARD1 induces the formation of conjugated ubiquitin structures, dependent on K6 of ubiquitin, in cells during DNA replication and repair.

PMID:16331276

BRCA1 and FOXA1 proteins coregulate the expression of the cell cycle-dependent kinase inhibitor p27(Kip1).

PMID:16391231

Multifactorial contributions to an acute DNA damage response by BRCA1/BARD1-containing complexes.

PMID:17525341

RAP80 targets BRCA1 to specific ubiquitin structures at DNA damage sites.

PMID:17525342

Ubiquitin-binding protein RAP80 mediates BRCA1-dependent DNA damage response.

PMID:18171670

Cell cycle-dependent complex formation of BRCA1.CtIP.MRN is important for DNA double-strand break repair.

PMID:18809582

Nucleophosmin serves as a rate-limiting nuclear export chaperone for the Mammalian ribosome.

PMID:19261749

NBA1, a new player in the Brca1 A complex, is required for DNA damage resistance and checkpoint control.

PMID:21282464

A novel role for BRCA1 in regulating breast cancer cell spreading and motility.

PMID:23855721

Localization of BRCA1 protein in breast cancer tissue and cell lines with mutations.

PMID:29709199

The MRE11-RAD50-NBS1 Complex Conducts the Orchestration of Damage Signaling and Outcomes to Stress in DNA Replication and Repair.

PMID:9342365

Cell cycle-dependent colocalization of BARD1 and BRCA1 proteins in discrete nuclear domains.

Reactome:R-HSA-2997616

PIAS1,4 SUMOylates BRCA1 with SUMO2,3

Reactome:R-HSA-2997709

PIAS1,4 SUMOylates BRCA1 with SUMO1

Reactome:R-HSA-5659781

BRCA1 forms a heterodimer with BARD1

Reactome:R-HSA-5683385

Formation of BRCA1-A complex at DNA DSBs

Reactome:R-HSA-5683735

CHEK2 is recruited to DNA DSBs

Reactome:R-HSA-5683801

CHEK2 phosphorylates BRCA1

Reactome:R-HSA-5684052

PIAS4 SUMOylates MDC1

Reactome:R-HSA-5684071

RNF4 ubiquitinates MDC1

Reactome:R-HSA-5684108

BRCA1 binds phosphorylated RBBP8

Reactome:R-HSA-5684875

Binding of ATR:ATRIP to RPA at resected DNA DSBs

Reactome:R-HSA-5684882

CHEK1 is recruited to resected DNA DSBs

Reactome:R-HSA-5684887

Activation of CHEK1 at resected DNA DSBs

Reactome:R-HSA-5685011

ATR activation at DNA DSBs

Reactome:R-HSA-5685156

ATR phosphorylates RPA2

Reactome:R-HSA-5685341

BCDX2 complex stabilizes RAD51 filament

Reactome:R-HSA-5685838

CX3 complex binds D-loop structures

Reactome:R-HSA-5685985

EXO1 or DNA2 in complex with BLM or WRN binds initially resected DNA DSBs along with BRIP1 recruitment

Reactome:R-HSA-5685994

Long-range resection of DNA DSBs by EXO1 or DNA2

Reactome:R-HSA-5686410

BLM mediates dissolution of double Holliday junction

Reactome:R-HSA-5686440

MUS81:EME1,EME2 cleaves D-loop

Reactome:R-HSA-5686469

Resolution of D-loops cleaved by MUS81:EME1 or MUS81:EME2

Reactome:R-HSA-5686483

Resolution of Holliday junctions cleaved by GEN1 or SLX1A:SLX4:MUS81:EME1,(MUS81:EME2)

Reactome:R-HSA-5686642

RAD52 promotes single strand annealing at resected DNA DSBs

Reactome:R-HSA-5686657

ERCC1:XPF cleaves flaps generated by SSA

Reactome:R-HSA-5686685

RIF1 and PAX1IP bind TP53BP1 at DNA DSBs

Reactome:R-HSA-5691411

BRCA1-A complex deubiquitinates K63polyUb-histone H2A

Reactome:R-HSA-5693539

Ligation of DNA and formation of Holliday structures following repair synthesis

Reactome:R-HSA-5693542

Association of RPA complexes with ssDNA at resected DNA DSBs

Reactome:R-HSA-5693551

Phosphorylation of BRCA1-A complex at multiple sites by ATM

Reactome:R-HSA-5693561

RAD51 binds BRCA2 at resected DNA DSBs

Reactome:R-HSA-5693564

Association of RAD51 with RAD52:DNA double-strand break ends

Reactome:R-HSA-5693580

Association of RAD52 with the RPA complex at resected DNA DSBs

Reactome:R-HSA-5693584

Cleavage of Holliday junctions by GEN1 or SLX1A:SLX4:MUS81:EME1,(MUS81:EME2)

Reactome:R-HSA-5693589

D-loop dissociation and strand annealing

Reactome:R-HSA-5693593

D-loop extension by DNA polymerases

Reactome:R-HSA-5693608

Initial resection of double-strand break ends

Reactome:R-HSA-5693620

D-loop formation mediated by PALB2, BRCA2 and RAD51

Reactome:R-HSA-6797712

CDK12 stimulates expression of DNA repair genes

Reactome:R-HSA-6799332

ATR phosphorylates TP53

Reactome:R-HSA-69891

Phosphorylation and activation of CHEK2 by ATM

Reactome:R-HSA-9007605

BRCA1 gene expression is inhibited by E2F6

Reactome:R-HSA-9663194

Some pathogenic BRCA1 mutants do not bind BARD1

Reactome:R-HSA-9699163

Defective BARD1 does not bind BRCA1

Reactome:R-HSA-9700998

BAP1 disrupts the BRCA1:BARD1 heterodimer

Reactome:R-HSA-9701003

BAP1 binds BRCA1:BARD1 heterodimer

Reactome:R-HSA-9701199

Defective D-loop formation mediated by PALB2, BRCA2 and RAD51 due to loss-of-function of BRCA1 in PALB2 binding

Reactome:R-HSA-9704330

Defective D-loop formation mediated by PALB2, BRCA2 and RAD51 due to loss-of-function of PALB2 in BRCA1 binding

Reactome:R-HSA-9704408

Defective D-loop formation mediated by PALB2, BRCA2 and RAD51 due to loss-of-function of PALB2 in binding to BRCA2/RAD51/RAD51C

Reactome:R-HSA-9707051

UBXN1 binds BRCA1:BARD1 heterodimer

Reactome:R-HSA-9709571

BRCA2 mutants with BRC defects or a defect in the C-terminal RAD51 binding site do not bind RAD51

Reactome:R-HSA-9709601

Defective recruitment of BRCA2 and RAD51 due to loss of BRCA2 function in PALB2 binding

Reactome:R-HSA-9853389

FIGNL1 binds RAD51

Reactome:R-HSA-9926521

MITF-M-dependent BRCA1 gene expression

file:human/BRCA1/BRCA1-deep-research-falcon.md

Deep research on BRCA1 function

Deep Research

Falcon

(BRCA1-deep-research-falcon.md)

this with annotations you find in gene/protein databases, but these can be outdated or inaccurate. Falcon Edison Scientific Literature 19 citations 2025-12-26T10:40:42.106765

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

BRCA1 (UniProt P38398; Human) — domains: N‑terminal RING, central coiled‑coil (PALB2 binding), C‑terminal tandem BRCT repeats. (ismail2024brca1andits pages 1-2, barili2024geneticbasisof pages 2-4)

2024 Nature: BRCA1–BARD1 directly promotes long‑range DNA end resection (stimulates EXO1/DNA2 pathways), forms BRCA1–C with MRN + phosphorylated CtIP, and switches to replication‑fork protection in the presence of RAD51. (moser2025thirtyyearsof pages 1-3, ismail2024brca1andits pages 7-9)

Key complexes: BRCA1‑A (RAP80–ABRAXAS), BRCA1‑B (BRIP1/BACH1), BRCA1‑C (CtIP–MRN); downstream axis: BRCA1–PALB2–BRCA2–RAD51. (sherker2021tworedundantubiquitin‐dependent pages 12-13, moser2025thirtyyearsof pages 1-3)

Ubiquitin signaling: BRCA1–BARD1 RING E3 ligase ubiquitylates nucleosomal H2A to antagonize 53BP1 and promote HR; BRCA1 recruitment uses redundant ubiquitin‑dependent pathways. (sherker2021tworedundantubiquitin‐dependent pages 12-13, moser2025thirtyyearsof pages 1-3)

Clinical implications: PARP inhibitor maintenance benefits BRCA/HRD ovarian cancer; HRD testing guides therapy selection; ClinGen/ENIGMA 2024 updated gene‑specific ACMG/AMP variant curation recommendations. (ismail2024brca1andits pages 7-9, barili2024geneticbasisof pages 2-4, ismail2024brca1andits pages 11-13)

Blockquote: Terse, citable summary of BRCA1 identity, 2024 mechanistic advances (BRCA1–BARD1 and resection/fork protection), principal complexes and ubiquitin signaling, and key clinical applications (PARPi, HRD testing, ClinGen/ENIGMA 2024).

Abstract
We confirm the target as human BRCA1 (UniProt P38398), a nuclear tumor suppressor with an N‑terminal RING domain, a central coiled‑coil, and C‑terminal tandem BRCT repeats. BRCA1 functions chiefly in DNA double‑strand break repair by homologous recombination (HR), integrating checkpoint signaling and ubiquitin‑dependent chromatin signaling. Recent 2024 studies provide direct mechanistic evidence that the BRCA1–BARD1 heterodimer promotes long‑range DNA end resection and forms a functional BRCA1–C ensemble with CtIP and MRN; paradoxically, BRCA1–BARD1 switches to replication‑fork protection in the presence of RAD51. Clinically, BRCA1 loss confers sensitivity to PARP inhibitors and platinum, with 2023–2024 reviews clarifying HRD testing and evolving maintenance indications, while ClinGen/ENIGMA 2024 issued updated gene‑specific ACMG/AMP variant curation guidance. We synthesize molecular function, complexes, localization, pathways, and current applications with citations, URLs, and dates.

Identity and domain architecture
Gene/protein: BRCA1, Breast cancer type 1 susceptibility protein, Homo sapiens (UniProt P38398). Key domains: N‑terminal RING (E3 ubiquitin ligase with BARD1), central coiled‑coil (PALB2 interface), C‑terminal tandem BRCT repeats (phosphopeptide binding for DDR adaptors) (https://doi.org/10.3390/ph17030333, Mar 2024) (ismail2024brca1andits pages 1-2). Contemporary reviews place BRCA1 as a core HR/DDR factor with RING–BRCT architecture and checkpoint integration (https://doi.org/10.1016/j.celrep.2024.113803, Feb 2024) (gracia2024proteinfoldingchaperonespredict pages 23-24).
Molecular functions and mechanisms
E3 ubiquitin ligase activity: BRCA1–BARD1 is a RING‑type E3 ligase. Ubiquitylation of nucleosomal H2A by BRCA1–BARD1 helps antagonize 53BP1 and favors HR over c‑NHEJ; BRCA1 recruitment to DSBs relies on redundant ubiquitin‑dependent routes involving RAP80–ABRAXAS (BRCA1‑A) and a RING/E2‑dependent pathway (https://doi.org/10.15252/embr.202153679, Nov 2021) (sherker2021tworedundantubiquitin‐dependent pages 12-13). Canonical domain functions and DDR integration are summarized in expert reviews (https://doi.org/10.1016/j.celrep.2024.113803, Feb 2024) (gracia2024proteinfoldingchaperonespredict pages 23-24).
End resection and HR: Two 2024 Nature studies establish that purified BRCA1–BARD1 directly stimulates long‑range DNA end resection via EXO1‑ or DNA2‑dependent pathways; in the DNA2 arm, BRCA1–BARD1 enhances WRN/BLM helicase activity. Together with MRN and phosphorylated CtIP, BRCA1–BARD1 forms the BRCA1–C complex, synergistically promoting resection. Disruption of BRCT–CtIP binding (CtIP S327A) impairs resection, attesting to functional integration (https://doi.org/10.1038/s41586-024-07909-9, Sep 2024; https://doi.org/10.1038/s41586-024-07910-2, Sep 2024) (moser2025thirtyyearsof pages 1-3, ismail2024brca1andits pages 7-9).
Replication‑fork protection: In the presence of RAD51, BRCA1–BARD1 switches from resection promotion to inhibiting nucleolytic degradation, explaining context‑dependent “resection vs fork protection” outcomes (https://doi.org/10.1038/s41586-024-07909-9, Sep 2024) (moser2025thirtyyearsof pages 1-3).
BRCA1 complexes and pathway placement: BRCA1 engages multiple complexes—BRCA1‑A (RAP80–ABRAXAS; ubiquitin‑dependent DSB recognition), BRCA1‑B (BRIP1/BACH1; helicase interface), BRCA1‑C (CtIP–MRN; resection)—and connects to the downstream PALB2–BRCA2–RAD51 axis through its coiled‑coil (https://doi.org/10.15252/embr.202153679, Nov 2021; https://doi.org/10.1016/j.celrep.2024.113803, Feb 2024) (sherker2021tworedundantubiquitin‐dependent pages 12-13, gracia2024proteinfoldingchaperonespredict pages 23-24).
Upstream signaling: BRCT repeats recognize phosphopeptides produced by ATM/ATR‑DDR, coordinating checkpoint and repair factor assembly (https://doi.org/10.3390/ph17030333, Mar 2024) (ismail2024brca1andits pages 1-2). Broader DDR reviews situate BRCA1 within ATM/ATR checkpoints and HR choice (https://doi.org/10.1016/j.celrep.2024.113803, Feb 2024) (gracia2024proteinfoldingchaperonespredict pages 23-24).
Cellular localization and dynamics
BRCA1 is predominantly nuclear, forming ionizing radiation‑induced foci at DSBs. Recruitment requires ubiquitin signaling and can proceed via RAP80‑BRCA1‑A or RING/E2‑dependent pathways, ensuring robustness to pathway losses (https://doi.org/10.15252/embr.202153679, Nov 2021) (sherker2021tworedundantubiquitin‐dependent pages 12-13). Domain‑guided nuclear focus formation via BRCT phospho‑interactions is well documented (https://doi.org/10.3390/ph17030333, Mar 2024; https://doi.org/10.1016/j.celrep.2024.113803, Feb 2024) (ismail2024brca1andits pages 1-2, gracia2024proteinfoldingchaperonespredict pages 23-24).
Substrate specificity and biochemical activities
Enzymatic role: E3 ubiquitin ligase (EC 2.3.2.27) with BARD1; physiological substrates include chromatin components (e.g., nucleosomal H2A) at DSBs to regulate 53BP1 occupancy and resection competence, integrating with ubiquitin marks generated by RNF8/RNF168 (https://doi.org/10.15252/embr.202153679, Nov 2021) (sherker2021tworedundantubiquitin‐dependent pages 12-13). BRCT‑mediated phospho‑ligand binding (e.g., pSer motifs in CtIP) provides substrate/adaptor recognition for complex assembly (https://doi.org/10.1038/s41586-024-07909-9, Sep 2024; https://doi.org/10.3390/ph17030333, Mar 2024) (moser2025thirtyyearsof pages 1-3, ismail2024brca1andits pages 1-2).
Pathway integration: HR initiation, pathway choice, and checkpoint control
HR initiation: BRCA1–BARD1 promotes long‑range resection with MRN/CtIP and helicases, committing to HR. BRCA1‑dependent H2A ubiquitylation reduces 53BP1 barrier, enabling resection (https://doi.org/10.1038/s41586-024-07909-9, Sep 2024; https://doi.org/10.15252/embr.202153679, Nov 2021) (moser2025thirtyyearsof pages 1-3, sherker2021tworedundantubiquitin‐dependent pages 12-13).
Pathway choice: BRCA1 counteracts 53BP1 to favor HR, while BRCA1‑A enforces spatiotemporal control via ubiquitin‑dependent targeting; downstream PALB2–BRCA2 loads RAD51 for strand invasion (https://doi.org/10.1016/j.celrep.2024.113803, Feb 2024) (gracia2024proteinfoldingchaperonespredict pages 23-24).
Recent developments (2023–2024)
Direct resection function of BRCA1–BARD1, BRCA1–C ensemble synergy, and RAD51‑dependent switch to fork protection (Nature, Sep 2024) (https://doi.org/10.1038/s41586-024-07909-9; https://doi.org/10.1038/s41586-024-07910-2) (moser2025thirtyyearsof pages 1-3, ismail2024brca1andits pages 7-9).
Domain and structure‑function updates of BRCT as a phosphopeptide reader in DDR scaffolding (Mar 2024) (https://doi.org/10.3390/ph17030333) (ismail2024brca1andits pages 1-2).
Contemporary synthesis of BRCA1’s mechanistic roles and translational impact (Feb 2024) (https://doi.org/10.1016/j.celrep.2024.113803) (gracia2024proteinfoldingchaperonespredict pages 23-24).
Clinical applications and real‑world implementation
PARP inhibitors and HRD: Reviews/meta‑analyses reaffirm that PARP inhibitor maintenance provides substantial PFS benefit in ovarian cancer, most pronounced in BRCA‑mutated and HRD‑positive populations; evolving practice emphasizes first‑line maintenance and careful selection as later‑line indications were curtailed for OS concerns (Feb 2024) (https://doi.org/10.1186/s13048-024-01362-y) (barili2024geneticbasisof pages 2-4).
Broader HRD/BRCA framework across cancers, testing and “BRCAness”: 2024 reviews summarize HRD biomarkers, testing strategies, and “BRCAness” beyond BRCA1/2, informing PARP/platinum sensitivity and trial eligibility (Feb 2024) (https://doi.org/10.3390/genes15020219) (barili2024geneticbasisof pages 2-4).
Variant interpretation and clinical genetics infrastructure: The ClinGen ENIGMA BRCA1/2 Variant Curation Expert Panel released gene‑specific ACMG/AMP specifications (Jan 2024 preprint), resolving many VUS and aligning evidence strengths for BRCA1/2—critical for clinical decision‑making (https://doi.org/10.1101/2024.01.22.24301588) (ismail2024brca1andits pages 11-13).
Expert opinions and consensus
Mechanistic reviews and expert syntheses emphasize BRCA1’s dual chromatin‑ubiquitin signaling and resection control as central to HR, clarifying how domain‑specific variants perturb function and therapy response (Feb 2024) (https://doi.org/10.1016/j.celrep.2024.113803) (gracia2024proteinfoldingchaperonespredict pages 23-24). The BRCT domain is highlighted as a vulnerable, mutation‑enriched reader module essential for DDR complex assembly (Mar 2024) (https://doi.org/10.3390/ph17030333) (ismail2024brca1andits pages 1-2). EMBO Reports (2021) provides authoritative context for ubiquitin‑dependent recruitment and resistance mechanisms relevant to clinical strategies (https://doi.org/10.15252/embr.202153679) (sherker2021tworedundantubiquitin‐dependent pages 12-13).
Relevant statistics and data
Scale of clinically important variation: Contemporary reviews summarize thousands of pathogenic/likely pathogenic BRCA1/2 variants curated in ClinVar as of late 2023, with truncating variants predominating and substantial VUS burden motivating functional and expert curation (Feb 2024) (https://doi.org/10.3390/genes15020219) (barili2024geneticbasisof pages 2-4).
Ovarian cancer context: BRCA1/2 alterations account for a significant subset of high‑grade serous ovarian carcinomas; PARP inhibitor maintenance meta‑analysis across 5,815 patients shows large PFS gains in BRCA‑mutated cohorts (HR ~0.24–0.36 depending on setting) (Feb 2024) (https://doi.org/10.1186/s13048-024-01362-y) (barili2024geneticbasisof pages 2-4).
Conclusion
Human BRCA1 (UniProt P38398) is a modular DDR scaffold and RING‑type E3 ligase that orchestrates chromatin ubiquitylation, end resection, and HR pathway commitment via defined complexes and phospho‑dependent BRCT interactions. 2024 mechanistic studies provide direct biochemical proof that BRCA1–BARD1 stimulates long‑range end resection and dynamically shifts to fork protection with RAD51, integrating chromatin signaling and recombination. Clinically, BRCA1 deficiency underpins the success of PARP inhibitor maintenance in ovarian cancer and informs HRD testing paradigms; concurrent 2024 ClinGen/ENIGMA guidance strengthens variant classification for precision management. Ongoing work to map domain‑specific variant effects and ubiquitylation circuits will refine therapeutic stratification and resistance mitigation.

References (with URLs and dates)
- Ismail T et al. BRCA1 and Its Vulnerable C‑Terminal BRCT Domain. Pharmaceuticals. Mar 2024. https://doi.org/10.3390/ph17030333 (ismail2024brca1andits pages 1-2)
- Gracia B et al. Protein‑folding chaperones predict structure‑function relationships and cancer risk in BRCA1 mutation carriers. Cell Reports. Feb 2024. https://doi.org/10.1016/j.celrep.2024.113803 (gracia2024proteinfoldingchaperonespredict pages 23-24)
- Ceppi I et al. Mechanism of BRCA1–BARD1 function in DNA end resection and DNA protection. Nature. Sep 2024. https://doi.org/10.1038/s41586-024-07909-9 (moser2025thirtyyearsof pages 1-3)
- Salunkhe S et al. Promotion of DNA end resection by BRCA1–BARD1 in homologous recombination. Nature. Sep 2024. https://doi.org/10.1038/s41586-024-07910-2 (ismail2024brca1andits pages 7-9)
- Sherker A et al. Two redundant ubiquitin‑dependent pathways of BRCA1 localization to DNA damage sites. EMBO Reports. Nov 2021. https://doi.org/10.15252/embr.202153679 (sherker2021tworedundantubiquitin‐dependent pages 12-13)
- Barili V et al. Genetic Basis of Breast and Ovarian Cancer. Genes. Feb 2024. https://doi.org/10.3390/genes15020219 (barili2024geneticbasisof pages 2-4)
- Parsons MT et al. Evidence‑based recommendations for gene‑specific ACMG/AMP variant classification (ClinGen ENIGMA). medRxiv. Jan 2024. https://doi.org/10.1101/2024.01.22.24301588 (ismail2024brca1andits pages 11-13)
- Baradács I et al. PARP inhibitor era in ovarian cancer treatment: systematic review and meta‑analysis. J Ovarian Res. Feb 2024. https://doi.org/10.1186/s13048-024-01362-y (barili2024geneticbasisof pages 2-4)

References

(ismail2024brca1andits pages 1-2): Tala Ismail, Safa Alzneika, Emna Riguene, Salwa Al-maraghi, Aya Alabdulrazzak, Noof Al-Khal, Sara Fetais, Angelos Thanassoulas, Halema AlFarsi, and Michail Nomikos. Brca1 and its vulnerable c-terminal brct domain: structure, function, genetic mutations and links to diagnosis and treatment of breast and ovarian cancer. Pharmaceuticals, 17:333, Mar 2024. URL: https://doi.org/10.3390/ph17030333, doi:10.3390/ph17030333. This article has 21 citations and is from a poor quality or predatory journal.
(barili2024geneticbasisof pages 2-4): Valeria Barili, Enrico Ambrosini, Beatrice Bortesi, Roberta Minari, Erika De Sensi, Ilenia Rita Cannizzaro, Antonietta Taiani, Maria Michiara, Angelica Sikokis, Daniela Boggiani, Chiara Tommasi, Olga Serra, Francesco Bonatti, Alessia Adorni, Anita Luberto, Patrizia Caggiati, Davide Martorana, Vera Uliana, Antonio Percesepe, Antonino Musolino, and Benedetta Pellegrino. Genetic basis of breast and ovarian cancer: approaches and lessons learnt from three decades of inherited predisposition testing. Genes, 15:219, Feb 2024. URL: https://doi.org/10.3390/genes15020219, doi:10.3390/genes15020219. This article has 42 citations and is from a poor quality or predatory journal.
(moser2025thirtyyearsof pages 1-3): Sarah C. Moser and Jos Jonkers. Thirty years of brca1: mechanistic insights and their impact on mutation carriers. Cancer discovery, 15 3:461-480, Mar 2025. URL: https://doi.org/10.1158/2159-8290.cd-24-1326, doi:10.1158/2159-8290.cd-24-1326. This article has 5 citations and is from a highest quality peer-reviewed journal.
(ismail2024brca1andits pages 7-9): Tala Ismail, Safa Alzneika, Emna Riguene, Salwa Al-maraghi, Aya Alabdulrazzak, Noof Al-Khal, Sara Fetais, Angelos Thanassoulas, Halema AlFarsi, and Michail Nomikos. Brca1 and its vulnerable c-terminal brct domain: structure, function, genetic mutations and links to diagnosis and treatment of breast and ovarian cancer. Pharmaceuticals, 17:333, Mar 2024. URL: https://doi.org/10.3390/ph17030333, doi:10.3390/ph17030333. This article has 21 citations and is from a poor quality or predatory journal.
(sherker2021tworedundantubiquitin‐dependent pages 12-13): Alana Sherker, Natasha Chaudhary, Salomé Adam, Anne Margriet Heijink, Sylvie M Noordermeer, Amélie Fradet‐Turcotte, and Daniel Durocher. Two redundant ubiquitin‐dependent pathways of brca1 localization to dna damage sites. EMBO reports, Nov 2021. URL: https://doi.org/10.15252/embr.202153679, doi:10.15252/embr.202153679. This article has 25 citations and is from a highest quality peer-reviewed journal.
(ismail2024brca1andits pages 11-13): Tala Ismail, Safa Alzneika, Emna Riguene, Salwa Al-maraghi, Aya Alabdulrazzak, Noof Al-Khal, Sara Fetais, Angelos Thanassoulas, Halema AlFarsi, and Michail Nomikos. Brca1 and its vulnerable c-terminal brct domain: structure, function, genetic mutations and links to diagnosis and treatment of breast and ovarian cancer. Pharmaceuticals, 17:333, Mar 2024. URL: https://doi.org/10.3390/ph17030333, doi:10.3390/ph17030333. This article has 21 citations and is from a poor quality or predatory journal.
(gracia2024proteinfoldingchaperonespredict pages 23-24): Brant Gracia, Patricia Montes, Angelica Maria Gutierrez, Banu Arun, and Georgios Ioannis Karras. Protein-folding chaperones predict structure-function relationships and cancer risk in brca1 mutation carriers. Cell reports, 43:113803-113803, Feb 2024. URL: https://doi.org/10.1016/j.celrep.2024.113803, doi:10.1016/j.celrep.2024.113803. This article has 9 citations and is from a highest quality peer-reviewed journal.

Citations

gracia2024proteinfoldingchaperonespredict pages 23-24
moser2025thirtyyearsof pages 1-3
barili2024geneticbasisof pages 2-4
https://doi.org/10.3390/ph17030333,
https://doi.org/10.1016/j.celrep.2024.113803,
https://doi.org/10.15252/embr.202153679,
https://doi.org/10.1038/s41586-024-07909-9,
https://doi.org/10.1038/s41586-024-07910-2,
https://doi.org/10.1038/s41586-024-07909-9;
https://doi.org/10.1038/s41586-024-07910-2
https://doi.org/10.3390/ph17030333
https://doi.org/10.1016/j.celrep.2024.113803
https://doi.org/10.1186/s13048-024-01362-y
https://doi.org/10.3390/genes15020219
https://doi.org/10.1101/2024.01.22.24301588
https://doi.org/10.15252/embr.202153679
https://doi.org/10.1038/s41586-024-07909-9
https://doi.org/10.3390/genes15020219,
https://doi.org/10.1158/2159-8290.cd-24-1326,

Perplexity

(BRCA1-deep-research-perplexity.md)

The BRCA1 Protein: Structure, Function, and Mechanisms in Genomic Stability Maintenance Perplexity sonar-deep-research 58 citations 2025-12-28T10:44:47.310409

The BRCA1 Protein: Structure, Function, and Mechanisms in Genomic Stability Maintenance

The BRCA1 (Breast Cancer Type 1 Susceptibility) protein represents one of the most extensively characterized tumor suppressors in human biology, functioning as a multidomain protein that orchestrates the cellular response to DNA damage through its roles as an E3 ubiquitin ligase and DNA repair orchestrator. This comprehensive report synthesizes recent findings on BRCA1's molecular mechanisms, subcellular localization, biochemical functions, and integration into critical cellular pathways including homologous recombination-mediated DNA double-strand break repair, cell cycle checkpoint control, transcriptional regulation, and metabolic sensing. The approximately 1863 amino acid protein (with EC number 2.3.2.27, indicating ubiquitin transferase activity) operates at the intersection of multiple cellular processes that collectively maintain genomic integrity and suppress malignant transformation.

Structural Organization and Protein Architecture of BRCA1

The BRCA1 protein displays a modular architecture characterized by multiple functional domains that mediate its diverse cellular roles[1][5][6]. At the N-terminal region lies a RING finger domain (amino acids 1-100), which contains two zinc finger-like motifs connected through linking C₃HC₄ regions[1][15]. This domain is essential for the formation of a tight heterodimeric complex with BARD1 (BRCA1-associated RING domain protein), through the establishment of an extensive four-helix-bundle dimerization interface[41]. The RING domain mediates the E3 ubiquitin ligase activity of the BRCA1-BARD1 heterodimer, with the interaction surface formed by helices adjacent to the RING motifs rather than by the zinc-coordinated regions themselves[38][41].

The protein contains multiple distinct functional subdomains within its central and C-terminal regions. Between amino acids approximately 1280 and 1524, BRCA1 contains an SQ cluster region with multiple serine residues that serve as targets for phosphorylation by damage-responsive kinases such as ATM and Chk2[37][59]. The C-terminal region of BRCA1 comprises two tandem BRCT (BRCA1 C-terminal) domains connected by a 22-amino-acid linker[23]. Each BRCT repeat consists of three α-helix structures arranged around a four-stranded β-sheet core[23]. These BRCT domains form a head-to-tail structure involving hydrophobic interactions between the α2 helix of BRCT1 and the α1 and α3 helices of BRCT2[23]. The BRCT domains function as phosphoprotein binding modules that recognize the phosphorylated protein sequence motif pSXXF (phosphoserine-X-X-phenylalanine) of various kinase substrates, enabling phospho-dependent protein-protein interactions critical for DNA damage response functions[23][20].

The transactivation domain of BRCA1, comprising the last 570 amino acids including both BRCT repeats, independently confers transcriptional activation capability[43]. This domain includes activation domain 1 and the two BRCT repeats themselves, which act synergistically to stimulate transcription[43]. The minimal transactivation domain identified encompasses exons 21-24 (amino acids 1760-1863), with sequences in adjacent exons 16-20 enhancing full activity[8].

Primary Enzymatic Function: E3 Ubiquitin Ligase Activity and Substrate Specificity

The biochemical hallmark of BRCA1 function centers on its role as a component of a RING-type E3 ubiquitin ligase complex with BARD1[1][3][6][38][41]. The E3 ubiquitin ligase activity represents the only directly catalytic enzymatic function with established kinetic parameters, characterized by EC number 2.3.2.27 (transferase activity)[4]. This activity catalyzes the transfer of ubiquitin molecules from a ubiquitin-conjugating enzyme (E2) to protein substrates, a process essential for ubiquitin-dependent cellular signaling and protein regulation.

NMR spectroscopy studies demonstrate that the ubiquitin-conjugating enzyme UbcH5c binds exclusively to the BRCA1 RING domain, not the BARD1 RING, with the binding interface formed by the first and second zinc-binding motifs of the BRCA1 RING[41]. Single residue changes on the UbcH5c recognition surface of BRCA1 are sufficient to severely decrease or abrogate ubiquitin ligase activity[41]. Notably, BRCA1 and BARD1 RING domains have evolved what appears to be attenuated catalytic activity compared to other RING-containing proteins[38]. The BARD1 RING domain itself appears to play an attenuating role on BRCA1 ligase activity; disruption of the BARD1 RING through zinc-coordinating ligand mutations unexpectedly increases BRCA1 ligase activity, while complete elimination of the BARD1 RING still supports BRCA1 ligase activity as long as the BRCA1-binding helices remain[38].

In vivo substrate specificity for the BRCA1-BARD1 complex has remained partially enigmatic despite decades of research, though several substrates have been characterized. Histone H2A and the phosphorylated histone variant H2AX (γ-H2AX) represent well-characterized BRCA1-BARD1 substrates[13][16]. Following DNA damage, BRCA1 forms acid-stable biochemical complexes with γ-H2AX on chromatin and catalyzes ubiquitination at lysine residues 118 and 119 of H2AX[13]. This ubiquitination is proteasome-dependent, and when BRCA1 levels are reduced, H2AX ubiquitination is substantially reduced while phosphorylated H2AX levels increase, suggesting BRCA1 participates in attenuating the γ-H2AX repair signal as a late phase of DNA repair[13]. Additional histone substrates include H2B, H3, and H4, though H1 is notably not ubiquitinated by BRCA1-BARD1[16].

Recent comprehensive studies using full-length BRCA1-BARD1 have established robust, substrate-specific ubiquitylation activity with previously unrecognized modes of activity modulation[3]. The investigation revealed that BRCA1-BARD1 ligase activity is required not only for DNA resection during homology-directed repair but also for later stages of HDR completion, suggesting substrates critical to strand exchange and D-loop formation remain to be fully characterized[3]. Separation-of-function alleles that are truly ligase-null or specifically impaired in nucleosomal histone targeting render cells hypersensitive to DNA-damaging agents, establishing that ubiquitin E3 activity contributes to multiple sequential stages of DNA repair rather than a single discrete step[3].

The BRCA1-BARD1 E3 Ubiquitin Ligase Complex and Nuclear Trafficking

The assembly and localization of the BRCA1-BARD1 complex represents a crucial regulatory mechanism for BRCA1 function[7][10]. BARD1 functions as a critical nuclear chaperone for BRCA1; BARD1 directly masks the BRCA1 nuclear export signal and mediates RING-dependent BRCA1 nuclear import through complex formation[7]. Both components of this BRCA1 RING-domain mediated interaction are required for nuclear localization of ectopic and endogenous BRCA1[7]. Notably, BRCA1 exon 11 splice variants, which lack the previously identified nuclear localization signals (NLSs) but retain the RING domain, are frequently detected in the nucleus and in nuclear foci in vivo, explaining this apparent paradox through BARD1-mediated nuclear targeting[7].

The subcellular distribution of BARD1 undergoes cell cycle-dependent changes that reflect its functional association with BRCA1[10]. While BRCA1 expression and nuclear accumulation increase dramatically in S-phase cells, BARD1 levels remain relatively constant throughout the cell cycle; however, BARD1 specifically localizes within BRCA1 nuclear dots during S-phase but not during G₁ phase[10]. This cell cycle-dependent colocalization indicates a role for BARD1 in BRCA1-mediated tumor suppression that is particularly active during DNA replication. Co-expression of BARD1 promotes formation of DNA damage-induced nuclear foci containing wild-type or NLS-deficient BRCA1, further implicating BARD1 in nuclear targeting of BRCA1 for DNA repair functions[7]. These results reveal that BARD1's effects on BRCA1 protein stability, ubiquitin ligase activity, and DNA repair function are mediated in part through its role as a BRCA1 nuclear chaperone[7].

BRCA1 and Homologous Recombination-Mediated DNA Double-Strand Break Repair

The role of BRCA1 in homologous recombination (HR) mediated repair represents the primary mechanism contributing to its tumor suppression activity[2][5]. HR is required for repairing multiple types of DNA damage including single-stranded DNA lesions, DNA double-strand breaks (DSBs), and DNA cross-links[2]. Additionally, HR is a critical mechanism for recovery of stalled or broken DNA replication forks, with certain genetic alterations such as BRCA1 mutations conferring increased risk of malignancy and enhanced sensitivity to chemotherapeutic agents, including PARP inhibitors[2][5]. The observation that BRCA1 associates and colocalizes with RAD51 in nuclear foci in mitotic cells represents one of the earliest indications that BRCA1 functions in HR repair[2]. These foci form before and after DNA damage, indicating BRCA1's role in both repair of intrinsic and induced DNA damage[2].

BRCA1 functions in HR repair through two major mechanistic steps: (1) promotion of 5′ to 3′ end resection of DSBs to generate 3′ single-stranded DNA (ssDNA) overhangs, and (2) loading of the RAD51 recombinase onto the ssDNA[5][14][17]. End resection represents a key decision point in DSB repair pathway selection, as it promotes pathways utilizing homology (HR and single-strand annealing) while suppressing canonical non-homologous end joining (NHEJ)[5]. BRCA1 involvement in resection was first suggested by observations that BRCA1 mutant cells are defective in single-strand annealing (SSA), a homology-based DSB repair pathway that relies on a resection intermediate[5]. Consistent with a resection role, BRCA1 colocalizes with the resection complex MRE11-RAD50-NBS1 (MRN) after DNA damage and directly interacts with the resection factor CtIP (C-terminal binding protein-interacting protein)[5].

The detailed mechanisms of BRCA1-dependent end resection have been elucidated through studies of replication fork stalling and collapse[2]. Following replication fork collapse or stalling induced by DNA-damaging agents, BRCA1 promotes repair through distinct mechanisms. The observation that BRCA1 associates and colocalizes with RAD51 at ssDNA regions following hydroxyurea (HU) treatment even in the absence of detectable DSBs indicates BRCA1's involvement in HR upon replication fork stalling[2]. When BRCA1 is depleted, reduced proportions of cells with RAD51 foci and sister chromatid exchange (SCE) frequency are observed under replication stress conditions without DSBs, suggesting BRCA1 regulates RAD51 recruitment in the absence of DNA DSBs[2]. This study was the first to illuminate how BRCA1 deficiency influences HR repair in the context of stalled replication forks[2].

BRCA1 promotes repair of DSBs following replication fork collapse via multiple mechanisms, whereas BRCA1 promotes HR following replication fork stalling solely via facilitation of ssDNA resection[2]. The interaction between CtIP and BRCA1 appears central to resection regulation; cells expressing CtIP protein that cannot be phosphorylated at serine 327 are specifically defective in HR with decreased ssDNA levels following X-ray damage[2]. This supports a model in which phosphorylation of CtIP S327 as cells enter S-phase and recruitment of BRCA1 function as a molecular switch shifting DSB repair balance from error-prone end-joining to error-free HR by facilitating ssDNA resection[2]. Furthermore, knockdown or loss of BRCA1 protein results in increased frequency of plasmid DNA mutagenesis and microhomology-mediated end joining following DSBs, suggesting BRCA1 protects DNA from mutagenesis during non-homologous DSB repair[2].

BRCA1 as an Antagonist of 53BP1 and Regulation of Repair Pathway Choice

BRCA1 functions as an antagonist of 53BP1 (tumor suppressor p53-binding protein 1), which serves as a resection suppressor[5]. In the absence of BRCA1, 53BP1 accumulates at DSBs to block resection and HR, ultimately leading to chromosomal aberrations and cell death; deletion of 53BP1, however, rescues the viability of BRCA1 mutant cells and mice, as well as HR defects of BRCA1-deficient cells[5]. This antagonism extends beyond DSB repair; 53BP1 and BRCA1 have antagonistic interactions governing fork restart pathways, with 53BP1 promoting a fork cleavage-free pathway while BRCA1 facilitates a break-induced replication (BIR) pathway coupled with SLX-MUS complex-mediated fork cleavage[25][28]. The antagonistic functions of 53BP1 and BRCA1 in replication restart mimic their counteracting functions in DSB repair, with both processes involving mutually counteracting functions at initiation steps[25].

BRCA1 as a Recombination Mediator and Facilitator of RAD51 Loading

While BRCA2 is directly involved in RAD51-mediated repair, BRCA1 acts through more complicated mechanisms via interaction with other proteins[2]. The BRCA1-PALB2-BRCA2 axis plays essential roles in the cellular response to DSBs, maintenance of genome integrity, and suppression of cancer development[17]. Upon DNA damage, BRCA1 is recruited to DSBs where it facilitates end resection and recruits PALB2 and its associated BRCA2 to load RAD51 to initiate HR repair[17]. In the HR pathway, BRCA1 functions upstream of BRCA2, facilitating DSB end resection while BRCA2 loads RAD51 to resected ssDNA to initiate strand invasion[17].

The direct interaction between BRCA1 and PALB2 represents the primary mechanism for PALB2, BRCA2, and RAD51 recruitment to DSBs in normal cells[17]. BRCA1 associates with BRCA2 through PALB2/FANCN, with PALB2 serving as the linker between BRCA1 and BRCA2[14]. BRCA1 is an upstream regulator of BRCA2 in the DNA-damage response, with PALB2 being the direct linker[14]. The interaction between PALB2 and BRCA1 occurs constitutively and is DNA-damage-independent, comparable to the interaction between PALB2 and BRCA2[14]. In PALB2-null cells, BRCA2 fails to co-immunoprecipitate with BRCA1, whereas reconstitution with wild-type PALB2 restores the association between BRCA1 and BRCA2[14].

BRCA1 is required for targeting PALB2 and BRCA2 to DNA-damage sites[14]. In the presence of intact BRCA1, its direct interaction with PALB2 plays a dominant role for targeting PALB2-BRCA2-RAD51 to DSB-proximal chromatin, with the interaction between RNF168 and PALB2 helping retain the recruited PALB2[17]. The BRCA1 coiled-coil motif interacts with the N-terminal coiled-coil motif of PALB2, and deletions of conserved residues within these motifs abrogate the binding[14]. The interaction between BRCA1 and PALB2 is critical for HR repair, cell cycle checkpoint control, genome stability, and tumor suppression[17]. In absence of BRCA1 or in cells with mutations disrupting BRCA1-PALB2 interaction, PALB2 can be recruited through backup mechanisms involving RNF168 and other pathways to sustain residual HR[17].

Recent structural and functional studies have comprehensively mapped BRCA1-BRCT domain interactions with HR regulatory proteins[20]. The tandem BRCT domains mediate phospho-dependent interactions with multiple proteins including ABRAXAS1, CtIP, and BRIP1, with a common phosphorylated motif in these three proteins competing for a shared binding pocket within the BRCT domains[20]. Many pathogenic missense mutations cluster within this pocket and are known to impair HR; for instance, mutations at arginine 1699, such as R1699W, result in HR deficiency and are clinically recognized as pathogenic[20]. Site-saturated mutagenesis of the BRCT domains generated over 4,000 mutants assessed for binding to ABRAXAS1 and CtIP, enabling construction of an extensive interaction landscape[20]. Loss of CtIP binding resulted in the most pronounced impact on HR, indicating differential functional importance of specific BRCT-mediated interactions[20].

Post-translational Modifications and Phosphorylation-Dependent Functions

BRCA1 undergoes dynamic phosphorylation at multiple sites in response to DNA damage, with these modifications regulating distinct cellular functions[37][59]. Upon DNA damage induced by ionizing radiation, BRCA1 protein is rapidly phosphorylated by multiple kinases involved in DNA repair and cell-cycle checkpoint control including ATM, CHK2, and ATR[37]. ATM-dependent phosphorylation occurs at multiple serine residues; however, the specific ATM phosphorylation sites mapped in vivo and in vitro are not completely identical[37].

The ATM phosphorylation site at mouse BRCA1-S1152 (corresponding to human BRCA1-S1189) appears functionally critical[37]. Mutation of mouse BRCA1-S1152 resulted in increased genomic instability and tumor incidence, indicating this site is functionally important for DDR and DSB repair[37]. BRCA1-S1152 is part of a feedback loop that sustains ATM activity; abrogation of phosphorylation at this site impairs end resection without affecting assembly of the MRE11-RAD50-CtIP resection complex at DSBs[37]. Consistently, both Brca1^S971A/S971A^ MEFs (disrupting Chk2 phosphorylation) and Brca1^S1152A/S1152A^ MEFs showed impaired end resection[37]. Most remarkably, ATM phosphorylation upon γ-irradiation was significantly impaired in Brca1^S1152A/S1152A^ cells, and the "SKP2-NBS1 ubiquitination-ATM activation" circuit is impaired in these cells, indicating BRCA1-S1152 phosphorylation sustains ATM activation in a feedback mechanism[37].

The Chk2-mediated phosphorylation at BRCA1-S988 regulates both promotion of HR and suppression of error-prone NHEJ[56]. Prevention of Chk2-mediated phosphorylation via mutation of serine 988 disrupted both BRCA1-dependent promotion of HR and suppression of NHEJ; similar results were obtained when endogenous Chk2 kinase activity was inhibited[56]. Intriguingly, the opposing regulation of HR and NHEJ did not require ATM phosphorylation sites on serines 1423 and 1524[56], suggesting dual regulatory roles for distinct BRCA1 phosphorylation events[56]. This dual regulation indicates a functional link between recombination control and breast cancer predisposition in carriers of Chk2 and BRCA1 germ-line mutations[56].

ATM-dependent phosphorylation at BRCA1-S1387 is specifically required for ionizing radiation-induced S-phase arrest but not G₂-M checkpoint control[59]. Overexpression of a BRCA1 protein with serine 1387 mutated to alanine specifically abrogates the IR-induced S-phase arrest, acting as a dominant-negative activity[59]. In contrast, phosphorylation at BRCA1-S1423 is important for IR-induced G₂-M checkpoint arrest but not the S-phase checkpoint, demonstrating that distinct BRCA1 phosphorylation sites mediate distinct functional roles[59]. Among multiple serine sites, ionizing irradiation appears to induce phosphorylation of serines 1387, 1423, and 1524 in an ATM-dependent manner[59].

BRCA1 also undergoes ATR-dependent phosphorylation at serine-1423 in response to replication stress, distinct from ATM-mediated phosphorylation[50]. Following DNA damage, phosphorylated BRCA1 (BRCA1^pSer-1423^) recruits BCLAF1 and associated spliceosomal proteins, facilitating DNA damage-induced mRNA splicing[50]. This phosphorylation event represents a commitment step in BRCA1-dependent functions following DNA damage, activating formation of the BRCA1-mRNA splicing complex[50].

Cell Cycle Checkpoint Control Functions of BRCA1

BRCA1 plays critical roles in controlling cell cycle checkpoints at multiple phases, particularly the G₁/S and G₂/M transitions in response to DNA damage[12][31]. The ATM-BRCA1/BARD1-p53-p21 axis represents a major checkpoint regulatory mechanism; phosphorylation of human ATM-S1981 (mouse ATM-S1987) has been well-established as a marker of ATM kinase activation[37]. BRCA1-BARD1 mediates acute suppression that compromises p53(Ser-15) phosphorylation, which in turn compromises p21 induction and G₁/S checkpoint arrest[12]. These observations reveal an important role of p21 in mediating BRCA1 function in G₁/S arrest, with p21 induction transcription requiring p53 activation[12].

BRCA1 functions as a co-activator of p53-dependent transcription, but with remarkable selectivity[9]. BRCA1-stabilized p53 regulates transcription of DNA repair and growth arrest genes while p53 stabilized by DNA-damaging agents induces a broader array of genes including those involved in apoptosis[9]. The differential expression profile results in growth arrest following BRCA1 expression versus apoptosis following DNA damage, indicating BRCA1 exerts selective control over p53 transcriptional targets[9]. Depletion of BRCA1 in wild-type-p53-expressing cells abolishes induction of repair genes such as p53R2, while expression of PIG3 (an apoptosis-inducing gene) is still induced[9]. BRCA1 also confers diminished cell death in a p53-dependent manner in response to adriamycin compared to controls[9].

The molecular mechanism appears to involve BRCA1 associating with and stabilizing p53 alongside other stabilizing events such as phosphorylation, and directing p53 transcription towards growth arrest and DNA repair genes[9]. After DNA damage, BRCA1 associates with and stabilizes p53, directing p53 transcription towards growth arrest and DNA repair genes, allowing growth arrest and repair to proceed[9]. If damage to the genome is significant and repair continues for extended periods, p53 overcomes the BRCA1-mediated effect through repression of the BRCA1 gene and proceeds to activate the apoptosis pathway[9]. This temporal control mechanism allows cells time for DNA repair before committing to programmed cell death.

Evidence indicates that BRCA1 deficiency activates the ATM-Chk2-p53 DNA damage response pathway as a natural barrier against malignant transformation[12][31]. BRCA1^Δ11/Δ11^ cells die early in utero, but this lethality can be partially rescued by a nullizygous p53 mutation[1]. Deletion of p53 and/or its downstream mediator p21 partially rescues BRCA1-null embryos, with elimination of either one or both wild-type p53 alleles completely overcoming embryonic lethality caused by targeted deletion of full-length Brca1[31]. Haploid loss or complete loss of ATM also rescued Brca1 deficiency-associated embryonic lethality and premature aging[31]. ATM or Chk2 inactivation is equivalent to p53 inactivation in allowing Brca1^Δ11/+^ embryos to survive to adulthood[31]. These genetic interactions demonstrate that the activation of the ATM-Chk2-p53 signaling pathway in response to Brca1 deficiency contributes to suppression of neoplastic transformation while compromising organismal homeostasis[31].

BRCA1 Localization and Nuclear Foci Formation

BRCA1 demonstrates dynamic subcellular localization patterns that reflect its functional roles in nuclear processes[21][24]. BRCA1 forms approximately 10-20 prominent nuclear foci in normal cells, with these foci localizing predominantly to heterochromatic nuclear regions[24]. BRCA1 frequently associates with interphase centromere-kinetochore complexes, including pericentric heterochromatin, particularly the nucleolar periphery where many centromeres reside[21][24]. Approximately 32% of BRCA1 foci localize to the region abutting or within the nucleolus, another 14% localize to peripheral heterochromatin, and 35% colocalize with small discrete "holes" in hnRNA signal[24]. This heterochromatin-associated localization suggests BRCA1 involvement in replication-linked maintenance of centric/pericentric heterochromatin[21][24].

BRCA1 demonstrates S-phase-dependent accumulation into nuclear foci with spatially discrete organization[10][21]. Most BRCA1 foci position overwhelmingly in heterochromatic regions; BRCA1 does not substantially colocalize with facultative heterochromatin markers like H3mK27 or XIST RNA on the inactive X chromosome[24]. Through simultaneous detection of nuclear RNA and protein using optimized methods, BRCA1 partially overlaps or closely abuts XIST RNA in only 3-5% of cells, with 3D analysis showing even apparent overlaps are largely distinct spatial territories[24]. Proliferating cell nuclear antigen or BrdU labeling demonstrates BRCA1 localizes adjacent to or "paints" major satellite blocks as chromocenters replicate, where topoisomerase is also enriched[21][24].

The mechanism underlying BRCA1 accumulation into nuclear dots and its S-phase-dependent organization remains incompletely understood, although BRCA1 undergoes hyperphosphorylation at S-phase, which may be significant[10]. BRCA1 loss is often associated with proliferative defects including postmitotic bridges enriched with satellite DNA, suggesting a novel mechanism whereby BRCA1 loss contributes to genomic instability[21]. These findings implicate BRCA1 in replication-linked maintenance of centric/pericentric heterochromatin as a previously unrecognized function distinct from damage-induced foci formation[21][24].

Transcriptional Regulation Functions and Target Gene Selection

BRCA1 functions as a transcriptional regulator with selectivity for specific target genes, involving both transcriptional activation and repression mechanisms[8][9][27][32]. The C-terminal region of BRCA1, comprising exons 16-24 (amino acids 1560-1863), can activate transcription when fused to a heterologous GAL4 DNA binding domain both in yeast and mammalian cells[8]. The minimal transactivation domain comprises exons 21-24 (amino acids 1760-1863), with exons 16-20 contributing to full activity[8]. The presence of an acidic region, nuclear localization signals, and zinc finger domain in BRCA1 suggests a role in transcriptional regulation[8].

Germ-line mutations in BRCA1 impair transcriptional activation; four reported mutations associated with disease (Ala-1708→Glu, Gln-1756 C+, Met-1775→Arg, Tyr-1853→Stop) demonstrated markedly impaired transcription activity[8]. Most mutations found in patients generate proteins lacking all or part of the minimal transactivation domain; for instance, truncated proteins lacking even small regions of this domain would be predicted to have no function in transcriptional activation[8]. This suggests that mutations in BRCA1 impairing the ability to activate transcription may predispose carriers to tumors, indicating BRCA1 may function to activate transcription of genes involved in suppressing transformation[8].

BRCA1 participates in regulating insulin-like growth factor 1 receptor (IGF1R) gene expression through interaction with the zinc-finger transcription factor Sp1[19]. The mechanism involves BRCA1 binding to and sequestering Sp1, preventing Sp1 from binding cis-elements in the IGF1R promoter region, leading to reduction in IGF1R levels and ensuing decrease in IGF1-mediated proliferation[19]. Loss-of-function BRCA1 mutations render mutant BRCA1 unable to bind Sp1 and suppress IGF1R gene transcription, with enhanced IGF1R levels associated with augmented cell proliferation[19]. Maximal BRCA1 expression occurs during the pre-replicative G₁ phase of the cell cycle, and BRCA1 is involved in control of G₁-S and G₂-M transition checkpoints[19].

BRCA1 associates with regulatory regions of genes involved in DNA repair and checkpoint control, including the rRNA genes regulated by RNA Polymerase I (Pol-I)[32]. BRCA1 associates with the rDNA repeat and interacts with components of Pol-I transcription machinery including the upstream binding factor (UBF) and selectivity factor-1 (SL1), as well as RNA Pol-I itself[32]. A rDNA-associated fraction of BRCA1 is involved in DNA damage-dependent regulation of Pol-I transcription, regulating the stability and formation of the Pol-I holoenzyme during initiation and/or elongation in response to DNA damage[32]. BRCA1 occupancy at the rDNA repeat is decreased in response to DNA damage, and the observed BRCA1 interactions with Pol-I transcription machinery are weakened[32]. These findings indicate BRCA1 has novel regulatory functions in the control of Pol-I transcription and therefore ribosome biogenesis[32].

Metabolic Sensing and Regulation of BRCA1 Expression

BRCA1 expression undergoes dynamic regulation in response to cellular metabolic status through a "metabolic switch" mechanism involving the C-terminal-binding protein (CtBP) and histone deacetylase 1[22][29]. Estrogen represents the most potent stimulus for BRCA1 expression, inducing 6-7-fold increases in both mature and unspliced (nascent) BRCA1 RNA in hormone-responsive cells[29]. This regulation reflects a direct link between cellular metabolic status and the expression of BRCA1, suggesting caloric intake may selectively influence the levels of tumor suppressor function in mammary tissues[22].

BRCA1 transcription is controlled by a dynamic equilibrium between transcriptional co-activators and co-repressors that govern histone modifications at the BRCA1 promoter[22]. CtBP assembles at the BRCA1 promoter as part of a multi-component co-repressor complex containing p130, HDAC1, and other factors that represses local histone acetylation and BRCA1 transcription[22]. Eviction of CtBP from the BRCA1 promoter through estrogen induction, RNAi depletion, or increased NAD⁺/NADH ratio results in HDAC1 dismissal, elevated histone acetylation, and increased BRCA1 transcription[22]. This represents an important molecular link between caloric intake and tumor suppressor expression in mammary cells[22].

CtBP functions as a "metabolic switch" at the BRCA1 promoter selectively controlling histone acetylation, chromatin structure, and transcription in response to cellular metabolic status[22]. CtBP is most active as a dimer with dimerization promoted by binding to NAD⁺ and NADH[22]. CtBP has greater than 100-fold higher affinity for NADH compared to NAD⁺, and free cellular concentrations of both NAD species approach their CtBP binding affinities[22]. Hypoxia produces a selective block to estrogen induction of BRCA1 transcription while not influencing induction of other estrogen-responsive genes, demonstrating CtBP functions as a metabolic switch controlling BRCA1 expression specifically[22].

BRCA1 induces metabolic reprogramming in breast cancer cells as demonstrated by global metabolomics and transcriptomics platforms[19]. Wild-type BRCA1 induces numerous metabolic modifications including marked inhibition of glycolysis; all glycolysis indicators were largely decreased (~50%) in BRCA1 wild-type compared to BRCA1 mutant cells[19]. Five major glycolytic enzymes including HK2 and PFKFB3, and both pyruvate and lactate were down-regulated by BRCA1 transfection[19]. Conversely, the tricarboxylic acid (TCA) cycle and oxidative phosphorylation were activated in BRCA1-expressing cells[19]. BRCA1 induced a decrease of ketone bodies and free fatty acids, which were likely employed to supply Acetyl-CoA for the TCA cycle[19]. BRCA1-transfected cells displayed enhanced activity of antioxidative pathways, likely as a result of ROS production by oxidative phosphorylation[19]. The overall implication is that BRCA1 is capable of reversing the Warburg effect[19].

RNA Processing and mRNA Splicing Functions

BRCA1 participates in regulating pre-mRNA splicing of numerous genes involved in DNA damage signaling and repair through formation of a DNA damage-induced BRCA1-mRNA splicing complex[50][57]. This complex contains BCLAF1 (BCL2-associated factor 1) and other key components of the mRNA-splicing machinery[50]. In response to DNA damage from multiple sources (MMS-induced DNA alkylation, HU-induced replication fork stalling, and DSBs from IR and etoposide), BCLAF1 interacts with BRCA1, mediated through phosphorylation of BRCA1 at serine-1423[50]. This complex formation appears as part of a general DNA damage response mechanism, reflecting BRCA1^Ser-1423^ being a substrate of both ATM (in response to DSBs) and ATR (in response to single-strand breaks and stalled forks)[50].

BRCA1, constitutively bound at gene promoters, regulates expression following DNA damage through recruitment of BCLAF1 and the cotranscriptional spliceosome, promoting mRNA splicing and transcript production/stability[50]. Phosphorylated BRCA1 bound at promoters facilitates DNA damage-induced mRNA splicing through recruitment of spliceosomal proteins; mRNA splicing of ATRIP, BACH1, and EXO1 transcripts was significantly upregulated in response to DNA damage in both BRCA1- and BCLAF1-dependent manner[50]. This regulation operates through the nonsense-mediated decay (NMD) pathway; siRNA-mediated depletion of SMG1, a key NMD pathway player, led to marked increase in pre-spliced ATRIP, BACH1, and EXO1 mRNAs in BRCA1- and BCLAF1-depleted cells following DNA damage[50]. These observations define a direct link between phosphorylation-dependent BRCA1 function and the control of DNA damage response gene expression[50].

The THRAP3 and BCLAF1 factors promote selective mRNA splicing and export of transcripts encoding key DNA damage response proteins including the ATM kinase[57]. THRAP3 contains a serine-arginine (SR) rich region consistent with a role in pre-mRNA processing and splicing[50]. THRAP3 is phosphorylated at five different serine residues in an ATR kinase-dependent manner in response to DNA-damaging agents, and is PARylated in response to oxidative stress, which facilitates its localization to nuclear speckles with other splicing factors[57]. Loss of THRAP3 and/or BCLAF1 leads to sensitivity to DNA-damaging agents, defective DNA repair, and genomic instability[57].

Protection Against Oxidative DNA Damage

BRCA1 and BRCA2 are essential for the repair of oxidative DNA damage repair intermediates that persist into S-phase, producing double-strand breaks[33]. Hydrogen peroxide exposure leads to oxidative DNA damage-induced DSBs in BRCA-deficient cells, causing them to accumulate in S-phase[33]. After hydrogen peroxide treatment, BRCA-deficient cells showed impaired RAD51 foci formation, which is dependent on an intact BRCA1-BRCA2 pathway[33]. These DSBs result in increased chromatid-type aberrations characteristic for BRCA1 and BRCA2-deficient cells[33]. The most common result of oxidative DNA damage-induced processing of S-phase DSBs is an interstitial chromatid deletion, though insertions and exchanges are also observed in BRCA-deficient cells[33].

The implication is that DSBs formed in S-phase cells cannot be processed by the HR machinery when BRCA1 or BRCA2 are deficient[33]. Illegitimate end-joining results as a consequence of failure to process DSBs in the normal time frame, producing the characteristic chromatid-type aberrations[33]. These observations suggest HR is utilized in repair of oxidative DNA damage-produced DSBs arising in S-phase, and that oxidative stress plays a role in the etiology of hereditary breast cancer[33]. The tissue specificity of breast and ovarian cancer in BRCA mutation carriers may relate in part to the oxidative metabolic profile of these tissues[33].

Chromatin Remodeling and Large-Scale Chromatin Decondensation

Targeting BRCA1 to an amplified lac operator-containing chromosome region in the mammalian genome results in large-scale chromatin decondensation, a function independently conferred by three subdomains within the transactivation domain of BRCA1: activation domain 1 and the two BRCT repeats[43]. This chromatin unfolding activity is not accompanied by histone hyperacetylation, distinguishing it from other well-characterized transactivation domains such as VP16, E2F1, and p53, which all induce chromatin unfolding accompanied by histone hyperacetylation[43].

Deletion analysis showed that chromatin-unfolding activity is conferred by the last 570 amino acids of BRCA1, while further dissection revealed that the 50-amino-acid C-terminal half of BRCT1 is sufficient for inducing maximal chromatin unfolding[43]. The N-terminal half of BRCT1, despite comparable size, fails to mediate any chromatin decondensation, suggesting specific structural elements within BRCT1C confer this activity[43]. Cancer-predisposing mutations of BRCA1 display allele-specific effects on chromatin unfolding: 5′ mutations resulting in gross truncation abolish chromatin unfolding activity, whereas 3′ region mutations markedly enhance this activity[43].

A novel BRCA1 cofactor designated COBRA1 is recruited to chromosome sites by the first BRCT repeat of BRCA1 and is itself sufficient to induce chromatin unfolding[43]. BRCA1 mutations that enhance chromatin unfolding also increase BRCA1's affinity for and recruitment of COBRA1[43]. These results indicate that reorganization of higher-order chromatin structure is an important regulated step in BRCA1-mediated nuclear functions[43]. BRCA1 recruitment of nucleases might generate products unsuitable for 53BP1 and RIF1 binding, or BRCA1 might destabilize the chromatin structures necessary for 53BP1 and RIF1 accumulation[25].

Protein-Protein Interaction Networks and Multiprotein Complex Assembly

BRCA1 binds to numerous cellular proteins that together coordinate its diverse functions in DNA repair, transcriptional activation, and cell cycle control[1][5]. These proteins likely mediate BRCA1's involvement in DNA repair, transcriptional transactivation, and cell cycle control[1]. Wild-type BRCA1 protein binds DNA repair protein RAD51, tumor suppressor p53, RNA polymerase II holoenzyme, RNA helicase A, CtBP-interacting protein, c-myc, BARD1, BRCA2 protein, and numerous other factors[1].

The BRCA1-ABRAXAS-RAP80 complex represents a key BRCA1-associated complex mediating DNA damage recognition and BRCA1 recruitment[49]. Phosphopeptide affinity proteomic analysis identified ABRAXAS protein binding the BRCA1 BRCT repeats through a phospho-Ser-X-X-Phe motif[49]. ABRAXAS binds BRCA1 to the mutual exclusion of BACH1 and CtIP, forming a distinct type of BRCA1 complex[49]. ABRAXAS recruits the ubiquitin-interacting motif (UIM)-containing protein RAP80 to BRCA1; both ABRAXAS and RAP80 were required for DNA damage resistance, G₂-M checkpoint control, and DNA repair[49]. RAP80 was required for optimal accumulation of BRCA1 on damaged DNA (foci) in response to ionizing radiation, and the UIM domains alone were capable of foci formation[49]. The RAP80-ABRAXAS complex may help recruit BRCA1 to DNA damage sites in part through recognition of ubiquitinated proteins[49].

BRCA1 also directly interacts with Fanconi anemia proteins, directly connecting BRCA1 to the FA pathway of DNA repair[51]. This connection indicates BRCA1 participates in interstrand crosslink (ICL) repair and other FA pathway functions beyond its established roles in homologous recombination[51]. The Fanconi anemia pathway involves monoubiquitination of FANCI and FANCD2 proteins by the FA core complex, with downstream participation of BRCA1 (designated FANCS) in HR during ICL repair[54]. BRCA1 and other HR proteins work at earlier steps of ICL repair to protect DNA at the ICL from inappropriate degradation by the DNA2 nuclease-WRN complex[54].

BRCA1 interacts with the basal Pol-II transcription factors and components of the mRNA splicing machinery through multiple interaction surfaces[35][50]. Two RNA polymerase II subunits, hRPB2 and hRPB10α, mediate regulated stimulation of transcription by BRCA1[35]. This broad interaction network enables BRCA1 to function as a cellular hub coordinating diverse DNA damage response processes.

Hereditary Breast and Ovarian Cancer Susceptibility

Mutations in BRCA1 account for a substantial proportion of hereditary breast and ovarian cancer cases, with approximately half of familial breast cancer cases bearing mutations in BRCA1[1][44]. The majority of BRCA1 mutations produce a truncated protein, and BRCA1-associated breast tumors exhibit defined tumor phenotypes[1]. BRCA1-related breast cancers are more likely than sporadic breast cancers to be triple-negative (lacking estrogen receptors, progesterone receptors, and HER2/neu protein), making them harder to treat with poorer prognosis[47].

People who inherit a harmful change in BRCA1 have markedly increased risks of several cancers, most notably breast and ovarian cancer but also several other cancer types[47]. More than 60% of women who inherit a harmful change in BRCA1 will develop breast cancer during their lifetime, compared with approximately 13% of women in the general population[47]. About 39-58% of women who inherit a harmful change in BRCA1 will develop ovarian cancer during their lifetime, compared with about 1.1% in the general population[47]. Additionally, mutations in BRCA1 are associated with approximately 5% lifetime risk of pancreatic cancer and increased risks of prostate, skin, stomach, and gallbladder cancers[47].

Among women diagnosed with breast cancer, those with an inherited harmful change in BRCA1 have an increased risk of developing cancer in the opposite (contralateral) breast in the future compared with those without such changes[47]. Approximately 30-40% of breast cancer survivors with inherited BRCA1 changes will develop contralateral breast cancer by 20 years after their first diagnosis, compared with about 8% in the general population[47].

Conclusion and Integration of BRCA1 Functions

BRCA1 emerges from contemporary research as a multi-functional tumor suppressor orchestrating genomic stability through integrated mechanisms spanning DNA damage recognition and repair, transcriptional regulation, cell cycle control, metabolic sensing, and chromatin remodeling[1][2][3][5][9][14][17][20][22][37]. The protein functions as the obligate heterodimeric partner of BARD1 in executing its primary catalytic activity as an E3 ubiquitin ligase (EC 2.3.2.27), targeting substrates including phosphorylated histone H2AX and other chromatin-associated proteins[3][13][38][41]. This enzymatic activity participates in multiple sequential stages of DNA repair from initial DSB resection through later stages of strand exchange and recombination intermediate resolution[3].

The remarkable complexity of BRCA1 biology reflects its centrality in maintaining genomic integrity through parallel and sequential mechanisms. BRCA1 orchestrates homologous recombination-mediated repair through facilitation of DNA end resection, antagonism of 53BP1-mediated NHEJ promotion, and recruitment of PALB2-BRCA2-RAD51 complexes to resected ssDNA[5][14][17]. Simultaneously, BRCA1 governs cell cycle checkpoints through selective activation of p53-dependent transcription favoring DNA repair over apoptosis[9], and regulates expression of repair genes through control of pre-mRNA splicing[50]. The dynamic phosphorylation of BRCA1 at multiple serine residues by ATM, Chk2, and ATR kinases enables integration of multiple DNA damage signals and temporal coordination of distinct repair and checkpoint functions[37][56][59].

BRCA1 localization undergoes dynamic regulation reflecting its functional diversity, with constitutive nuclear localization dependent on BARD1-mediated masking of nuclear export signals[7], concentration into S-phase-dependent nuclear foci[10], and association with heterochromatic regions including centromeres and pericentromeric regions[21][24]. The protein's role in metabolic sensing through CtBP-dependent transcriptional regulation links cellular nutrient and energy status to tumor suppressor expression, providing a mechanistic explanation for how caloric intake and metabolic state influence cancer risk in tissues expressing high BRCA1 levels[22][29].

The substrate specificity of BRCA1 remains partially incompletely characterized despite decades of research, with well-established histone substrates but likely numerous unidentified physiological substrates awaiting discovery. The recently identified BRCA1-BCLAF1 complex mediating DNA damage-induced pre-mRNA splicing represents an emerging regulatory mechanism distinct from classical E3 ubiquitin ligase activity, suggesting BRCA1 possesses functional repertoires beyond those traditionally emphasized in the literature[50].

Mutations in BRCA1 confer extraordinarily high lifetime risks of breast cancer (>60%), ovarian cancer (39-58%), and elevated risks of additional cancers, establishing BRCA1 as one of the most penetrant cancer susceptibility genes in human genetics[44][47]. The specificity of cancer development in hormone-responsive tissues (breast, ovary) likely relates to the estrogen-responsive regulation of BRCA1 expression and metabolic attributes of these tissues[19][22][29]. Future research directions include comprehensive mapping of physiological BRCA1-BARD1 substrates, structural determination of BRCA1-protein complexes, characterization of tissue-specific BRCA1 functions, and therapeutic strategies targeting BRCA1-deficient cancers through synthetic lethality and targeted degradation approaches. Understanding BRCA1 biology remains central to comprehending hereditary cancer susceptibility and developing prevention and treatment strategies for carriers of BRCA1 mutations.

Citations

https://pubmed.ncbi.nlm.nih.gov/10195418/
https://pmc.ncbi.nlm.nih.gov/articles/PMC3599463/
https://pubmed.ncbi.nlm.nih.gov/37797621/
https://www.uniprot.org/uniprotkb/P38398/entry
https://pmc.ncbi.nlm.nih.gov/articles/PMC4382744/
https://star-protocols.cell.com/protocols/3701
https://pubmed.ncbi.nlm.nih.gov/11925436/
https://pmc.ncbi.nlm.nih.gov/articles/PMC19361/
https://pmc.ncbi.nlm.nih.gov/articles/PMC133857/
https://www.pnas.org/doi/10.1073/pnas.94.22.12075
https://aacrjournals.org/cancerres/article/70/2/532/560818/Transcriptional-Autoregulation-by-BRCA1BRCA1
https://academic.oup.com/nar/article/34/5/1416/1145745
https://pmc.ncbi.nlm.nih.gov/articles/PMC2948912/
https://pmc.ncbi.nlm.nih.gov/articles/PMC2750839/
https://pmc.ncbi.nlm.nih.gov/articles/PMC140135/
https://febs.onlinelibrary.wiley.com/doi/10.1016/j.febslet.2011.05.005
https://pmc.ncbi.nlm.nih.gov/articles/PMC9481714/
https://pubs.acs.org/doi/abs/10.1021/bi970863d
https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2022.844575/full
https://academic.oup.com/nar/article/53/17/gkaf848/8256625
https://pubmed.ncbi.nlm.nih.gov/17145961/
https://pmc.ncbi.nlm.nih.gov/articles/PMC3460552/
https://pmc.ncbi.nlm.nih.gov/articles/PMC10974778/
https://rupress.org/jcb/article/175/5/693/44619/BRCA1-foci-in-normal-S-phase-nuclei-are-linked-to
https://elifesciences.org/articles/30523
https://aacrjournals.org/cancerres/article/69/2_Supplement/606/552655/CtIP-a-BRCA1-binding-protein-is-a-transcriptional
https://pmc.ncbi.nlm.nih.gov/articles/PMC3141769/
https://pmc.ncbi.nlm.nih.gov/articles/PMC5683755/
https://pmc.ncbi.nlm.nih.gov/articles/PMC1462967/
https://www.oncotarget.com/article/11770/text/
https://pmc.ncbi.nlm.nih.gov/articles/PMC4442488/
https://aacrjournals.org/cancerres/article/66/3/1401/527497/Checkpoint-Kinase-2-Mediated-Phosphorylation-of
https://pmc.ncbi.nlm.nih.gov/articles/PMC16207/
https://pubs.acs.org/doi/pdf/10.1021/acs.biochem.5c00333
https://pmc.ncbi.nlm.nih.gov/articles/PMC9440284/
https://pmc.ncbi.nlm.nih.gov/articles/PMC5326557/
https://elifesciences.org/articles/80687
https://aacrjournals.org/cancerres/article/60/12/3299/506321/Role-for-ATM-in-DNA-Damage-induced-Phosphorylation
https://www.pnas.org/doi/10.1073/pnas.0836054100
https://pmc.ncbi.nlm.nih.gov/articles/PMC3982690/
https://pmc.ncbi.nlm.nih.gov/articles/PMC2150890/
https://en.wikipedia.org/wiki/Hereditary_breast%E2%80%93ovarian_cancer_syndrome
https://febs.onlinelibrary.wiley.com/doi/10.1111/febs.13150
https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2013.00182/full
https://www.cancer.gov/about-cancer/causes-prevention/genetics/brca-fact-sheet
https://pmc.ncbi.nlm.nih.gov/articles/PMC9643514/
https://pubmed.ncbi.nlm.nih.gov/17525340/
https://pmc.ncbi.nlm.nih.gov/articles/PMC4017265/
https://pubmed.ncbi.nlm.nih.gov/12354784/
https://www.science.org/doi/10.1126/science.1139476
https://aacrjournals.org/cancerres/article/79/9/2091/640683/BRCA1-No-Matter-How-You-Splice-ItBRCA1-Alternative
https://fanconi.org/clinical-care-guidelines/the-fanconi-anemia-dna-repair-pathway/
https://pubmed.ncbi.nlm.nih.gov/29440709/
https://pubmed.ncbi.nlm.nih.gov/14701743/
https://academic.oup.com/nar/article/45/22/12816/4588108
https://pmc.ncbi.nlm.nih.gov/articles/PMC2802901/
https://aacrjournals.org/cancerres/article/62/16/4588/509179/Phosphorylation-of-Serine-1387-in-Brca1-Is
https://pubmed.ncbi.nlm.nih.gov/24746700/

BRCA1 Deep Research Document

(BRCA1-deep-research.md)

BRCA1 Deep Research Document

Gene Overview and Importance

BRCA1 (BReast CAncer gene 1) is a critical tumor suppressor gene located on chromosome 17q21.31 that encodes a large multifunctional protein of 1863 amino acids. BRCA1 serves as a central hub for maintaining genomic stability through its essential roles in DNA damage response, homologous recombination repair, and cell cycle checkpoint control. The gene is most prominently known for its association with hereditary breast and ovarian cancer syndrome (HBOC), where pathogenic variants confer significantly increased cancer risks.

Core Molecular Functions

1. E3 Ubiquitin Ligase Activity

BRCA1 forms a heterodimeric RING-type E3 ubiquitin ligase complex with BARD1 through their N-terminal RING domains, representing the only known enzymatic activity of BRCA1 PMID:23007347. This ubiquitin ligase activity:

Modifies nucleosomal histones and other protein substrates
Is required for DNA resection during homologous recombination repair
Contributes to later stages of the DNA repair process
Promotes chromatin remodeling and 53BP1 positioning through the remodeler SMARCAD1

2. Homologous Recombination-Mediated DNA Repair

BRCA1 functions as a master regulator of homologous recombination (HR) through multiple mechanisms PMID:10549283:

DNA End Resection: BRCA1 promotes 5' to 3' resection of DNA double-strand breaks to generate 3' single-strand DNA overhangs
RAD51 Loading: Facilitates loading of RAD51 recombinase onto single-strand DNA
Competition with 53BP1: BRCA1 competes with the antagonistic protein 53BP1 to determine whether end resection occurs
Two-Phase Process: Governs both initial short 3' overhang formation (<100 bp) and extensive longer overhang generation (hundreds of bp)

3. Transcriptional Regulation

BRCA1 has important roles in gene transcription:
- The C-terminal region can transactivate heterologous promoters
- Involved in epigenetic regulation through chromatin remodeling
- Required for maintaining gene silencing in constitutive heterochromatin via histone H2A ubiquitination
- Subject to transcriptional regulation by factors like E2F4/p130 and E2F7

Key Biological Processes

1. DNA Damage Response and Cell Cycle Checkpoints

BRCA1 is involved in all phases of the cell cycle and regulates orderly progression:

S-Phase Checkpoint: Critical for proper S-phase progression and replication fork protection
G2/M Checkpoint: Essential for G2/M checkpoint control; deficiency leads to premature mitotic entry despite DNA damage
Spindle Checkpoint: Regulates mitotic spindle checkpoint through control of multiple genes (Bub1, Bub1b, Stk6, Birc5)
Replication Stress Response: Protects stalled replication forks during replication stress by stabilizing RAD51 filaments

2. Centrosome Regulation and Mitotic Control

BRCA1 localizes to centrosomes and plays crucial roles in mitotic processes:

Associates with γ-tubulin at mother centrioles in unduplicated centrosomes
Most abundantly localized at centrosomes during mitosis
Suppresses centrosomal aster formation
Blocks centrosome reduplication, preventing formation of multiple functional centrosomes
Essential for preventing unequal chromosome segregation and aneuploidy

3. Chromatin Remodeling and Epigenetic Regulation

BRCA1 functions in chromatin structure maintenance:
- E3 ligase activity promotes chromatin remodeling
- Required for maintaining heterochromatin structure
- Involved in histone modifications through ubiquitination
- Collaborates with chromatin remodeling complexes

Protein Structure and Functional Domains

1. RING Domain (N-terminal)

Function: Mediates E3 ubiquitin ligase activity and BARD1 interaction
Clinical Significance: High density of pathogenic mutations
Structure: Forms stable BRCA1-BARD1 heterodimer essential for ligase activity

2. Central Region (Exons 11-13)

Coverage: Over 65% of BRCA1 sequence
Components: Two nuclear localization sequences (NLS)
Binding Sites: Retinoblastoma protein (RB), cMyc, Rad50, and Rad51
Coiled-Coil Domain: Binds PALB2 N-terminal coiled-coil domain

3. BRCT Domain (C-terminal)

Structure: Two BRCT domains connected by a short linker
Function: Binds phosphoproteins with sequences recognized by ATM/ATR kinases
Clinical Significance: High density of pathogenic mutations, particularly in inter-BRCT linker
Complex Formation: Mediates formation of four major BRCA1 complexes

Major Protein Interactions and Complexes

1. BRCA1-BARD1 Complex

Function: E3 ubiquitin ligase activity
Location: Nuclear and centrosomal
Role: DNA repair and chromatin remodeling

2. BRCA1-A Complex (RAP80/Abraxas)

Function: DNA damage recognition and signaling
Components: RAP80, Abraxas, BRCC36, BRCC45
Role: Early DNA damage response

3. BRCA1-B Complex (BACH1/BRIP1)

Function: Replication stress response
Components: TOPBP1, BRIP1/FANCJ/BACH1
Role: S-phase checkpoint and interstrand cross-link repair
Interaction: BACH1 binds directly to BRCA1 BRCT repeats

4. BRCA1-C Complex (CtIP/MRN)

Function: DNA end resection
Components: CtIP, MRE11-RAD50-NBS1 complex
Role: Determines speed of DNA end resection during HR initiation
Mechanism: BRCA1 binding to phosphorylated CtIP (Ser327) enhances MRN nuclease activity

5. BRCA1-D Complex (PALB2/BRCA2/RAD51)

Function: RAD51 recruitment and HR completion
Components: PALB2, BRCA2, RAD51
Role: Facilitates RPA-to-RAD51 exchange and sister chromatid invasion
Connection: PALB2 serves as molecular bridge between BRCA1 and BRCA2

Disease Associations

1. Hereditary Breast and Ovarian Cancer (HBOC)

Risk Statistics (2024 data):
- Breast Cancer: 66% cumulative risk to age 70 (Asian populations)
- Ovarian Cancer: 41% cumulative risk to age 70 (Asian populations)
- General Population Comparison: >60% vs 13% for breast cancer in general population

Additional Cancer Risks:
- Male breast cancer
- Pancreatic cancer
- Stomach cancer
- Prostate cancer (BRCA2 > BRCA1)

2. Mutation Spectrum and Clinical Variants

ClinVar Database (December 2023):
- ~4300 different germline variants classified as pathogenic/likely pathogenic
- ~80% are truncating modifications (frameshift and nonsense changes)
- Highest mutation density in RING domain and BRCT domain
- Inter-BRCT linker region shows highest mutation intolerance

Key Experimental Findings

1. Foundational HR Studies

PMID:10549283

2. Synthetic Lethality Discovery

Multiple studies established synthetic lethality between BRCA1 deficiency and PARP inhibition [Bryant et al. 2005; Farmer et al. 2005; McCabe et al. 2006], forming the basis for targeted cancer therapy.

3. Centrosome Association

PMID:9789027

4. E3 Ligase Function Validation

Recent separation-of-function studies using triple mutants (I26A/L63A/K65A) definitively established the importance of BRCA1 E3 ligase activity in homologous recombination repair.

5. Replication Fork Protection

[PMID:multiple "BRCA1, BRCA2, and other HR proteins protect nascent strands from degradation by stabilizing RAD51 filaments at stalled forks"]

Core vs Peripheral Functions

Core Functions (Essential for Tumor Suppression)

Homologous Recombination Repair: Primary tumor suppressor function
E3 Ubiquitin Ligase Activity: Essential for multiple stages of HR
DNA End Resection: Critical initial step in HR pathway
Cell Cycle Checkpoint Control: Prevents genomic instability
Centrosome Regulation: Maintains chromosomal stability

Peripheral/Contextual Functions

Transcriptional Regulation: Important but not primary tumor suppressor mechanism
Nuclear Speckle Localization: Regulatory rather than essential
Development-Specific Roles: Context-dependent functions in embryogenesis
Tissue-Specific Expression: Variable importance across different cell types

Commonly Over-Annotated Aspects

1. General Protein Binding

Issue: Terms like "protein binding" are uninformative
Better Annotation: Specific molecular function terms (e.g., "damaged DNA binding", "E3 ubiquitin ligase activity")

2. Broad Transcriptional Terms

Issue: Over-emphasis on general transcriptional regulation
Reality: Transcriptional function is secondary to DNA repair roles

3. Development-Specific Over-Attribution

Issue: Attributing all developmental defects directly to BRCA1 function
Reality: Many effects are secondary consequences of genomic instability

4. Non-Specific DNA Repair Terms

Issue: Using broad terms like "DNA repair" without specificity
Better Annotation: "double-strand break repair via homologous recombination"

Clinical and Therapeutic Implications

1. PARP Inhibitor Therapy

BRCA1 deficiency creates vulnerability to PARP inhibitors through synthetic lethality, with major clinical success in treating BRCA1-associated cancers.

2. Screening Recommendations

Earlier breast cancer screening (before age 40)
Enhanced screening with MRI in addition to mammography
Consideration of prophylactic surgeries

3. Treatment Response

BRCA1-mutated cancers show:
- Better response to platinum-based chemotherapy
- Improved progression-free survival with PARP inhibitors
- Enhanced sensitivity to DNA-damaging agents

Recent Research Directions (2023-2024)

Refined E3 Ligase Function: Development of truly ligase-null variants for functional studies
Replication Stress Response: Emerging recognition of BRCA1's role in protecting stalled replication forks
Population-Specific Risk Assessment: Updated risk estimates for different populations
Therapeutic Resistance Mechanisms: Understanding how BRCA1 function can be restored in resistant tumors
Meiotic Functions: Novel roles in oocyte chromosome integrity during meiosis

Conclusion

BRCA1 represents one of the most thoroughly studied tumor suppressor genes, with its core function centered on maintaining genomic stability through homologous recombination-mediated DNA repair. The protein's multidomain structure enables complex formation with various partners, allowing it to function at multiple stages of the DNA damage response. While BRCA1 has diverse cellular functions, its primary tumor suppressor activity stems from its essential roles in HR repair, E3 ubiquitin ligase activity, and cell cycle checkpoint control. Understanding these core functions has been crucial for developing targeted therapies and improving clinical management of BRCA1-associated cancers.

📚 Additional Documentation

Notes

(BRCA1-notes.md)

BRCA1 Gene Review Notes

2025-01-14 - Term Label Update

Issue: Validation failure due to 1 GO term having an outdated label.

Root Cause: GO:0006301 had the label "DNA damage tolerance" but the current ontology uses "postreplication repair".

Action Taken: Updated the term label from "DNA damage tolerance" to "postreplication repair" to match the current GO ontology.

Validation Status: After fixing the term label, the gene now passes validation with only warnings about PENDING annotations.

Note: This represents a routine ontology term label update. BRCA1 is a critical DNA repair protein associated with hereditary breast and ovarian cancer, and the term "postreplication repair" more accurately describes one of its DNA repair functions.

📄 View Raw YAML

id: P38398
gene_symbol: BRCA1
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: 'BRCA1 is a critical tumor suppressor protein that functions as a central
  hub for maintaining genomic stability. Its primary molecular function is as a RING-type
  E3 ubiquitin ligase (in complex with BARD1) that catalyzes K6-linked polyubiquitin
  chains. BRCA1 orchestrates the cellular response to DNA double-strand breaks through
  multiple mechanisms: promoting homologous recombination repair via DNA end resection
  and RAD51 loading, regulating cell cycle checkpoints (particularly S-phase and G2/M),
  and maintaining centrosome stability. The protein contains three key domains: an
  N-terminal RING domain mediating E3 ligase activity, a large central region with
  nuclear localization signals and protein interaction sites, and C-terminal BRCT
  domains that bind phosphoproteins. BRCA1 forms at least four major complexes (BRCA1-A
  through BRCA1-D) that execute distinct functions in the DNA damage response. Germline
  pathogenic variants in BRCA1 cause hereditary breast and ovarian cancer syndrome,
  with carriers having approximately 66% risk of breast cancer and 41% risk of ovarian
  cancer by age 70.'
existing_annotations:
  - term:
      id: GO:0004842
      label: ubiquitin-protein transferase activity
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: BRCA1 functions as a RING-type E3 ubiquitin ligase in complex 
        with BARD1, catalyzing the formation of K6-linked polyubiquitin chains. 
        This enzymatic activity is essential for multiple stages of homologous 
        recombination repair and represents the only known enzymatic function of
        BRCA1. The IBA annotation is well-supported by extensive experimental 
        evidence across multiple species.
      action: ACCEPT
      reason: This annotation accurately captures BRCA1s core enzymatic 
        function. Multiple studies have demonstrated that BRCA1-BARD1 
        heterodimer possesses E3 ubiquitin ligase activity, forming 
        unconventional K6-linked polyubiquitin chains [PMID:12890688]. Recent 
        work using ligase-null mutants (I26A/L63A/K65A) has definitively 
        established this activity is required for homologous recombination 
        [PMID:23007347]. The IBA annotation correctly identifies this conserved 
        function across species.
      supported_by:
        - reference_id: PMID:12890688
          supporting_text: The BRCA1/BARD1 heterodimer directs polymerization of
            ubiquitin primarily through an unconventional linkage involving 
            lysine residue K6
        - reference_id: file:human/BRCA1/BRCA1-deep-research-falcon.md
          supporting_text: See deep research file for comprehensive analysis
  - term:
      id: GO:0003677
      label: DNA binding
    evidence_type: IEA
    original_reference_id: GO_REF:0000120
    review:
      summary: BRCA1 has DNA binding activity, though this is a general 
        annotation that could be more specific. BRCA1 binds to damaged DNA at 
        double-strand breaks and associates with chromatin during the DNA damage
        response. The central region contains DNA-binding capability.
      action: MODIFY
      reason: While BRCA1 does bind DNA, this annotation is too general and 
        uninformative. BRCA1 specifically binds to damaged DNA and DNA 
        structures at double-strand breaks. A more specific term like "damaged 
        DNA binding" (GO:0003684) would better represent its actual function in 
        the DNA damage response.
      proposed_replacement_terms:
        - id: GO:0003684
          label: damaged DNA binding
  - term:
      id: GO:0004842
      label: ubiquitin-protein transferase activity
    evidence_type: IEA
    original_reference_id: GO_REF:0000002
    review:
      summary: Duplicate annotation of BRCA1s E3 ubiquitin ligase activity, this
        time from InterPro domain prediction. The annotation is correct as BRCA1
        contains a RING domain that mediates E3 ligase activity.
      action: ACCEPT
      reason: This IEA annotation correctly identifies BRCA1s E3 ubiquitin 
        ligase activity based on its RING domain. While redundant with the IBA 
        annotation, it provides complementary evidence from protein domain 
        analysis. The RING domain at the N-terminus is essential for BRCA1s E3 
        ligase function in complex with BARD1.
      supported_by:
        - reference_id: PMID:12890688
          supporting_text: The BRCA1/BARD1 heterodimer assembles polyubiquitin 
            chains through an unconventional linkage involving lysine residue K6
            of ubiquitin
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:10477523
    review:
      summary: Generic protein binding annotation from a study showing BRCA1 
        interaction with polyadenylation factor CstF-50. This is an 
        uninformative annotation that should be replaced with more specific 
        molecular function terms.
      action: REMOVE
      reason: The generic "protein binding" term provides no useful functional 
        information about BRCA1. While BRCA1 does interact with many proteins 
        including CstF-50 (as shown in PMID:10477523), this should be captured 
        through more specific functional annotations like "RNA polymerase II 
        C-terminal domain binding" or annotations related to its core functions 
        in DNA repair and ubiquitination. Generic protein binding annotations 
        should be avoided per curation guidelines.
      supported_by:
        - reference_id: PMID:10477523
          supporting_text: Functional interaction of BRCA1-associated BARD1 with
            polyadenylation factor CstF-50
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:11090615
    review:
      summary: Generic protein binding annotation from BRCA1-ZBRK1 interaction 
        study. ZBRK1 is a transcriptional corepressor that interacts with BRCA1.
      action: REMOVE
      reason: Generic protein binding annotation provides no functional 
        information. The ZBRK1 interaction relates to transcriptional 
        regulation, which is a peripheral function of BRCA1. If retained, should
        use more specific terms related to transcriptional regulation.
      supported_by:
        - reference_id: PMID:11090615
          supporting_text: Sequence-specific transcriptional corepressor 
            function for BRCA1 through a novel zinc finger protein, ZBRK1
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:11739404
    review:
      summary: Generic protein binding annotation from chromatin unfolding study
        showing BRCA1 interaction with NELFB.
      action: REMOVE
      reason: Uninformative generic protein binding term. The study shows BRCA1 
        involvement in chromatin remodeling, which should be annotated with 
        specific chromatin-related GO terms rather than generic protein binding.
      supported_by:
        - reference_id: PMID:11739404
          supporting_text: BRCA1-induced large-scale chromatin unfolding and 
            allele-specific effects of cancer-predisposing mutations
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:11836499
    review:
      summary: Generic protein binding from BRCA1-CHEK1 interaction study 
        related to G2/M checkpoint control.
      action: REMOVE
      reason: Generic protein binding term is uninformative. This interaction 
        with CHEK1 is specifically related to cell cycle checkpoint control, 
        which is better captured by process annotations like "mitotic G2/M 
        transition checkpoint" rather than generic binding.
      supported_by:
        - reference_id: PMID:11836499
          supporting_text: BRCA1 regulates the G2/M checkpoint by activating 
            Chk1 kinase upon DNA damage
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:12419185
    review:
      summary: Generic protein binding from study showing NBS1 localization to 
        γ-H2AX foci through BRCA1 BRCT domain interaction.
      action: REMOVE
      reason: Generic protein binding is uninformative. This interaction is 
        specifically related to DNA damage response and double-strand break 
        repair, which should be captured through more specific functional 
        annotations.
      supported_by:
        - reference_id: PMID:12419185
          supporting_text: NBS1 localizes to gamma-H2AX foci through interaction
            with the FHA/BRCT domain
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:12607005
    review:
      summary: Generic protein binding from MDC1 interaction study. MDC1 is a 
        key mediator of DNA damage checkpoint.
      action: REMOVE
      reason: Generic protein binding provides no functional insight. The MDC1 
        interaction is specifically important for DNA damage checkpoint 
        signaling and should be captured through checkpoint-related process 
        annotations.
      supported_by:
        - reference_id: PMID:12607005
          supporting_text: MDC1 is a mediator of the mammalian DNA damage 
            checkpoint
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:14550570
    review:
      summary: Generic protein binding from FHL2 interaction study.
      action: REMOVE
      reason: Uninformative generic protein binding annotation. FHL2 interaction
        relates to transcriptional activation, a peripheral function.
      supported_by:
        - reference_id: PMID:14550570
          supporting_text: BRCA1 interacts with FHL2 and enhances FHL2 
            transactivation function
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:14654789
    review:
      summary: Generic protein binding from IFI16 interaction study related to 
        p53-mediated apoptosis.
      action: REMOVE
      reason: Generic protein binding is uninformative. The IFI16 interaction is
        specifically related to apoptotic signaling, which is captured by the 
        separate apoptosis annotation from the same paper.
      supported_by:
        - reference_id: PMID:14654789
          supporting_text: A member of the Pyrin family, IFI16, is a novel 
            BRCA1-associated protein involved in the p53-mediated apoptosis 
            pathway
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:15125843
    review:
      summary: Generic protein binding from structural study of BRCT-BACH1 
        phosphopeptide interaction.
      action: REMOVE
      reason: Generic protein binding provides no functional information. The 
        BACH1/BRIP1 interaction through BRCT domains is critical for DNA repair,
        but this should be captured through specific DNA repair annotations 
        rather than generic binding.
      supported_by:
        - reference_id: PMID:15125843
          supporting_text: 'Structure of the BRCT repeats of BRCA1 bound to a BACH1
            phosphopeptide: implications for signaling'
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:15133502
    review:
      summary: Generic protein binding from BRCT-BACH1 structural study.
      action: REMOVE
      reason: Uninformative generic protein binding. The BACH1/BRIP1 interaction
        is important for DNA repair but should be captured through specific 
        functional annotations.
      supported_by:
        - reference_id: PMID:15133502
          supporting_text: Structure and mechanism of BRCA1 BRCT domain 
            recognition of phosphorylated BACH1 with implications for cancer
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:15674350
    review:
      summary: Generic protein binding from BRCA1-estrogen receptor interaction 
        study.
      action: REMOVE
      reason: Uninformative generic annotation. The estrogen receptor 
        interaction may relate to hormone-responsive transcription but is not 
        core to BRCA1 function.
      supported_by:
        - reference_id: PMID:15674350
          supporting_text: 'Structural determinants of the BRCA1 : estrogen receptor
            interaction'
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:15965487
    review:
      summary: Generic protein binding from study on BRCA1 role in DNA 
        decatenation.
      action: REMOVE
      reason: Generic protein binding provides no functional information. The 
        DNA decatenation function should be captured through specific process 
        annotations.
      supported_by:
        - reference_id: PMID:15965487
          supporting_text: BRCA1 participates in DNA decatenation
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:16326698
    review:
      summary: Generic protein binding from BRCA1-acetyl-CoA carboxylase 
        interaction study.
      action: REMOVE
      reason: Uninformative generic annotation. The ACACA interaction relates to
        lipid metabolism, which is not a core BRCA1 function.
      supported_by:
        - reference_id: PMID:16326698
          supporting_text: BRCA1 affects lipid synthesis through its interaction
            with acetyl-CoA carboxylase
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:16452482
    review:
      summary: Generic protein binding from BAAT1 interaction study related to 
        ATM activation.
      action: REMOVE
      reason: Generic protein binding is uninformative. The BAAT1 interaction is
        important for ATM activation in DNA damage response but should be 
        captured through checkpoint annotations.
      supported_by:
        - reference_id: PMID:16452482
          supporting_text: ATM activation by ionizing radiation requires 
            BRCA1-associated BAAT1
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:17334399
    review:
      summary: Generic protein binding from cyclin D1-BRCA1 interaction study.
      action: REMOVE
      reason: Uninformative generic annotation. Cyclin D1 interaction relates to
        cell cycle regulation, which is captured by specific cell cycle 
        annotations.
      supported_by:
        - reference_id: PMID:17334399
          supporting_text: Functional consequences of cyclin D1/BRCA1 
            interaction in breast cancer cells
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:17511879
    review:
      summary: Generic protein binding from PP1-BRCA1 interaction study.
      action: REMOVE
      reason: Uninformative generic annotation. PP1 phosphatase interaction may 
        regulate BRCA1 phosphorylation status but is not core function.
      supported_by:
        - reference_id: PMID:17511879
          supporting_text: The interaction of PP1 with BRCA1 and analysis of 
            their expression in breast tumors
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:17525332
    review:
      summary: Generic protein binding from ATM/ATR substrate analysis showing 
        BRCA1 in DNA damage network.
      action: REMOVE
      reason: Generic protein binding is uninformative. This large-scale study 
        identified BRCA1 in ATM/ATR response networks, which is better captured 
        through DNA damage response annotations.
      supported_by:
        - reference_id: PMID:17525332
          supporting_text: ATM and ATR substrate analysis reveals extensive 
            protein networks responsive to DNA damage
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:17525340
    review:
      summary: Generic protein binding from Abraxas-RAP80 complex study, key 
        components of BRCA1-A complex.
      action: REMOVE
      reason: While this interaction is functionally important for BRCA1-A 
        complex formation in DNA damage response, generic protein binding term 
        is uninformative. The function is better captured through DNA repair 
        process annotations.
      supported_by:
        - reference_id: PMID:17525340
          supporting_text: Abraxas and RAP80 form a BRCA1 protein complex 
            required for the DNA damage response
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:17581638
    review:
      summary: Generic protein binding from FANCJ/MutLalpha interaction study 
        related to cross-link repair.
      action: REMOVE
      reason: Uninformative generic annotation. The FANCJ interaction is 
        important for interstrand cross-link repair but should be captured 
        through specific DNA repair annotations.
      supported_by:
        - reference_id: PMID:17581638
          supporting_text: The FANCJ/MutLalpha interaction is required for 
            correction of the cross-link response in FA-J cells
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:17643121
    review:
      summary: Generic protein binding from CCDC98/Abraxas study targeting BRCA1
        to DNA damage sites.
      action: REMOVE
      reason: Generic annotation. CCDC98/Abraxas is part of BRCA1-A complex 
        crucial for DNA damage response, but this is captured by DNA repair 
        annotations.
      supported_by:
        - reference_id: PMID:17643121
          supporting_text: CCDC98 targets BRCA1 to DNA damage sites
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:17873885
    review:
      summary: Generic protein binding from E2-BRCA1 RING interaction study on 
        ubiquitin chain synthesis.
      action: REMOVE
      reason: Generic annotation. E2 enzyme interactions are captured by 
        ubiquitin ligase activity annotations.
      supported_by:
        - reference_id: PMID:17873885
          supporting_text: E2-BRCA1 RING interactions dictate synthesis of mono-
            or specific polyubiquitin chain linkages
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:18001824
    review:
      summary: Generic protein binding from RNF8 study on histone ubiquitylation
        at DSBs.
      action: REMOVE
      reason: Generic annotation. RNF8 interaction is important for DNA damage 
        signaling but captured by DNA repair annotations.
      supported_by:
        - reference_id: PMID:18001824
          supporting_text: RNF8 ubiquitylates histones at DNA double-strand 
            breaks and promotes assembly of repair proteins
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:18001825
    review:
      summary: Generic protein binding from RNF8 DNA damage signaling study.
      action: REMOVE
      reason: Duplicate generic annotation for RNF8 interaction. DNA damage 
        response function captured elsewhere.
      supported_by:
        - reference_id: PMID:18001825
          supporting_text: RNF8 transduces the DNA-damage signal via histone 
            ubiquitylation and checkpoint protein assembly
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:18285836
    review:
      summary: Generic protein binding from study of M1775K variant disrupting 
        BRCT phosphopeptide binding.
      action: REMOVE
      reason: Generic annotation. Study demonstrates importance of BRCT domain 
        interactions but this is captured by functional annotations.
      supported_by:
        - reference_id: PMID:18285836
          supporting_text: Pathogenicity of the BRCA1 missense variant M1775K is
            determined by the disruption of the BRCT phosphopeptide-binding 
            pocket
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:19369211
    review:
      summary: Generic protein binding from PALB2 interaction study, critical 
        for BRCA1-BRCA2 connection in HR.
      action: REMOVE
      reason: While PALB2 interaction is crucial for HR by bridging BRCA1 and 
        BRCA2, generic protein binding is uninformative. This function is 
        captured by HR repair annotations.
      supported_by:
        - reference_id: PMID:19369211
          supporting_text: PALB2 is an integral component of the BRCA complex 
            required for homologous recombination repair
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:20016594
    review:
      summary: Generic protein binding from SUMO pathway involvement in BRCA1 
        response to genotoxic stress.
      action: REMOVE
      reason: Generic annotation. SUMOylation pathway interactions are 
        regulatory but not core to BRCA1 function.
      supported_by:
        - reference_id: PMID:20016594
          supporting_text: The SUMO modification pathway is involved in the 
            BRCA1 response to genotoxic stress
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:20016603
    review:
      summary: Generic protein binding from PIAS1/PIAS4 SUMO E3 ligase 
        interaction study.
      action: REMOVE
      reason: Generic annotation. SUMO E3 ligase interactions relate to 
        post-translational regulation but are not core function.
      supported_by:
        - reference_id: PMID:20016603
          supporting_text: Mammalian SUMO E3-ligases PIAS1 and PIAS4 promote 
            responses to DNA double-strand breaks
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:21240188
    review:
      summary: Generic protein binding from FANCJ-BLM helicase interaction 
        study.
      action: REMOVE
      reason: Generic annotation. Helicase interactions are important for DNA 
        repair but captured by specific repair annotations.
      supported_by:
        - reference_id: PMID:21240188
          supporting_text: interaction between the helicases genetically linked 
            to Fanconi anemia group J and Bloom's syndrome
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:21407215
    review:
      summary: Generic protein binding from TFII-I transcription factor 
        interaction study.
      action: REMOVE
      reason: Generic annotation. TFII-I interaction relates to transcriptional 
        regulation, a peripheral function.
      supported_by:
        - reference_id: PMID:21407215
          supporting_text: Multifunctional transcription factor TFII-I is an 
            activator of BRCA1 function
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:21951318
    review:
      summary: Generic protein binding from estrogen receptor beta interaction 
        in lung adenocarcinoma cells.
      action: REMOVE
      reason: Generic annotation. Estrogen receptor interactions are 
        tissue-specific and not core to BRCA1 tumor suppressor function.
      supported_by:
        - reference_id: PMID:21951318
          supporting_text: Ligand-dependent differences in estrogen receptor 
            beta-interacting proteins identified in lung adenocarcinoma cells 
            corresponds to estrogenic responses
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:21988832
    review:
      summary: Generic protein binding from large-scale liver protein 
        interaction network study.
      action: REMOVE
      reason: Generic annotation from proteomics screen provides no functional 
        information.
      supported_by:
        - reference_id: PMID:21988832
          supporting_text: Toward an understanding of the protein interaction 
            network of the human liver
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:22110403
    review:
      summary: Generic protein binding from RHAMM interaction study on 
        epithelial polarization.
      action: REMOVE
      reason: Generic annotation. RHAMM interaction relates to cell 
        polarization, not core BRCA1 function.
      supported_by:
        - reference_id: PMID:22110403
          supporting_text: Interplay between BRCA1 and RHAMM regulates 
            epithelial apicobasal polarization and may influence risk of breast 
            cancer
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:22193777
    review:
      summary: Generic protein binding from PALB2 ChAM motif study on chromatin 
        binding and DNA repair.
      action: REMOVE
      reason: Generic annotation. PALB2 interaction is crucial for HR but 
        captured by DNA repair annotations.
      supported_by:
        - reference_id: PMID:22193777
          supporting_text: ChAM, a novel motif that mediates PALB2 intrinsic 
            chromatin binding and facilitates DNA repair
  - term:
      id: GO:0004842
      label: ubiquitin-protein transferase activity
    evidence_type: IDA
    original_reference_id: PMID:12890688
    review:
      summary: Direct experimental evidence for BRCA1-BARD1 E3 ubiquitin ligase 
        activity forming K6-linked polyubiquitin chains. This is a core 
        molecular function of BRCA1.
      action: ACCEPT
      reason: This IDA annotation provides direct experimental evidence for 
        BRCA1s E3 ubiquitin ligase activity. The cited paper demonstrates that 
        BRCA1-BARD1 heterodimer catalyzes formation of unconventional K6-linked 
        polyubiquitin chains, distinguishing it from other E3 ligases. This 
        enzymatic activity is essential for BRCA1s tumor suppressor function.
      supported_by:
        - reference_id: PMID:12890688
          supporting_text: The BRCA1/BARD1 heterodimer directs polymerization of
            ubiquitin primarily through an unconventional linkage involving 
            lysine residue K6
  - term:
      id: GO:0000976
      label: transcription cis-regulatory region binding
    evidence_type: IEA
    original_reference_id: GO_REF:0000107
    review:
      summary: Automated annotation for transcriptional regulatory region 
        binding based on ortholog evidence.
      action: KEEP_AS_NON_CORE
      reason: While BRCA1 does have transcriptional regulatory functions 
        including binding to cis-regulatory regions, this is a peripheral 
        function compared to its core role in DNA repair. The transcriptional 
        activities are secondary to its primary tumor suppressor function 
        through homologous recombination repair.
      supported_by:
        - reference_id: PMID:20820192
          supporting_text: BRCA1 affects global DNA methylation through 
            regulation of DNMT1
  - term:
      id: GO:0003684
      label: damaged DNA binding
    evidence_type: IEA
    original_reference_id: GO_REF:0000107
    review:
      summary: BRCA1 binds to damaged DNA at double-strand breaks as part of its
        DNA repair function. This is more specific than generic DNA binding.
      action: ACCEPT
      reason: This annotation correctly captures BRCA1s ability to recognize and
        bind damaged DNA, particularly at double-strand breaks. BRCA1 is 
        recruited to DSBs through multiple mechanisms including its BRCT domains
        binding to phosphorylated proteins and direct DNA interaction. This is a
        core function related to its role in homologous recombination repair.
      supported_by:
        - reference_id: PMID:15125843
          supporting_text: 'Structure of the BRCT repeats of BRCA1 bound to a BACH1
            phosphopeptide: implications for signaling'
  - term:
      id: GO:0003713
      label: transcription coactivator activity
    evidence_type: IEA
    original_reference_id: GO_REF:0000107
    review:
      summary: BRCA1 has transcription coactivator activity, demonstrated 
        through interaction with RNA polymerase II and various transcription 
        factors.
      action: KEEP_AS_NON_CORE
      reason: While BRCA1 does function as a transcription coactivator through 
        its C-terminal transactivation domain and interactions with RNA pol II, 
        this is a peripheral function. The transcriptional role is secondary to 
        its primary tumor suppressor function through DNA repair. Multiple 
        studies confirm this activity but it is not essential for tumor 
        suppression.
      supported_by:
        - reference_id: PMID:9662397
          supporting_text: BRCA1 protein is linked to the RNA polymerase II 
            holoenzyme complex via RNA helicase A
        - reference_id: PMID:20820192
          supporting_text: BRCA1 affects global DNA methylation through 
            regulation of DNMT1
  - term:
      id: GO:0007098
      label: centrosome cycle
    evidence_type: IEA
    original_reference_id: GO_REF:0000107
    review:
      summary: BRCA1 localizes to centrosomes and regulates centrosome 
        duplication and function, preventing centrosome amplification and 
        maintaining chromosomal stability.
      action: ACCEPT
      reason: This annotation correctly identifies BRCA1s important role in 
        centrosome regulation. BRCA1 localizes to centrosomes during mitosis, 
        associates with gamma-tubulin, and prevents centrosome reduplication. 
        Loss of BRCA1 leads to centrosome amplification and chromosomal 
        instability. This is a core function contributing to genomic stability 
        maintenance.
      supported_by:
        - reference_id: PMID:9789027
          supporting_text: Our results indicate that BRCA1 localizes with the 
            centrosome during mitosis and coimmunoprecipitates with 
            gamma-tubulin, a centrosomal component essential for nucleation of 
            microtubules
        - reference_id: PMID:21673012
          supporting_text: KIAA0101 interacts with BRCA1 and regulates 
            centrosome number
  - term:
      id: GO:0043009
      label: chordate embryonic development
    evidence_type: IEA
    original_reference_id: GO_REF:0000107
    review:
      summary: BRCA1 knockout mice show embryonic lethality, indicating a role 
        in development. However, this is likely secondary to genomic 
        instability.
      action: KEEP_AS_NON_CORE
      reason: While BRCA1-null mice do show embryonic lethality around E7.5-8.5,
        this developmental role is likely secondary to severe genomic 
        instability from loss of DNA repair function. The embryonic lethality 
        results from accumulated DNA damage rather than a specific developmental
        program. This is a consequence of BRCA1 loss rather than a primary 
        function.
      supported_by:
        - reference_id: PMID:10549283
          supporting_text: We report here that Brca1-deficient mouse embryonic 
            stem cells have impaired repair of chromosomal DSBs by homologous 
            recombination
  - term:
      id: GO:0044027
      label: negative regulation of gene expression via chromosomal CpG island 
        methylation
    evidence_type: IEA
    original_reference_id: GO_REF:0000107
    review:
      summary: BRCA1 regulates DNA methylation through interaction with DNMT1, 
        affecting global methylation patterns.
      action: KEEP_AS_NON_CORE
      reason: BRCA1 does regulate DNA methylation and epigenetic silencing, 
        particularly through DNMT1 regulation. However, this epigenetic function
        is peripheral to its core tumor suppressor role in DNA repair. The 
        methylation effects may be secondary to transcriptional regulation or 
        chromatin remodeling activities.
      supported_by:
        - reference_id: PMID:20820192
          supporting_text: BRCA1 affects global DNA methylation through 
            regulation of DNMT1
  - term:
      id: GO:0044818
      label: mitotic G2/M transition checkpoint
    evidence_type: IEA
    original_reference_id: GO_REF:0000107
    review:
      summary: BRCA1 is essential for G2/M checkpoint control, activating CHEK1 
        kinase upon DNA damage to prevent premature mitotic entry.
      action: ACCEPT
      reason: This annotation correctly captures BRCA1s critical role in cell 
        cycle checkpoint control. BRCA1 activates CHEK1 upon DNA damage, 
        enforcing the G2/M checkpoint to prevent cells with damaged DNA from 
        entering mitosis. Loss of BRCA1 leads to checkpoint defects and genomic 
        instability. This is a core function essential for tumor suppression.
      supported_by:
        - reference_id: PMID:11836499
          supporting_text: BRCA1 regulates the G2/M checkpoint by activating 
            Chk1 kinase upon DNA damage
  - term:
      id: GO:0060816
      label: random inactivation of X chromosome
    evidence_type: IEA
    original_reference_id: GO_REF:0000107
    review:
      summary: BRCA1 supports XIST RNA concentration on the inactive X 
        chromosome, contributing to X-inactivation.
      action: KEEP_AS_NON_CORE
      reason: While BRCA1 does interact with XIST RNA and localizes to the 
        inactive X chromosome, this is a specialized peripheral function not 
        related to its core tumor suppressor role. The X-inactivation function 
        is tissue and context-specific and not essential for BRCA1s primary DNA 
        repair activities.
      supported_by:
        - reference_id: PMID:12419249
          supporting_text: BRCA1 supports XIST RNA concentration on the inactive
            X chromosome
  - term:
      id: GO:0003713
      label: transcription coactivator activity
    evidence_type: IDA
    original_reference_id: PMID:20820192
    review:
      summary: Direct evidence for BRCA1 transcription coactivator activity in 
        DNMT1 regulation and methylation control.
      action: KEEP_AS_NON_CORE
      reason: This IDA annotation provides direct evidence for transcriptional 
        coactivator function, specifically in regulating DNMT1. However, 
        transcriptional regulation is a peripheral function compared to BRCA1s 
        core role in DNA repair. The transcriptional activities contribute to 
        but are not essential for tumor suppression.
      supported_by:
        - reference_id: PMID:20820192
          supporting_text: BRCA1 affects global DNA methylation through 
            regulation of DNMT1
  - term:
      id: GO:0004842
      label: ubiquitin-protein transferase activity
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-9701000
    review:
      summary: Reactome pathway annotation for BRCA1-BARD1 autoubiquitination 
        activity.
      action: ACCEPT
      reason: This TAS annotation from Reactome correctly identifies BRCA1s E3 
        ubiquitin ligase activity, specifically its autoubiquitination in 
        complex with BARD1. This enzymatic activity is well-established and 
        essential for BRCA1 function in DNA repair.
      supported_by:
        - reference_id: Reactome:R-HSA-9701000
          supporting_text: BRCA1:BARD1 heterodimer autoubiquitinates
  - term:
      id: GO:0044027
      label: negative regulation of gene expression via chromosomal CpG island 
        methylation
    evidence_type: IMP
    original_reference_id: PMID:20820192
    review:
      summary: Direct evidence showing BRCA1 regulates CpG methylation through 
        DNMT1 control.
      action: KEEP_AS_NON_CORE
      reason: This IMP annotation demonstrates BRCA1s role in epigenetic 
        regulation through DNA methylation. While experimentally validated, this
        epigenetic function is peripheral to BRCA1s core tumor suppressor role 
        in DNA repair. The methylation effects may be indirect consequences of 
        transcriptional regulation.
      supported_by:
        - reference_id: PMID:20820192
          supporting_text: BRCA1 affects global DNA methylation through 
            regulation of DNMT1
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:16101277
    review:
      summary: Generic protein binding from BRCA1-CtIP complex structural study 
        for cell cycle checkpoint control.
      action: REMOVE
      reason: While CtIP interaction is crucial for DNA end resection in HR, 
        generic protein binding is uninformative. Function captured by DNA 
        repair annotations.
      supported_by:
        - reference_id: PMID:16101277
          supporting_text: Structural basis for cell cycle checkpoint control by
            the BRCA1-CtIP complex
  - term:
      id: GO:0004842
      label: ubiquitin-protein transferase activity
    evidence_type: IDA
    original_reference_id: PMID:17349954
    review:
      summary: Direct evidence showing BRCA1 E3 ligase activity is critical for 
        initiating homologous recombination through Ubc13 interaction.
      action: ACCEPT
      reason: This IDA annotation provides crucial evidence that BRCA1s E3 
        ubiquitin ligase activity, working with the E2 enzyme Ubc13, is required
        for initiating homologous recombination. This study demonstrates the 
        functional importance of BRCA1s enzymatic activity in its core DNA 
        repair function.
      supported_by:
        - reference_id: PMID:17349954
          supporting_text: A critical role for the ubiquitin-conjugating enzyme 
            Ubc13 in initiating homologous recombination
  - term:
      id: GO:0002039
      label: p53 binding
    evidence_type: IDA
    original_reference_id: PMID:15571721
    review:
      summary: BRCA1 central region contains intrinsically disordered segments 
        that interact with p53 and other proteins involved in DNA damage 
        response.
      action: ACCEPT
      reason: The p53 binding annotation is specific and functionally relevant, 
        unlike generic protein binding. BRCA1-p53 interaction is important for 
        coordinating DNA damage response and apoptosis. The central region of 
        BRCA1 forms an intrinsically disordered scaffold for multiple 
        protein-protein interactions including p53. This interaction contributes
        to BRCA1s tumor suppressor function.
      supported_by:
        - reference_id: PMID:15571721
          supporting_text: 'Characterization of segments from the central region of
            BRCA1: an intrinsically disordered scaffold for multiple protein-protein
            and protein-DNA interactions'
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:10518542
    review:
      summary: Generic protein binding from RB interaction study on growth 
        arrest.
      action: REMOVE
      reason: Generic annotation. RB interaction relates to cell cycle control, 
        captured by cell cycle annotations.
      supported_by:
        - reference_id: PMID:10518542
          supporting_text: BRCA1-associated growth arrest is RB-dependent
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:12354784
    review:
      summary: Generic protein binding from BRCA1-FANCA interaction in Fanconi 
        anemia pathway.
      action: REMOVE
      reason: Generic annotation. FANCA interaction is important for interstrand
        cross-link repair, captured by DNA repair annotations.
      supported_by:
        - reference_id: PMID:12354784
          supporting_text: BRCA1 interacts directly with the Fanconi anemia 
            protein FANCA
  - term:
      id: GO:0051726
      label: regulation of cell cycle
    evidence_type: IDA
    original_reference_id: PMID:21102443
    review:
      summary: BRCA1 regulates cell cycle progression through multiple 
        checkpoints and is subject to metabolic regulation.
      action: ACCEPT
      reason: This annotation correctly captures BRCA1s broad role in cell cycle
        regulation. BRCA1 controls S-phase progression, G2/M checkpoint, and 
        spindle checkpoint. It prevents premature cell cycle progression when 
        DNA damage is present. This is a core function essential for maintaining
        genomic stability and tumor suppression.
      supported_by:
        - reference_id: PMID:21102443
          supporting_text: Transcriptional regulation of BRCA1 expression by a 
            metabolic switch
        - reference_id: PMID:11836499
          supporting_text: BRCA1 regulates the G2/M checkpoint by activating 
            Chk1 kinase upon DNA damage
  - term:
      id: GO:0003713
      label: transcription coactivator activity
    evidence_type: IMP
    original_reference_id: PMID:9662397
    review:
      summary: BRCA1 links to RNA polymerase II holoenzyme complex via RNA 
        helicase A, functioning as transcription coactivator.
      action: KEEP_AS_NON_CORE
      reason: While this IMP annotation confirms BRCA1s transcription 
        coactivator function through RNA pol II interaction, this is a 
        peripheral function. The transcriptional role is secondary to BRCA1s 
        primary tumor suppressor function through DNA repair mechanisms. 
        Transcriptional defects do not fully explain BRCA1-associated cancer 
        predisposition.
      supported_by:
        - reference_id: PMID:9662397
          supporting_text: BRCA1 protein is linked to the RNA polymerase II 
            holoenzyme complex via RNA helicase A
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:20160719
    review:
      summary: Generic protein binding from DBC1 transcriptional repressor 
        interaction study.
      action: REMOVE
      reason: Generic annotation. DBC1 interaction relates to transcriptional 
        regulation, a peripheral function.
      supported_by:
        - reference_id: PMID:20160719
          supporting_text: Identification of DBC1 as a transcriptional repressor
            for BRCA1
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:21673012
    review:
      summary: Generic protein binding from KIAA0101 interaction study on 
        centrosome regulation.
      action: REMOVE
      reason: Generic annotation. KIAA0101 interaction relates to centrosome 
        regulation, captured by centrosome cycle annotation.
      supported_by:
        - reference_id: PMID:21673012
          supporting_text: KIAA0101 interacts with BRCA1 and regulates 
            centrosome number
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:11751867
    review:
      summary: Generic protein binding from LMO4-CtIP-BRCA1 interaction study.
      action: REMOVE
      reason: Generic annotation. LMO4 acts as a negative regulator of BRCA1 
        activity but generic binding is uninformative.
      supported_by:
        - reference_id: PMID:11751867
          supporting_text: The LIM domain protein LMO4 interacts with the 
            cofactor CtIP and the tumor suppressor BRCA1 and inhibits BRCA1 
            activity
  - term:
      id: GO:0000976
      label: transcription cis-regulatory region binding
    evidence_type: IDA
    original_reference_id: PMID:20820192
    review:
      summary: Direct evidence for BRCA1 binding to transcriptional regulatory 
        regions in context of DNMT1 regulation.
      action: KEEP_AS_NON_CORE
      reason: This IDA annotation demonstrates BRCA1 binding to cis-regulatory 
        regions, but this transcriptional function is peripheral to its core DNA
        repair role. While BRCA1 does regulate transcription and epigenetic 
        modifications, these activities are not the primary mechanism of tumor 
        suppression.
      supported_by:
        - reference_id: PMID:20820192
          supporting_text: BRCA1 affects global DNA methylation through 
            regulation of DNMT1
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:18716619
    review:
      summary: Generic protein binding from CDK-Sae2 study on DNA end resection 
        control.
      action: REMOVE
      reason: Generic annotation. Study relates to DNA end resection regulation,
        captured by DNA repair annotations.
      supported_by:
        - reference_id: PMID:18716619
          supporting_text: CDK targets Sae2 to control DNA-end resection and 
            homologous recombination
  - term:
      id: GO:0004842
      label: ubiquitin-protein transferase activity
    evidence_type: IDA
    original_reference_id: PMID:20351172
    review:
      summary: Study showing UBXN1 associates with autoubiquitinated BRCA1 and 
        inhibits its enzymatic function, confirming E3 ligase activity.
      action: ACCEPT
      reason: This IDA annotation provides additional evidence for BRCA1s E3 
        ubiquitin ligase activity, specifically showing autoubiquitination. The 
        study demonstrates negative regulation by UBXN1, further validating the 
        functional importance of BRCA1s enzymatic activity. This is a core 
        molecular function.
      supported_by:
        - reference_id: PMID:20351172
          supporting_text: The UBXN1 protein associates with autoubiquitinated 
            forms of the BRCA1 tumor suppressor and inhibits its enzymatic 
            function
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:20351172
    review:
      summary: Generic protein binding from UBXN1 interaction study.
      action: REMOVE
      reason: Generic annotation. UBXN1 regulates BRCA1 E3 ligase activity, 
        captured by ubiquitin ligase annotations.
      supported_by:
        - reference_id: PMID:20351172
          supporting_text: The UBXN1 protein associates with autoubiquitinated 
            forms of the BRCA1 tumor suppressor
  - term:
      id: GO:0004842
      label: ubiquitin-protein transferase activity
    evidence_type: IDA
    original_reference_id: PMID:19117993
    review:
      summary: Study showing BAP1 interferes with BRCA1-BARD1 RING heterodimer 
        E3 ligase activity, providing evidence through negative regulation.
      action: ACCEPT
      reason: This IDA annotation confirms BRCA1s E3 ligase activity by 
        demonstrating that BAP1 (BRCA1-associated protein 1) can interfere with 
        the BRCA1-BARD1 heterodimer ubiquitin ligase function. This regulatory 
        interaction validates the importance of BRCA1s enzymatic activity.
      supported_by:
        - reference_id: PMID:19117993
          supporting_text: BRCA1-associated protein 1 interferes with 
            BRCA1/BARD1 RING heterodimer activity
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:19117993
    review:
      summary: Generic protein binding from BAP1 interference with BRCA1-BARD1 
        activity.
      action: REMOVE
      reason: Generic annotation. BAP1 interaction regulates E3 ligase activity,
        captured by ubiquitin ligase annotations.
      supported_by:
        - reference_id: PMID:19117993
          supporting_text: BRCA1-associated protein 1 interferes with 
            BRCA1/BARD1 RING heterodimer activity
  - term:
      id: GO:0003723
      label: RNA binding
    evidence_type: IDA
    original_reference_id: PMID:12419249
    review:
      summary: BRCA1 binds to XIST RNA and supports its concentration on the 
        inactive X chromosome.
      action: KEEP_AS_NON_CORE
      reason: While BRCA1 does bind RNA, specifically XIST RNA for 
        X-inactivation, this is a specialized peripheral function. RNA binding 
        is not central to BRCA1s tumor suppressor role. The X-inactivation 
        function is context-specific and not required for DNA repair or genomic 
        stability maintenance.
      supported_by:
        - reference_id: PMID:12419249
          supporting_text: BRCA1 supports XIST RNA concentration on the inactive
            X chromosome
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:19261748
    review:
      summary: Generic protein binding from MERIT40 study facilitating BRCA1 
        localization.
      action: REMOVE
      reason: Generic annotation. MERIT40 is part of BRCA1-A complex for DNA 
        damage repair, captured by repair annotations.
      supported_by:
        - reference_id: PMID:19261748
          supporting_text: MERIT40 facilitates BRCA1 localization and DNA damage
            repair
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:12242698
    review:
      summary: Generic protein binding from general BRCA1/BRCA2 protein review.
      action: REMOVE
      reason: Generic annotation from review article provides no specific 
        functional information.
      supported_by:
        - reference_id: PMID:12242698
          supporting_text: 'Highlight: BRCA1 and BRCA2 proteins in breast cancer'
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:15107825
    review:
      summary: Generic protein binding from NUFIP and P-TEFb interaction for 
        transcription activation.
      action: REMOVE
      reason: Generic annotation. Relates to transcriptional function with RNA 
        pol II, a peripheral activity.
      supported_by:
        - reference_id: PMID:15107825
          supporting_text: BRCA1 cooperates with NUFIP and P-TEFb to activate 
            transcription by RNA polymerase II
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:10855792
    review:
      summary: Generic protein binding from VCP ATPase interaction in nucleus.
      action: REMOVE
      reason: Generic annotation. VCP interaction function unclear, not core to 
        BRCA1 tumor suppressor role.
      supported_by:
        - reference_id: PMID:10855792
          supporting_text: VCP, a weak ATPase involved in multiple cellular 
            events, interacts physically with BRCA1 in the nucleus of living 
            cells
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:11301010
    review:
      summary: Generic protein binding from BACH1/BRIP1 helicase interaction 
        critical for DNA repair.
      action: REMOVE
      reason: While BACH1/BRIP1 interaction is crucial for DNA repair and forms 
        BRCA1-B complex, generic protein binding is uninformative. Function 
        captured by DNA repair annotations.
      supported_by:
        - reference_id: PMID:11301010
          supporting_text: BACH1, a novel helicase-like protein, interacts 
            directly with BRCA1 and contributes to its DNA repair function
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:14576433
    review:
      summary: Generic protein binding from BRCT domain phospho-protein binding 
        study.
      action: REMOVE
      reason: Generic annotation. BRCT domains bind phospho-proteins for DNA 
        damage signaling, better captured by specific functional annotations.
      supported_by:
        - reference_id: PMID:14576433
          supporting_text: The BRCT domain is a phospho-protein binding domain
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:11877377
    review:
      summary: Generic protein binding from SMC1 S-phase checkpoint study.
      action: REMOVE
      reason: Generic annotation. SMC1 interaction relates to S-phase 
        checkpoint, captured by cell cycle annotations.
      supported_by:
        - reference_id: PMID:11877377
          supporting_text: SMC1 is a downstream effector in the ATM/NBS1 branch 
            of the human S-phase checkpoint
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:15265711
    review:
      summary: Generic protein binding from BARD1 nuclear retention study on 
        apoptotic function.
      action: REMOVE
      reason: Generic annotation. BARD1 interaction is essential for E3 ligase 
        activity, captured by ubiquitin ligase annotations.
      supported_by:
        - reference_id: PMID:15265711
          supporting_text: BARD1 regulates BRCA1 apoptotic function by a 
            mechanism involving nuclear retention
  - term:
      id: GO:0008630
      label: intrinsic apoptotic signaling pathway in response to DNA damage
    evidence_type: IDA
    original_reference_id: PMID:14654789
    review:
      summary: BRCA1 participates in p53-mediated apoptosis through interaction 
        with IFI16, contributing to DNA damage-induced cell death.
      action: ACCEPT
      reason: This annotation correctly identifies BRCA1s role in DNA 
        damage-induced apoptosis. BRCA1 interacts with IFI16 (a Pyrin family 
        member) to promote p53-mediated apoptotic response to DNA damage. This 
        apoptotic function complements BRCA1s DNA repair role by eliminating 
        cells with irreparable damage, contributing to tumor suppression.
      supported_by:
        - reference_id: PMID:14654789
          supporting_text: A member of the Pyrin family, IFI16, is a novel 
            BRCA1-associated protein involved in the p53-mediated apoptosis 
            pathway
  - term:
      id: GO:0003677
      label: DNA binding
    evidence_type: TAS
    original_reference_id: PMID:9662397
    review:
      summary: BRCA1 has DNA binding activity confirmed by author statement, 
        though more specific terms would be preferable.
      action: MODIFY
      reason: While BRCA1 does bind DNA, this generic term is uninformative. 
        BRCA1 specifically binds to damaged DNA at double-strand breaks and DNA 
        structures during repair. The annotation should use more specific terms 
        like "damaged DNA binding" (GO:0003684) to better represent its 
        function.
      proposed_replacement_terms:
        - id: GO:0003684
          label: damaged DNA binding
      supported_by:
        - reference_id: PMID:9662397
          supporting_text: BRCA1 protein is linked to the RNA polymerase II 
            holoenzyme complex via RNA helicase A.
  - term:
      id: GO:0007095
      label: mitotic G2 DNA damage checkpoint signaling
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: BRCA1 is a critical component of G2 DNA damage checkpoint 
        signaling. It activates CHEK1 kinase upon DNA damage to prevent 
        premature entry into mitosis. This IBA annotation reflects conserved 
        checkpoint function across species.
      action: ACCEPT
      reason: This annotation correctly identifies BRCA1s essential role in G2 
        checkpoint signaling, which is a core function of the protein. BRCA1 is 
        required for CHEK1 activation and prevention of mitotic entry when DNA 
        damage is present. Loss of this function leads to genomic instability. 
        The IBA annotation captures this conserved function well.
      supported_by:
        - reference_id: PMID:11836499
          supporting_text: BRCA1 regulates the G2/M checkpoint by activating 
            Chk1 kinase upon DNA damage
  - term:
      id: GO:0000724
      label: double-strand break repair via homologous recombination
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: BRCA1 is essential for homologous recombination-mediated repair 
        of DNA double-strand breaks. This is the primary tumor suppressor 
        function of BRCA1. The IBA annotation correctly identifies this 
        conserved core function.
      action: ACCEPT
      reason: This is the most critical annotation for BRCA1. The protein 
        orchestrates HR through multiple mechanisms including DNA end resection,
        competition with 53BP1 for repair pathway choice, and facilitation of 
        RAD51 loading. Deficiency in HR repair is the primary mechanism of 
        BRCA1-associated cancer predisposition. This IBA annotation 
        appropriately captures the conserved and central function.
      supported_by:
        - reference_id: PMID:10549283
          supporting_text: We report here that Brca1-deficient mouse embryonic 
            stem cells have impaired repair of chromosomal DSBs by homologous 
            recombination
  - term:
      id: GO:0043009
      label: chordate embryonic development
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: BRCA1 knockout mice exhibit early embryonic lethality around 
        E7.5-8.5. However, this developmental requirement is likely secondary to
        genomic instability from loss of DNA repair function rather than a 
        direct developmental role.
      action: KEEP_AS_NON_CORE
      reason: While BRCA1 is indeed required for embryonic development 
        (knockouts are lethal), this is most likely a consequence of genomic 
        instability rather than a specific developmental function. The embryonic
        lethality results from accumulated DNA damage and chromosomal 
        abnormalities. The annotation is technically correct but represents a 
        secondary effect of BRCA1s core DNA repair function.
      supported_by:
        - reference_id: PMID:10549283
          supporting_text: Brca1-deficient mouse embryonic stem cells have 
            impaired repair of chromosomal DSBs by homologous recombination
  - term:
      id: GO:0061630
      label: ubiquitin protein ligase activity
    evidence_type: IEA
    original_reference_id: GO_REF:0000003
    review:
      summary: BRCA1 forms a RING-type E3 ubiquitin ligase complex with BARD1. 
        This enzymatic activity catalyzes K6-linked polyubiquitin chain 
        formation and is essential for multiple stages of homologous 
        recombination repair.
      action: ACCEPT
      reason: This IEA annotation correctly identifies BRCA1s E3 ubiquitin 
        ligase activity. The BRCA1-BARD1 heterodimer is a well-characterized 
        RING-type E3 ligase that produces unconventional K6-linked polyubiquitin
        chains. This is the only known enzymatic activity of BRCA1 and is 
        essential for its tumor suppressor function. While redundant with more 
        specific annotations, it provides complementary evidence.
      supported_by:
        - reference_id: PMID:12890688
          supporting_text: The BRCA1/BARD1 heterodimer directs polymerization of
            ubiquitin primarily through an unconventional linkage involving 
            lysine residue K6
  - term:
      id: GO:0006281
      label: DNA repair
    evidence_type: IEA
    original_reference_id: GO_REF:0000120
    review:
      summary: BRCA1 is a key DNA repair protein, particularly in homologous 
        recombination. This general DNA repair annotation is correct but could 
        be more specific.
      action: MODIFY
      reason: While BRCA1 does function in DNA repair, this general term is less
        informative than the more specific "double-strand break repair via 
        homologous recombination" (GO:0000724) which better captures BRCA1s 
        actual repair function. The generic DNA repair term obscures the 
        specific mechanism. Should use the more specific HR term.
      proposed_replacement_terms:
        - id: GO:0000724
          label: double-strand break repair via homologous recombination
  - term:
      id: GO:0006310
      label: DNA recombination
    evidence_type: IEA
    original_reference_id: GO_REF:0000043
    review:
      summary: BRCA1 participates in DNA recombination through its role in 
        homologous recombination. This general term is less specific than the 
        HR-specific annotation.
      action: ACCEPT
      reason: BRCA1 is indeed involved in DNA recombination, specifically 
        through homologous recombination. While the more specific HR annotation 
        is preferred, this general recombination term is not incorrect and 
        captures a broad aspect of BRCA1 function. The annotation is acceptable 
        as it provides a higher-level grouping of BRCA1s function.
      supported_by:
        - reference_id: PMID:10549283
          supporting_text: Brca1-deficient mouse embryonic stem cells have 
            impaired repair of chromosomal DSBs by homologous recombination
  - term:
      id: GO:0006629
      label: lipid metabolic process
    evidence_type: IEA
    original_reference_id: GO_REF:0000043
    review:
      summary: BRCA1 interacts with acetyl-CoA carboxylase and affects lipid 
        synthesis. However, this is a peripheral function not related to tumor 
        suppression.
      action: MARK_AS_OVER_ANNOTATED
      reason: While BRCA1 does interact with ACACA (acetyl-CoA carboxylase) and 
        can affect lipid metabolism, this is not a core function of the protein.
        The lipid metabolic role is tangential to BRCA1s primary tumor 
        suppressor function in DNA repair. This annotation likely represents an 
        over-annotation based on protein interaction data.
      supported_by:
        - reference_id: PMID:16326698
          supporting_text: BRCA1 affects lipid synthesis through its interaction
            with acetyl-CoA carboxylase
  - term:
      id: GO:0006631
      label: fatty acid metabolic process
    evidence_type: IEA
    original_reference_id: GO_REF:0000043
    review:
      summary: BRCA1 has been linked to fatty acid metabolism through 
        interaction with acetyl-CoA carboxylase, but this is not a core 
        function.
      action: MARK_AS_OVER_ANNOTATED
      reason: Similar to lipid metabolic process, this annotation reflects a 
        peripheral function. BRCA1s interaction with acetyl-CoA carboxylase may 
        affect fatty acid metabolism, but this is not related to its primary 
        tumor suppressor function. This represents over-annotation based on 
        interaction data rather than core biology.
      supported_by:
        - reference_id: PMID:16326698
          supporting_text: BRCA1 affects lipid synthesis through its interaction
            with acetyl-CoA carboxylase
  - term:
      id: GO:0006633
      label: fatty acid biosynthetic process
    evidence_type: IEA
    original_reference_id: GO_REF:0000043
    review:
      summary: BRCA1 negatively regulates fatty acid biosynthesis through 
        interaction with acetyl-CoA carboxylase. This is a peripheral function.
      action: MARK_AS_OVER_ANNOTATED
      reason: This is another metabolic annotation based on BRCA1-ACACA 
        interaction. While BRCA1 may negatively regulate fatty acid 
        biosynthesis, this is not a core tumor suppressor function. The 
        annotation represents over-attribution based on protein interaction 
        studies rather than central BRCA1 biology.
      supported_by:
        - reference_id: PMID:16326698
          supporting_text: BRCA1 affects lipid synthesis through its interaction
            with acetyl-CoA carboxylase
  - term:
      id: GO:0006974
      label: DNA damage response
    evidence_type: IEA
    original_reference_id: GO_REF:0000120
    review:
      summary: BRCA1 is a central hub in the DNA damage response, coordinating 
        checkpoint activation, DNA repair pathway choice, and chromatin 
        remodeling at damage sites.
      action: ACCEPT
      reason: This annotation correctly identifies BRCA1s critical role in the 
        DNA damage response. BRCA1 functions as a master coordinator of the DDR,
        being recruited to damage sites, activating checkpoints, promoting DNA 
        end resection, and facilitating repair. This is a core function of 
        BRCA1.
      supported_by:
        - reference_id: PMID:10724175
          supporting_text: hCds1-mediated phosphorylation of BRCA1 regulates the
            DNA damage response
  - term:
      id: GO:0008270
      label: zinc ion binding
    evidence_type: IEA
    original_reference_id: GO_REF:0000120
    review:
      summary: BRCA1 contains a RING domain that coordinates zinc ions. This is 
        structurally required for the domain fold and E3 ligase activity.
      action: ACCEPT
      reason: BRCA1 contains an N-terminal RING finger domain that coordinates 
        two zinc ions. This zinc binding is essential for maintaining the 
        structural integrity of the RING domain, which mediates E3 ubiquitin 
        ligase activity and BARD1 interaction. While a structural annotation, it
        correctly describes BRCA1 biochemistry.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: BRCA1 forms a heterodimeric RING-type E3 ubiquitin 
            ligase complex with BARD1 through their N-terminal RING domains
  - term:
      id: GO:0016740
      label: transferase activity
    evidence_type: IEA
    original_reference_id: GO_REF:0000043
    review:
      summary: BRCA1 has E3 ubiquitin ligase (transferase) activity. This 
        general term is correct but less specific than the ubiquitin ligase 
        annotation.
      action: ACCEPT
      reason: BRCA1 does have transferase activity specifically as an E3 
        ubiquitin ligase. While this parent term is less informative than the 
        more specific ubiquitin ligase annotation, it is not incorrect and 
        provides a valid higher-level classification of BRCA1 enzymatic 
        function.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: BRCA1 forms a heterodimeric RING-type E3 ubiquitin 
            ligase complex with BARD1 through their N-terminal RING domains
  - term:
      id: GO:0046872
      label: metal ion binding
    evidence_type: IEA
    original_reference_id: GO_REF:0000120
    review:
      summary: BRCA1 binds zinc ions through its RING finger domain. This is a 
        parent term of zinc ion binding.
      action: ACCEPT
      reason: BRCA1 binds metal ions (specifically zinc) through its RING finger
        domain. This general term is correct but less specific than the zinc ion
        binding annotation. It provides valid higher-level classification.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: BRCA1 forms a heterodimeric RING-type E3 ubiquitin 
            ligase complex with BARD1 through their N-terminal RING domains
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:22792074
    review:
      summary: Generic protein binding annotation from proteomics study.
      action: REMOVE
      reason: Generic protein binding term provides no functional information 
        about BRCA1. Specific molecular interactions are better captured through
        more informative functional annotations.
      supported_by:
        - reference_id: PMID:22792074
          supporting_text: 2012 Jul 5. FANCJ/BACH1 acetylation at lysine 1249 
            regulates the DNA damage response.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:22884692
    review:
      summary: Generic protein binding annotation.
      action: REMOVE
      reason: Generic protein binding term is uninformative. Function should be 
        captured by more specific molecular function or process annotations.
      supported_by:
        - reference_id: PMID:22884692
          supporting_text: Aug 9. TRIP12 and UBR5 suppress spreading of 
            chromatin ubiquitylation at damaged chromosomes.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:23624935
    review:
      summary: Generic protein binding annotation.
      action: REMOVE
      reason: Generic protein binding term is uninformative and should be 
        replaced with more specific functional annotations.
      supported_by:
        - reference_id: PMID:23624935
          supporting_text: BRCA1 is a negative modulator of the PRC2 complex.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:23680151
    review:
      summary: Generic protein binding annotation.
      action: REMOVE
      reason: Generic protein binding term is uninformative.
      supported_by:
        - reference_id: PMID:23680151
          supporting_text: Function of BRCA1 in the DNA damage response is 
            mediated by ADP-ribosylation.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:24981860
    review:
      summary: Generic protein binding annotation.
      action: REMOVE
      reason: Generic protein binding term is uninformative.
      supported_by:
        - reference_id: PMID:24981860
          supporting_text: 2014 Jun 26. Human-chromatin-related protein 
            interactions identify a demethylase complex required for chromosome 
            segregation.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:28319063
    review:
      summary: Generic protein binding annotation.
      action: REMOVE
      reason: Generic protein binding term is uninformative.
      supported_by:
        - reference_id: PMID:28319063
          supporting_text: Mar 20. Compromised BRCA1-PALB2 interaction is 
            associated with breast cancer risk.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:29656893
    review:
      summary: Generic protein binding annotation.
      action: REMOVE
      reason: Generic protein binding term is uninformative.
      supported_by:
        - reference_id: PMID:29656893
          supporting_text: 2018 Apr 12. DNA Repair Network Analysis Reveals 
            Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:31527615
    review:
      summary: Generic protein binding annotation.
      action: REMOVE
      reason: Generic protein binding term is uninformative.
      supported_by:
        - reference_id: PMID:31527615
          supporting_text: The RNA-mediated estrogen receptor α interactome of 
            hormone-dependent human breast cancer cell nuclei.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:33961781
    review:
      summary: Generic protein binding annotation.
      action: REMOVE
      reason: Generic protein binding term is uninformative.
      supported_by:
        - reference_id: PMID:33961781
          supporting_text: 2021 May 6. Dual proteome-scale networks reveal 
            cell-specific remodeling of the human interactome.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:34552057
    review:
      summary: Generic protein binding annotation.
      action: REMOVE
      reason: Generic protein binding term is uninformative.
      supported_by:
        - reference_id: PMID:34552057
          supporting_text: ZGRF1 promotes end resection of DNA homologous 
            recombination via forming complex with BRCA1/EXO1.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:34591612
    review:
      summary: Generic protein binding annotation.
      action: REMOVE
      reason: Generic protein binding term is uninformative.
      supported_by:
        - reference_id: PMID:34591612
          supporting_text: Oct 1. A protein interaction landscape of breast 
            cancer.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:8944023
    review:
      summary: Generic protein binding from BAP1 interaction study.
      action: REMOVE
      reason: Generic protein binding term is uninformative. BAP1 interaction 
        regulates E3 ligase activity, which is captured by ubiquitin ligase 
        annotations.
      supported_by:
        - reference_id: PMID:8944023
          supporting_text: Identification of a RING protein that can interact in
            vivo with the BRCA1 gene product.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:9497340
    review:
      summary: Generic protein binding annotation.
      action: REMOVE
      reason: Generic protein binding term is uninformative.
      supported_by:
        - reference_id: PMID:9497340
          supporting_text: Identification of a novel cytoplasmic protein that 
            specifically binds to nuclear localization signal motifs.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:9528852
    review:
      summary: Generic protein binding from BAP1 interaction study.
      action: REMOVE
      reason: Generic protein binding term is uninformative. BAP1 interaction is
        captured by E3 ligase annotations.
      supported_by:
        - reference_id: PMID:9528852
          supporting_text: 'BAP1: a novel ubiquitin hydrolase which binds to the BRCA1
            RING finger and enhances BRCA1-mediated cell growth suppression.'
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:9811458
    review:
      summary: Generic protein binding from CtIP (RBBP8) interaction study.
      action: REMOVE
      reason: Generic protein binding term is uninformative. CtIP interaction is
        important for DNA end resection and is captured by DNA repair 
        annotations.
      supported_by:
        - reference_id: PMID:9811458
          supporting_text: Characterization of a carboxy-terminal BRCA1 
            interacting protein.
  - term:
      id: GO:0042802
      label: identical protein binding
    evidence_type: IPI
    original_reference_id: PMID:29656893
    review:
      summary: BRCA1 self-association or homodimerization annotation.
      action: REMOVE
      reason: This is a variant of protein binding that is not well-supported as
        a functional annotation for BRCA1. The primary BRCA1 interaction is 
        heterodimerization with BARD1, not homodimerization.
      supported_by:
        - reference_id: PMID:29656893
          supporting_text: 2018 Apr 12. DNA Repair Network Analysis Reveals 
            Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.
  - term:
      id: GO:0042802
      label: identical protein binding
    evidence_type: IPI
    original_reference_id: PMID:34591612
    review:
      summary: BRCA1 self-association annotation.
      action: REMOVE
      reason: Not a well-established functional annotation. BRCA1 primarily 
        functions as a heterodimer with BARD1.
      supported_by:
        - reference_id: PMID:34591612
          supporting_text: Oct 1. A protein interaction landscape of breast 
            cancer.
  - term:
      id: GO:0042802
      label: identical protein binding
    evidence_type: IPI
    original_reference_id: PMID:8944023
    review:
      summary: BRCA1 self-association annotation from BAP1 study.
      action: REMOVE
      reason: Not a core functional annotation. BRCA1 primarily forms 
        heterodimers with BARD1 rather than homodimers.
      supported_by:
        - reference_id: PMID:8944023
          supporting_text: Identification of a RING protein that can interact in
            vivo with the BRCA1 gene product.
  - term:
      id: GO:0006974
      label: DNA damage response
    evidence_type: TAS
    original_reference_id: PMID:10910365
    review:
      summary: BRCA1 is a central component of the DNA damage response, 
        coordinating repair and checkpoint functions.
      action: ACCEPT
      reason: This annotation correctly identifies BRCA1s critical role in the 
        DNA damage response. BRCA1 is phosphorylated by ATM/ATR kinases and 
        coordinates checkpoint activation, DNA repair pathway choice, and 
        chromatin remodeling. This is a core function.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: BRCA1 serves as a central hub for maintaining genomic
            stability through its essential roles in DNA damage response, 
            homologous recombination repair, and cell cycle checkpoint control
        - reference_id: PMID:10910365
          supporting_text: Functional link of BRCA1 and ataxia telangiectasia 
            gene product in DNA damage response.
  - term:
      id: GO:0006281
      label: DNA repair
    evidence_type: NAS
    original_reference_id: PMID:22369660
    review:
      summary: BRCA1 is a key DNA repair protein. This general term is correct 
        but less specific than the HR-specific annotation.
      action: MODIFY
      reason: While BRCA1 is a DNA repair protein, the more specific term 
        "double-strand break repair via homologous recombination" (GO:0000724) 
        is preferred as it captures BRCA1s actual repair mechanism.
      proposed_replacement_terms:
        - id: GO:0000724
          label: double-strand break repair via homologous recombination
      supported_by:
        - reference_id: PMID:22369660
          supporting_text: 'BRCA1 tumor suppressor network: focusing on its tail.'
  - term:
      id: GO:0006282
      label: regulation of DNA repair
    evidence_type: NAS
    original_reference_id: PMID:20656689
    review:
      summary: BRCA1 regulates DNA repair pathway choice between homologous 
        recombination and non-homologous end joining.
      action: ACCEPT
      reason: BRCA1 does regulate DNA repair by promoting homologous 
        recombination over NHEJ through competition with 53BP1 and DNA end 
        resection. This regulatory function is distinct from and complementary 
        to its direct role in HR.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: BRCA1 competes with the antagonistic protein 53BP1 to
            determine whether end resection occurs
        - reference_id: PMID:20656689
          supporting_text: 2010 Jul 22. Differential regulation of JAMM domain 
            deubiquitinating enzyme activity within the RAP80 complex.
  - term:
      id: GO:0035825
      label: homologous recombination
    evidence_type: NAS
    original_reference_id: PMID:22369660
    review:
      summary: BRCA1 is essential for homologous recombination. This is a core 
        function.
      action: ACCEPT
      reason: Homologous recombination is the primary mechanism by which BRCA1 
        maintains genomic stability and suppresses tumorigenesis. This 
        annotation is correct and represents a core function.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: BRCA1 functions as a master regulator of homologous 
            recombination (HR) through multiple mechanisms
        - reference_id: PMID:22369660
          supporting_text: 'BRCA1 tumor suppressor network: focusing on its tail.'
  - term:
      id: GO:0035825
      label: homologous recombination
    evidence_type: NAS
    original_reference_id: PMID:30657944
    review:
      summary: BRCA1 is essential for homologous recombination. Duplicate 
        annotation from different source.
      action: ACCEPT
      reason: Correct annotation for a core BRCA1 function. Homologous 
        recombination is the primary mechanism of BRCA1 tumor suppression.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: BRCA1 functions as a master regulator of homologous 
            recombination (HR) through multiple mechanisms
        - reference_id: PMID:30657944
          supporting_text: CtIP-BRCA1 complex and MRE11 maintain replication 
            forks in the presence of chain terminating nucleoside analogs.
  - term:
      id: GO:0044818
      label: mitotic G2/M transition checkpoint
    evidence_type: NAS
    original_reference_id: PMID:22369660
    review:
      summary: BRCA1 is essential for G2/M checkpoint control, activating CHEK1 
        upon DNA damage.
      action: ACCEPT
      reason: This annotation correctly identifies BRCA1s critical role in G2/M 
        checkpoint control. BRCA1 activates CHEK1 to prevent premature mitotic 
        entry when DNA damage is present. This is a core function.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: BRCA1 is involved in all phases of the cell cycle and
            regulates orderly progression
        - reference_id: PMID:22369660
          supporting_text: 'BRCA1 tumor suppressor network: focusing on its tail.'
  - term:
      id: GO:0006302
      label: double-strand break repair
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-5693606
    review:
      summary: BRCA1 is essential for DNA double-strand break repair via 
        homologous recombination.
      action: ACCEPT
      reason: This annotation correctly identifies BRCA1s role in DSB repair. 
        While the more specific HR term is preferred, DSB repair is accurate and
        represents a core function.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: BRCA1 serves as a central hub for maintaining genomic
            stability through its essential roles in DNA damage response, 
            homologous recombination repair
  - term:
      id: GO:0006302
      label: double-strand break repair
    evidence_type: IEA
    original_reference_id: GO_REF:0000107
    review:
      summary: BRCA1 is essential for DSB repair. Duplicate annotation from 
        ortholog transfer.
      action: ACCEPT
      reason: Correct annotation for a core BRCA1 function. DSB repair is 
        central to BRCA1 tumor suppression.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: BRCA1 serves as a central hub for maintaining genomic
            stability through its essential roles in DNA damage response, 
            homologous recombination repair
  - term:
      id: GO:0000724
      label: double-strand break repair via homologous recombination
    evidence_type: IDA
    original_reference_id: PMID:28398198
    review:
      summary: Direct experimental evidence for BRCA1 role in homologous 
        recombination repair. This is the most specific and accurate annotation 
        for BRCA1s primary tumor suppressor function.
      action: ACCEPT
      reason: This IDA annotation with direct experimental evidence correctly 
        identifies BRCA1s essential role in HR. This is the core tumor 
        suppressor function.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: BRCA1 functions as a master regulator of homologous 
            recombination (HR) through multiple mechanisms
        - reference_id: PMID:28398198
          supporting_text: Functional and mutational landscapes of BRCA1 for 
            homology-directed repair and therapy resistance.
  - term:
      id: GO:0006974
      label: DNA damage response
    evidence_type: NAS
    original_reference_id: PMID:16651405
    review:
      summary: BRCA1 is central to the DNA damage response. Duplicate 
        annotation.
      action: ACCEPT
      reason: Core function of BRCA1. DNA damage response is essential for tumor
        suppression.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: BRCA1 serves as a central hub for maintaining genomic
            stability through its essential roles in DNA damage response
        - reference_id: PMID:16651405
          supporting_text: DNA damage-induced BARD1 phosphorylation is critical 
            for the inhibition of messenger RNA processing by BRCA1/BARD1 
            complex.
  - term:
      id: GO:0045786
      label: negative regulation of cell cycle
    evidence_type: NAS
    original_reference_id: PMID:15159397
    review:
      summary: BRCA1 negatively regulates cell cycle by enforcing checkpoints 
        upon DNA damage.
      action: ACCEPT
      reason: BRCA1 enforces cell cycle checkpoints (S-phase and G2/M) upon DNA 
        damage, preventing progression of cells with damaged DNA. This 
        checkpoint function is a core tumor suppressor mechanism.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: BRCA1 is involved in all phases of the cell cycle and
            regulates orderly progression
        - reference_id: PMID:15159397
          supporting_text: 2004 May 24. BRCA1-BARD1 complexes are required for 
            p53Ser-15 phosphorylation and a G1/S arrest following ionizing 
            radiation-induced DNA damage.
  - term:
      id: GO:0006338
      label: chromatin remodeling
    evidence_type: TAS
    original_reference_id: PMID:35351360
    review:
      summary: BRCA1 promotes chromatin remodeling at DNA damage sites through 
        its E3 ligase activity and interaction with remodeling complexes.
      action: ACCEPT
      reason: BRCA1 plays an important role in chromatin remodeling at DNA 
        damage sites. Its E3 ligase activity promotes chromatin remodeling 
        through SMARCAD1 and other factors. This is part of the DNA damage 
        response pathway.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: E3 ligase activity promotes chromatin remodeling and 
            53BP1 positioning through the remodeler SMARCAD1
        - reference_id: PMID:35351360
          supporting_text: Epub 2022 Mar 26. BRCA1/BARD1 is a nucleosome reader 
            and writer.
  - term:
      id: GO:0061649
      label: ubiquitin-modified histone reader activity
    evidence_type: TAS
    original_reference_id: PMID:35351360
    review:
      summary: BRCA1 recognizes ubiquitinated histones at DNA damage sites as 
        part of its recruitment mechanism.
      action: ACCEPT
      reason: BRCA1-BARD1 complex recognizes ubiquitinated histones, which is 
        important for its recruitment to DNA damage sites and subsequent DNA 
        repair. This activity links its E3 ligase function to chromatin 
        recognition.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: Required for maintaining gene silencing in 
            constitutive heterochromatin via histone H2A ubiquitination
        - reference_id: PMID:35351360
          supporting_text: Epub 2022 Mar 26. BRCA1/BARD1 is a nucleosome reader 
            and writer.
  - term:
      id: GO:0140863
      label: histone H2AK127 ubiquitin ligase activity
    evidence_type: TAS
    original_reference_id: PMID:35351360
    review:
      summary: BRCA1-BARD1 complex ubiquitinates histone H2A at K127, a specific
        substrate of its E3 ligase activity.
      action: ACCEPT
      reason: This specific annotation captures a defined substrate of 
        BRCA1-BARD1 E3 ligase activity. H2A ubiquitination is important for DNA 
        repair and chromatin dynamics at damage sites.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: Involved in histone modifications through 
            ubiquitination
        - reference_id: PMID:35351360
          supporting_text: Epub 2022 Mar 26. BRCA1/BARD1 is a nucleosome reader 
            and writer.
  - term:
      id: GO:0140864
      label: histone H2AK129 ubiquitin ligase activity
    evidence_type: TAS
    original_reference_id: PMID:35351360
    review:
      summary: BRCA1-BARD1 complex ubiquitinates histone H2A at K129, a specific
        substrate of its E3 ligase activity.
      action: ACCEPT
      reason: This specific annotation captures a defined substrate of 
        BRCA1-BARD1 E3 ligase activity. H2A ubiquitination at K129 is another 
        site targeted by the BRCA1-BARD1 complex.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: Involved in histone modifications through 
            ubiquitination
        - reference_id: PMID:35351360
          supporting_text: Epub 2022 Mar 26. BRCA1/BARD1 is a nucleosome reader 
            and writer.
  - term:
      id: GO:0016567
      label: protein ubiquitination
    evidence_type: IEA
    original_reference_id: GO_REF:0000041
    review:
      summary: BRCA1 catalyzes protein ubiquitination as an E3 ubiquitin ligase 
        in complex with BARD1.
      action: ACCEPT
      reason: This annotation correctly identifies BRCA1s role in protein 
        ubiquitination. As an E3 ubiquitin ligase, BRCA1-BARD1 catalyzes 
        ubiquitination of multiple substrates including histones and itself.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: BRCA1 forms a heterodimeric RING-type E3 ubiquitin 
            ligase complex with BARD1
  - term:
      id: GO:0030308
      label: negative regulation of cell growth
    evidence_type: IMP
    original_reference_id: PMID:10518542
    review:
      summary: BRCA1 negatively regulates cell growth through RB-dependent 
        mechanisms.
      action: KEEP_AS_NON_CORE
      reason: While BRCA1 does contribute to negative regulation of cell growth,
        this is likely a secondary effect of its checkpoint and DNA repair 
        functions rather than a primary function. The growth suppression is 
        RB-dependent and relates to cell cycle control.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: BRCA1 is involved in all phases of the cell cycle and
            regulates orderly progression
        - reference_id: PMID:10518542
          supporting_text: BRCA1-associated growth arrest is RB-dependent.
  - term:
      id: GO:0045893
      label: positive regulation of DNA-templated transcription
    evidence_type: IMP
    original_reference_id: PMID:12080089
    review:
      summary: BRCA1 has transcriptional coactivator function through its 
        C-terminal transactivation domain.
      action: KEEP_AS_NON_CORE
      reason: BRCA1 does function as a transcriptional coactivator through 
        interaction with RNA pol II and its C-terminal domain. However, this 
        transcriptional function is peripheral to its core tumor suppressor role
        in DNA repair.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: The C-terminal region can transactivate heterologous 
            promoters
        - reference_id: PMID:12080089
          supporting_text: JunB potentiates function of BRCA1 activation domain 
            1 (AD1) through a coiled-coil-mediated interaction.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:26833090
    review:
      summary: Generic protein binding annotation.
      action: REMOVE
      reason: Generic protein binding term is uninformative.
      supported_by:
        - reference_id: PMID:26833090
          supporting_text: 2016 Jan 28. Non-catalytic Roles for XPG with BRCA1 
            and BRCA2 in Homologous Recombination and Genome Stability.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:29899443
    review:
      summary: Generic protein binding annotation.
      action: REMOVE
      reason: Generic protein binding term is uninformative.
      supported_by:
        - reference_id: PMID:29899443
          supporting_text: Jun 13. Structural basis for regulation of human 
            acetyl-CoA carboxylase.
  - term:
      id: GO:0007095
      label: mitotic G2 DNA damage checkpoint signaling
    evidence_type: IMP
    original_reference_id: PMID:17525340
    review:
      summary: BRCA1 is essential for G2 DNA damage checkpoint signaling, 
        demonstrated through BRCA1-A complex (Abraxas-RAP80) studies.
      action: ACCEPT
      reason: Core function of BRCA1. G2 checkpoint control is essential for 
        tumor suppression by preventing mitotic entry with damaged DNA.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: Essential for G2/M checkpoint control; deficiency 
            leads to premature mitotic entry despite DNA damage
        - reference_id: PMID:17525340
          supporting_text: Abraxas and RAP80 form a BRCA1 protein complex 
            required for the DNA damage response.
  - term:
      id: GO:0007095
      label: mitotic G2 DNA damage checkpoint signaling
    evidence_type: IMP
    original_reference_id: PMID:17643121
    review:
      summary: BRCA1 is essential for G2 checkpoint signaling. Duplicate 
        annotation from CCDC98/Abraxas study.
      action: ACCEPT
      reason: Core function of BRCA1. CCDC98 targets BRCA1 to DNA damage sites 
        for checkpoint signaling.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: Essential for G2/M checkpoint control; deficiency 
            leads to premature mitotic entry despite DNA damage
        - reference_id: PMID:17643121
          supporting_text: Jul 22. CCDC98 targets BRCA1 to DNA damage sites.
  - term:
      id: GO:0007095
      label: mitotic G2 DNA damage checkpoint signaling
    evidence_type: IMP
    original_reference_id: PMID:19261748
    review:
      summary: BRCA1 is essential for G2 checkpoint signaling. Duplicate 
        annotation from MERIT40 study.
      action: ACCEPT
      reason: Core function of BRCA1. MERIT40 facilitates BRCA1 localization for
        checkpoint function.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: Essential for G2/M checkpoint control; deficiency 
            leads to premature mitotic entry despite DNA damage
        - reference_id: PMID:19261748
          supporting_text: MERIT40 facilitates BRCA1 localization and DNA damage
            repair.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:9662397
    review:
      summary: Generic protein binding from RNA helicase A (DHX9) interaction 
        study.
      action: REMOVE
      reason: Generic protein binding term is uninformative. RNA pol II 
        interaction is captured by transcription annotations.
      supported_by:
        - reference_id: PMID:9662397
          supporting_text: BRCA1 protein is linked to the RNA polymerase II 
            holoenzyme complex via RNA helicase A.
  - term:
      id: GO:0006357
      label: regulation of transcription by RNA polymerase II
    evidence_type: IMP
    original_reference_id: PMID:9662397
    review:
      summary: BRCA1 regulates RNA pol II transcription through interaction with
        the holoenzyme complex via RNA helicase A.
      action: KEEP_AS_NON_CORE
      reason: While BRCA1 does regulate transcription through RNA pol II 
        interaction, this is a peripheral function. Transcriptional regulation 
        is secondary to BRCA1s primary tumor suppressor role in DNA repair.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: The C-terminal region can transactivate heterologous 
            promoters
        - reference_id: PMID:9662397
          supporting_text: BRCA1 protein is linked to the RNA polymerase II 
            holoenzyme complex via RNA helicase A.
  - term:
      id: GO:0070063
      label: RNA polymerase binding
    evidence_type: IDA
    original_reference_id: PMID:9662397
    review:
      summary: BRCA1 binds RNA polymerase II holoenzyme through RNA helicase A.
      action: KEEP_AS_NON_CORE
      reason: This is a more specific annotation than generic protein binding, 
        correctly identifying BRCA1s interaction with RNA pol II. However, this 
        transcriptional function is peripheral to its core DNA repair role.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: The C-terminal region can transactivate heterologous 
            promoters
        - reference_id: PMID:9662397
          supporting_text: BRCA1 protein is linked to the RNA polymerase II 
            holoenzyme complex via RNA helicase A.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:26807646
    review:
      summary: Generic protein binding annotation.
      action: REMOVE
      reason: Generic protein binding term is uninformative.
      supported_by:
        - reference_id: PMID:26807646
          supporting_text: EXD2 promotes homologous recombination by 
            facilitating DNA end resection.
  - term:
      id: GO:0045893
      label: positive regulation of DNA-templated transcription
    evidence_type: IDA
    original_reference_id: PMID:20160719
    review:
      summary: BRCA1 positively regulates transcription, identified through DBC1
        transcriptional repressor study.
      action: KEEP_AS_NON_CORE
      reason: BRCA1 does function as a transcriptional activator. However, 
        transcriptional regulation is peripheral to its core tumor suppressor 
        role in DNA repair.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: The C-terminal region can transactivate heterologous 
            promoters
        - reference_id: PMID:20160719
          supporting_text: Feb 16. Identification of DBC1 as a transcriptional 
            repressor for BRCA1.
  - term:
      id: GO:0010575
      label: positive regulation of vascular endothelial growth factor 
        production
    evidence_type: IMP
    original_reference_id: PMID:23415688
    review:
      summary: BRCA1 positively regulates VEGF production.
      action: MARK_AS_OVER_ANNOTATED
      reason: VEGF regulation is not a core function of BRCA1. This annotation 
        likely reflects a downstream or indirect effect of BRCA1 activity rather
        than a primary function. The connection to angiogenesis is tangential to
        BRCA1s tumor suppressor role in DNA repair.
      supported_by:
        - reference_id: PMID:23415688
          supporting_text: BRCA1 is a novel target to improve endothelial 
            dysfunction and retard atherosclerosis.
  - term:
      id: GO:0010628
      label: positive regulation of gene expression
    evidence_type: IMP
    original_reference_id: PMID:23415688
    review:
      summary: BRCA1 positively regulates gene expression.
      action: KEEP_AS_NON_CORE
      reason: BRCA1 does have transcriptional coactivator function and can 
        positively regulate gene expression. However, this general 
        transcriptional function is peripheral to its core DNA repair role.
      supported_by:
        - reference_id: PMID:23415688
          supporting_text: BRCA1 is a novel target to improve endothelial 
            dysfunction and retard atherosclerosis.
  - term:
      id: GO:0045766
      label: positive regulation of angiogenesis
    evidence_type: IMP
    original_reference_id: PMID:23415688
    review:
      summary: BRCA1 positively regulates angiogenesis.
      action: MARK_AS_OVER_ANNOTATED
      reason: Angiogenesis regulation is not a core function of BRCA1. This 
        annotation likely reflects an indirect or context-specific effect. The 
        primary function of BRCA1 is DNA repair, not vascular biology.
      supported_by:
        - reference_id: PMID:23415688
          supporting_text: BRCA1 is a novel target to improve endothelial 
            dysfunction and retard atherosclerosis.
  - term:
      id: GO:0033147
      label: negative regulation of intracellular estrogen receptor signaling 
        pathway
    evidence_type: IMP
    original_reference_id: PMID:17505062
    review:
      summary: BRCA1 negatively regulates estrogen receptor signaling.
      action: KEEP_AS_NON_CORE
      reason: While BRCA1 does interact with estrogen receptor and may modulate 
        its signaling, this is a tissue-specific peripheral function. It may 
        contribute to breast cancer biology but is not the primary tumor 
        suppressor mechanism.
      supported_by:
        - reference_id: PMID:17505062
          supporting_text: May 15. Growth factor signaling pathways modulate 
            BRCA1 repression of estrogen receptor-alpha activity.
  - term:
      id: GO:0006302
      label: double-strand break repair
    evidence_type: IDA
    original_reference_id: PMID:22186889
    review:
      summary: Direct experimental evidence for BRCA1 role in DSB repair.
      action: ACCEPT
      reason: Core function of BRCA1. DSB repair is central to its tumor 
        suppressor role.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: BRCA1 serves as a central hub for maintaining genomic
            stability through its essential roles in DNA damage response, 
            homologous recombination repair
        - reference_id: PMID:22186889
          supporting_text: BRCA1 is an essential regulator of heart function and
            survival following myocardial infarction.
  - term:
      id: GO:0031625
      label: ubiquitin protein ligase binding
    evidence_type: IPI
    original_reference_id: PMID:17873885
    review:
      summary: BRCA1 binds E2 ubiquitin-conjugating enzymes for its E3 ligase 
        activity.
      action: ACCEPT
      reason: BRCA1 interacts with E2 enzymes to catalyze ubiquitination. This 
        annotation correctly captures the E2-E3 interaction essential for BRCA1 
        ubiquitin ligase function.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: BRCA1 forms a heterodimeric RING-type E3 ubiquitin 
            ligase complex with BARD1
        - reference_id: PMID:17873885
          supporting_text: Sep 16. E2-BRCA1 RING interactions dictate synthesis 
            of mono- or specific polyubiquitin chain linkages.
  - term:
      id: GO:0006302
      label: double-strand break repair
    evidence_type: IMP
    original_reference_id: PMID:17525340
    review:
      summary: BRCA1 is essential for DSB repair. IMP annotation from BRCA1-A 
        complex study.
      action: ACCEPT
      reason: Core function of BRCA1.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: BRCA1 serves as a central hub for maintaining genomic
            stability through its essential roles in DNA damage response, 
            homologous recombination repair
        - reference_id: PMID:17525340
          supporting_text: Abraxas and RAP80 form a BRCA1 protein complex 
            required for the DNA damage response.
  - term:
      id: GO:0006302
      label: double-strand break repair
    evidence_type: IMP
    original_reference_id: PMID:17643121
    review:
      summary: BRCA1 is essential for DSB repair. IMP annotation from CCDC98 
        study.
      action: ACCEPT
      reason: Core function of BRCA1.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: BRCA1 serves as a central hub for maintaining genomic
            stability through its essential roles in DNA damage response, 
            homologous recombination repair
        - reference_id: PMID:17643121
          supporting_text: Jul 22. CCDC98 targets BRCA1 to DNA damage sites.
  - term:
      id: GO:0006302
      label: double-strand break repair
    evidence_type: IMP
    original_reference_id: PMID:19261748
    review:
      summary: BRCA1 is essential for DSB repair. IMP annotation from MERIT40 
        study.
      action: ACCEPT
      reason: Core function of BRCA1.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: BRCA1 serves as a central hub for maintaining genomic
            stability through its essential roles in DNA damage response, 
            homologous recombination repair
        - reference_id: PMID:19261748
          supporting_text: MERIT40 facilitates BRCA1 localization and DNA damage
            repair.
  - term:
      id: GO:0010212
      label: response to ionizing radiation
    evidence_type: IMP
    original_reference_id: PMID:17525340
    review:
      summary: BRCA1 responds to ionizing radiation-induced DNA damage.
      action: ACCEPT
      reason: BRCA1 is recruited to DNA damage sites induced by ionizing 
        radiation to mediate repair. This is consistent with its core DDR 
        function.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: BRCA1 serves as a central hub for maintaining genomic
            stability through its essential roles in DNA damage response
        - reference_id: PMID:17525340
          supporting_text: Abraxas and RAP80 form a BRCA1 protein complex 
            required for the DNA damage response.
  - term:
      id: GO:0010212
      label: response to ionizing radiation
    evidence_type: IMP
    original_reference_id: PMID:17643121
    review:
      summary: BRCA1 responds to ionizing radiation. Duplicate annotation.
      action: ACCEPT
      reason: Core DDR function.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: BRCA1 serves as a central hub for maintaining genomic
            stability through its essential roles in DNA damage response
        - reference_id: PMID:17643121
          supporting_text: Jul 22. CCDC98 targets BRCA1 to DNA damage sites.
  - term:
      id: GO:0010212
      label: response to ionizing radiation
    evidence_type: IMP
    original_reference_id: PMID:19261748
    review:
      summary: BRCA1 responds to ionizing radiation. Duplicate annotation.
      action: ACCEPT
      reason: Core DDR function.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: BRCA1 serves as a central hub for maintaining genomic
            stability through its essential roles in DNA damage response
        - reference_id: PMID:19261748
          supporting_text: MERIT40 facilitates BRCA1 localization and DNA damage
            repair.
  - term:
      id: GO:0045739
      label: positive regulation of DNA repair
    evidence_type: IMP
    original_reference_id: PMID:17525340
    review:
      summary: BRCA1 positively regulates DNA repair through its role in HR.
      action: ACCEPT
      reason: BRCA1 promotes HR repair through multiple mechanisms. Core 
        function.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: BRCA1 functions as a master regulator of homologous 
            recombination (HR) through multiple mechanisms
        - reference_id: PMID:17525340
          supporting_text: Abraxas and RAP80 form a BRCA1 protein complex 
            required for the DNA damage response.
  - term:
      id: GO:0045739
      label: positive regulation of DNA repair
    evidence_type: IMP
    original_reference_id: PMID:19261748
    review:
      summary: BRCA1 positively regulates DNA repair. Duplicate annotation.
      action: ACCEPT
      reason: Core function.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: BRCA1 functions as a master regulator of homologous 
            recombination (HR) through multiple mechanisms
        - reference_id: PMID:19261748
          supporting_text: MERIT40 facilitates BRCA1 localization and DNA damage
            repair.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:9774970
    review:
      summary: Generic protein binding annotation from meiotic chromosome study.
      action: REMOVE
      reason: Generic protein binding is uninformative.
      supported_by:
        - reference_id: PMID:9774970
          supporting_text: Stable interaction between the products of the BRCA1 
            and BRCA2 tumor suppressor genes in mitotic and meiotic cells.
  - term:
      id: GO:0000724
      label: double-strand break repair via homologous recombination
    evidence_type: IDA
    original_reference_id: PMID:17349954
    review:
      summary: Direct experimental evidence for BRCA1 role in HR through Ubc13 
        study.
      action: ACCEPT
      reason: Core tumor suppressor function.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: BRCA1 functions as a master regulator of homologous 
            recombination (HR) through multiple mechanisms
        - reference_id: PMID:17349954
          supporting_text: A critical role for the ubiquitin-conjugating enzyme 
            Ubc13 in initiating homologous recombination.
  - term:
      id: GO:0006301
      label: DNA damage tolerance
    evidence_type: IDA
    original_reference_id: PMID:17349954
    review:
      summary: BRCA1 involved in DNA damage tolerance through Ubc13-dependent 
        ubiquitination.
      action: ACCEPT
      reason: BRCA1 contributes to DNA damage tolerance through its ubiquitin 
        ligase activity and role in promoting DNA repair.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: BRCA1 serves as a central hub for maintaining genomic
            stability through its essential roles in DNA damage response
        - reference_id: PMID:17349954
          supporting_text: A critical role for the ubiquitin-conjugating enzyme 
            Ubc13 in initiating homologous recombination.
  - term:
      id: GO:0016567
      label: protein ubiquitination
    evidence_type: IDA
    original_reference_id: PMID:17349954
    review:
      summary: BRCA1 catalyzes ubiquitination through Ubc13.
      action: ACCEPT
      reason: Core E3 ligase function.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: BRCA1 forms a heterodimeric RING-type E3 ubiquitin 
            ligase complex with BARD1
        - reference_id: PMID:17349954
          supporting_text: A critical role for the ubiquitin-conjugating enzyme 
            Ubc13 in initiating homologous recombination.
  - term:
      id: GO:0045717
      label: negative regulation of fatty acid biosynthetic process
    evidence_type: IMP
    original_reference_id: PMID:16326698
    review:
      summary: BRCA1 negatively regulates fatty acid biosynthesis through ACACA 
        interaction.
      action: MARK_AS_OVER_ANNOTATED
      reason: This metabolic function is peripheral to BRCA1s core DNA repair 
        role. Not a primary tumor suppressor function.
      supported_by:
        - reference_id: PMID:16326698
          supporting_text: 2005 Dec 2. BRCA1 affects lipid synthesis through its
            interaction with acetyl-CoA carboxylase.
  - term:
      id: GO:0007059
      label: chromosome segregation
    evidence_type: IMP
    original_reference_id: PMID:15965487
    review:
      summary: BRCA1 participates in chromosome segregation through DNA 
        decatenation function.
      action: KEEP_AS_NON_CORE
      reason: BRCA1 participates in DNA decatenation which affects chromosome 
        segregation. This is a secondary function related to genomic stability 
        but not the primary tumor suppressor mechanism.
      supported_by:
        - reference_id: PMID:15965487
          supporting_text: Jun 19. BRCA1 participates in DNA decatenation.
  - term:
      id: GO:0019899
      label: enzyme binding
    evidence_type: IPI
    original_reference_id: PMID:15965487
    review:
      summary: BRCA1 binds topoisomerase II for DNA decatenation.
      action: KEEP_AS_NON_CORE
      reason: More informative than generic protein binding. Topoisomerase II 
        interaction contributes to decatenation function.
      supported_by:
        - reference_id: PMID:15965487
          supporting_text: Jun 19. BRCA1 participates in DNA decatenation.
  - term:
      id: GO:0045892
      label: negative regulation of DNA-templated transcription
    evidence_type: IDA
    original_reference_id: PMID:16288014
    review:
      summary: BRCA1 negatively regulates transcription through ZBRK1 
        interaction.
      action: KEEP_AS_NON_CORE
      reason: BRCA1 does have transcriptional repressor function, but this is 
        peripheral to its core DNA repair role.
      supported_by:
        - reference_id: PMID:16288014
          supporting_text: BRCA1 and c-Myc associate to transcriptionally 
            repress psoriasin, a DNA damage-inducible gene.
  - term:
      id: GO:0006357
      label: regulation of transcription by RNA polymerase II
    evidence_type: TAS
    original_reference_id: PMID:10910365
    review:
      summary: BRCA1 regulates RNA pol II transcription.
      action: KEEP_AS_NON_CORE
      reason: BRCA1 does regulate transcription through interaction with RNA pol
        II. Peripheral function.
      supported_by:
        - reference_id: PMID:10910365
          supporting_text: Functional link of BRCA1 and ataxia telangiectasia 
            gene product in DNA damage response.
  - term:
      id: GO:0008270
      label: zinc ion binding
    evidence_type: TAS
    original_reference_id: PMID:8944023
    review:
      summary: BRCA1 RING domain binds zinc ions. Duplicate annotation.
      action: ACCEPT
      reason: RING domain zinc binding is essential for E3 ligase function.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: BRCA1 forms a heterodimeric RING-type E3 ubiquitin 
            ligase complex with BARD1 through their N-terminal RING domains
        - reference_id: PMID:8944023
          supporting_text: Identification of a RING protein that can interact in
            vivo with the BRCA1 gene product.
  - term:
      id: GO:0015631
      label: tubulin binding
    evidence_type: NAS
    original_reference_id: PMID:12214252
    review:
      summary: BRCA1 binds tubulin/gamma-TuRC for centrosome regulation.
      action: KEEP_AS_NON_CORE
      reason: BRCA1 does interact with centrosomal components including 
        gamma-tubulin ring complex. This may relate to centrosome duplication 
        control but is peripheral to core DNA repair function.
      supported_by:
        - reference_id: PMID:12214252
          supporting_text: Roles of BRCA1 in centrosome duplication.
  - term:
      id: GO:0031436
      label: BRCA1-BARD1 complex
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: BRCA1 forms heterodimer with BARD1, the core E3 ligase complex. 
        Essential annotation.
      action: ACCEPT
      reason: The BRCA1-BARD1 complex is the functional E3 ubiquitin ligase. 
        BRCA1 does not function independently; BARD1 is required for stability 
        and activity. Core annotation.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: BRCA1 forms a heterodimeric RING-type E3 ubiquitin 
            ligase complex with BARD1 through their N-terminal RING domains
  - term:
      id: GO:0045944
      label: positive regulation of transcription by RNA polymerase II
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: BRCA1 positively regulates transcription. Conserved function from
        IBA.
      action: KEEP_AS_NON_CORE
      reason: BRCA1 does have transcriptional coactivator function, but this is 
        peripheral to its core DNA repair role.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: The C-terminal region can transactivate heterologous 
            promoters
  - term:
      id: GO:0070531
      label: BRCA1-A complex
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: BRCA1 forms BRCA1-A complex with Abraxas and RAP80 for DNA damage
        recognition.
      action: ACCEPT
      reason: The BRCA1-A complex (containing Abraxas, RAP80, MERIT40, BRCC45, 
        BRCC36) is essential for BRCA1 recruitment to DNA damage sites through 
        ubiquitin recognition. Core annotation.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: BRCA1 functions in multiple distinct complexes, 
            including BRCA1-A (Abraxas-RAP80)
  - term:
      id: GO:0005634
      label: nucleus
    evidence_type: IEA
    original_reference_id: GO_REF:0000120
    review:
      summary: BRCA1 localizes to nucleus. Core cellular component.
      action: ACCEPT
      reason: BRCA1 is primarily a nuclear protein. Nuclear localization is 
        essential for its DNA repair function.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: IEA
    original_reference_id: GO_REF:0000117
    review:
      summary: BRCA1 localizes to nucleoplasm.
      action: ACCEPT
      reason: BRCA1 is found in the nucleoplasm where it performs DNA repair 
        functions.
  - term:
      id: GO:0005694
      label: chromosome
    evidence_type: IEA
    original_reference_id: GO_REF:0000120
    review:
      summary: BRCA1 localizes to chromosomes, particularly at DNA damage sites.
      action: ACCEPT
      reason: BRCA1 associates with chromatin and chromosomes for DNA repair.
  - term:
      id: GO:0005737
      label: cytoplasm
    evidence_type: IEA
    original_reference_id: GO_REF:0000120
    review:
      summary: BRCA1 also found in cytoplasm though primarily nuclear.
      action: ACCEPT
      reason: BRCA1 can be found in the cytoplasm, especially in certain splice 
        variants. Some studies show cytoplasmic localization in certain 
        contexts.
  - term:
      id: GO:0005634
      label: nucleus
    evidence_type: IDA
    original_reference_id: PMID:17525340
    review:
      summary: BRCA1 nuclear localization confirmed experimentally.
      action: ACCEPT
      reason: Nuclear localization is essential for BRCA1 function.
      supported_by:
        - reference_id: PMID:17525340
          supporting_text: Abraxas and RAP80 form a BRCA1 protein complex 
            required for the DNA damage response.
  - term:
      id: GO:0005634
      label: nucleus
    evidence_type: NAS
    original_reference_id: PMID:18171670
    review:
      summary: BRCA1 nuclear localization.
      action: ACCEPT
      reason: Duplicate annotation. Nuclear localization is essential.
      supported_by:
        - reference_id: PMID:18171670
          supporting_text: 2008 Jan 2. Cell cycle-dependent complex formation of
            BRCA1.CtIP.MRN is important for DNA double-strand break repair.
  - term:
      id: GO:0005634
      label: nucleus
    evidence_type: NAS
    original_reference_id: PMID:20656689
    review:
      summary: BRCA1 nuclear localization.
      action: ACCEPT
      reason: Duplicate annotation. Nuclear localization is essential.
      supported_by:
        - reference_id: PMID:20656689
          supporting_text: 2010 Jul 22. Differential regulation of JAMM domain 
            deubiquitinating enzyme activity within the RAP80 complex.
  - term:
      id: GO:0005634
      label: nucleus
    evidence_type: NAS
    original_reference_id: PMID:22369660
    review:
      summary: BRCA1 nuclear localization.
      action: ACCEPT
      reason: Duplicate annotation. Nuclear localization is essential.
      supported_by:
        - reference_id: PMID:22369660
          supporting_text: 'BRCA1 tumor suppressor network: focusing on its tail.'
  - term:
      id: GO:0070531
      label: BRCA1-A complex
    evidence_type: NAS
    original_reference_id: PMID:20656689
    review:
      summary: BRCA1-A complex annotation.
      action: ACCEPT
      reason: Duplicate annotation. BRCA1-A complex is essential for DNA damage 
        response.
      supported_by:
        - reference_id: PMID:20656689
          supporting_text: 2010 Jul 22. Differential regulation of JAMM domain 
            deubiquitinating enzyme activity within the RAP80 complex.
  - term:
      id: GO:0070532
      label: BRCA1-B complex
    evidence_type: IPI
    original_reference_id: PMID:16391231
    review:
      summary: BRCA1-B complex contains BRCA1 and BRIP1/FANCJ for replication 
        fork protection.
      action: ACCEPT
      reason: The BRCA1-B complex is important for S-phase checkpoint and 
        replication-coupled DNA repair. Core annotation.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: BRCA1 functions in multiple distinct complexes, 
            including BRCA1-B
        - reference_id: PMID:16391231
          supporting_text: Multifactorial contributions to an acute DNA damage 
            response by BRCA1/BARD1-containing complexes.
  - term:
      id: GO:0070533
      label: BRCA1-C complex
    evidence_type: IPI
    original_reference_id: PMID:16391231
    review:
      summary: BRCA1-C complex contains BRCA1 and CtIP for DNA end resection.
      action: ACCEPT
      reason: The BRCA1-C complex is essential for DNA end resection, a critical
        step in homologous recombination. Core annotation.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: BRCA1 functions in multiple distinct complexes, 
            including BRCA1-C
        - reference_id: PMID:16391231
          supporting_text: Multifactorial contributions to an acute DNA damage 
            response by BRCA1/BARD1-containing complexes.
  - term:
      id: GO:0110025
      label: DNA strand resection involved in replication fork processing
    evidence_type: NAS
    original_reference_id: PMID:29709199
    review:
      summary: BRCA1 promotes DNA strand resection at stalled replication forks.
      action: ACCEPT
      reason: BRCA1 promotes DNA end resection, which is relevant for 
        replication fork processing. Core function related to HR.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: Promotes DNA strand resection by recruiting 
            RBBP8/CtIP and activating it
        - reference_id: PMID:29709199
          supporting_text: The MRE11-RAD50-NBS1 Complex Conducts the 
            Orchestration of Damage Signaling and Outcomes to Stress in DNA 
            Replication and Repair.
  - term:
      id: GO:0000152
      label: nuclear ubiquitin ligase complex
    evidence_type: IDA
    original_reference_id: PMID:14636569
    review:
      summary: BRCA1 forms nuclear ubiquitin ligase complex with BARD1.
      action: ACCEPT
      reason: Core function. BRCA1-BARD1 is a nuclear E3 ubiquitin ligase.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: BRCA1 forms a heterodimeric RING-type E3 ubiquitin 
            ligase complex with BARD1
        - reference_id: PMID:14636569
          supporting_text: Regulation of BRCC, a holoenzyme complex containing 
            BRCA1 and BRCA2, by a signalosome-like subunit and its role in DNA 
            repair.
  - term:
      id: GO:0005634
      label: nucleus
    evidence_type: IDA
    original_reference_id: PMID:14636569
    review:
      summary: BRCA1 nuclear localization.
      action: ACCEPT
      reason: Duplicate annotation. Nuclear localization is essential.
      supported_by:
        - reference_id: PMID:14636569
          supporting_text: Regulation of BRCC, a holoenzyme complex containing 
            BRCA1 and BRCA2, by a signalosome-like subunit and its role in DNA 
            repair.
  - term:
      id: GO:0071479
      label: cellular response to ionizing radiation
    evidence_type: IMP
    original_reference_id: PMID:14636569
    review:
      summary: BRCA1 mediates cellular response to ionizing radiation.
      action: ACCEPT
      reason: Core DDR function. BRCA1 responds to IR-induced DNA damage.
      supported_by:
        - reference_id: PMID:14636569
          supporting_text: Regulation of BRCC, a holoenzyme complex containing 
            BRCA1 and BRCA2, by a signalosome-like subunit and its role in DNA 
            repair.
  - term:
      id: GO:2000001
      label: regulation of DNA damage checkpoint
    evidence_type: NAS
    original_reference_id: PMID:14636569
    review:
      summary: BRCA1 regulates DNA damage checkpoints.
      action: ACCEPT
      reason: Core function. Checkpoint regulation is essential for BRCA1 tumor 
        suppression.
      supported_by:
        - reference_id: PMID:14636569
          supporting_text: Regulation of BRCC, a holoenzyme complex containing 
            BRCA1 and BRCA2, by a signalosome-like subunit and its role in DNA 
            repair.
  - term:
      id: GO:0000793
      label: condensed chromosome
    evidence_type: IEA
    original_reference_id: GO_REF:0000107
    review:
      summary: BRCA1 associates with condensed chromosomes.
      action: ACCEPT
      reason: BRCA1 localizes to chromosomes including during mitosis.
  - term:
      id: GO:0000794
      label: condensed nuclear chromosome
    evidence_type: IEA
    original_reference_id: GO_REF:0000107
    review:
      summary: BRCA1 localizes to condensed nuclear chromosomes.
      action: ACCEPT
      reason: Duplicate of condensed chromosome annotation.
  - term:
      id: GO:0001673
      label: male germ cell nucleus
    evidence_type: IEA
    original_reference_id: GO_REF:0000107
    review:
      summary: BRCA1 localizes to male germ cell nucleus (meiosis).
      action: KEEP_AS_NON_CORE
      reason: BRCA1 is expressed in male germ cells and may function in meiotic 
        recombination. Tissue-specific localization.
  - term:
      id: GO:0001741
      label: XY body
    evidence_type: IEA
    original_reference_id: GO_REF:0000107
    review:
      summary: BRCA1 localizes to XY body during male meiosis.
      action: KEEP_AS_NON_CORE
      reason: BRCA1 localizes to XY body and participates in meiotic sex 
        chromosome inactivation. Germline-specific function.
  - term:
      id: GO:0045944
      label: positive regulation of transcription by RNA polymerase II
    evidence_type: IEA
    original_reference_id: GO_REF:0000107
    review:
      summary: BRCA1 positively regulates transcription. Duplicate IEA 
        annotation.
      action: KEEP_AS_NON_CORE
      reason: Transcriptional coactivator function is peripheral to core DNA 
        repair role.
  - term:
      id: GO:0005634
      label: nucleus
    evidence_type: NAS
    original_reference_id: PMID:19369211
    review:
      summary: BRCA1 nuclear localization.
      action: ACCEPT
      reason: Nuclear localization is essential for function.
      supported_by:
        - reference_id: PMID:19369211
          supporting_text: PALB2 is an integral component of the BRCA complex 
            required for homologous recombination repair.
  - term:
      id: GO:1990391
      label: DNA repair complex
    evidence_type: IPI
    original_reference_id: PMID:19369211
    review:
      summary: BRCA1 forms DNA repair complex with PALB2.
      action: ACCEPT
      reason: BRCA1 functions in DNA repair complexes including with PALB2 for 
        HR.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: PALB2 is an integral component of the BRCA complex 
            required for homologous recombination repair
        - reference_id: PMID:19369211
          supporting_text: PALB2 is an integral component of the BRCA complex 
            required for homologous recombination repair.
  - term:
      id: GO:0005634
      label: nucleus
    evidence_type: IDA
    original_reference_id: PMID:9342365
    review:
      summary: BRCA1 nuclear localization.
      action: ACCEPT
      reason: Core localization. Nuclear is essential for function.
      supported_by:
        - reference_id: PMID:9342365
          supporting_text: Cell cycle-dependent colocalization of BARD1 and 
            BRCA1 proteins in discrete nuclear domains.
  - term:
      id: GO:0031436
      label: BRCA1-BARD1 complex
    evidence_type: IPI
    original_reference_id: PMID:11573085
    review:
      summary: BRCA1-BARD1 heterodimer formation.
      action: ACCEPT
      reason: Core complex. BRCA1-BARD1 is the functional E3 ligase unit.
      supported_by:
        - reference_id: PMID:11573085
          supporting_text: Structure of a BRCA1-BARD1 heterodimeric RING-RING 
            complex.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: IDA
    original_reference_id: GO_REF:0000052
    review:
      summary: BRCA1 nucleoplasm localization.
      action: ACCEPT
      reason: Nucleoplasm localization is essential for BRCA1 function.
  - term:
      id: GO:0016604
      label: nuclear body
    evidence_type: IDA
    original_reference_id: GO_REF:0000052
    review:
      summary: BRCA1 localizes to nuclear bodies including BRCA1 foci.
      action: ACCEPT
      reason: BRCA1 forms nuclear foci at DNA damage sites. This is consistent 
        with its repair function.
  - term:
      id: GO:0045944
      label: positive regulation of transcription by RNA polymerase II
    evidence_type: IMP
    original_reference_id: PMID:20820192
    review:
      summary: BRCA1 nucleoplasm localization from Reactome pathway.
      action: ACCEPT
      reason: Nucleoplasm localization is essential for BRCA1 function.
      supported_by:
        - reference_id: PMID:20820192
          supporting_text: BRCA1 affects global DNA methylation through 
            regulation of DNMT1.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-5683735
    review:
      summary: BRCA1 localizes to nucleoplasm where it performs its DNA repair 
        and checkpoint functions.
      action: ACCEPT
      reason: Nucleoplasm localization is fundamental for BRCA1 function in DNA 
        damage response and homologous recombination repair. Reactome pathway 
        annotation is consistent with established localization data.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: BRCA1 serves as a central hub for maintaining genomic
            stability through its essential roles in DNA damage response, 
            homologous recombination repair, and cell cycle checkpoint control
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-5683801
    review:
      summary: BRCA1 nucleoplasm localization from Reactome pathway annotation.
      action: ACCEPT
      reason: Nucleoplasm localization is well-established for BRCA1 DNA repair 
        functions.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-5684052
    review:
      summary: BRCA1 nucleoplasm localization from Reactome pathway annotation.
      action: ACCEPT
      reason: Nucleoplasm localization is well-established for BRCA1 DNA repair 
        functions.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-5684071
    review:
      summary: BRCA1 nucleoplasm localization from Reactome pathway annotation.
      action: ACCEPT
      reason: Nucleoplasm localization is well-established for BRCA1 DNA repair 
        functions.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-5684108
    review:
      summary: BRCA1 nucleoplasm localization from Reactome pathway annotation.
      action: ACCEPT
      reason: Nucleoplasm localization is well-established for BRCA1 DNA repair 
        functions.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-5684875
    review:
      summary: BRCA1 nucleoplasm localization from Reactome pathway annotation.
      action: ACCEPT
      reason: Nucleoplasm localization is well-established for BRCA1 DNA repair 
        functions.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-5684882
    review:
      summary: BRCA1 nucleoplasm localization from Reactome pathway annotation.
      action: ACCEPT
      reason: Nucleoplasm localization is well-established for BRCA1 DNA repair 
        functions.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-5684887
    review:
      summary: BRCA1 nucleoplasm localization from Reactome pathway annotation.
      action: ACCEPT
      reason: Nucleoplasm localization is well-established for BRCA1 DNA repair 
        functions.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-5685011
    review:
      summary: BRCA1 nucleoplasm localization from Reactome pathway annotation.
      action: ACCEPT
      reason: Nucleoplasm localization is well-established for BRCA1 DNA repair 
        functions.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-5685156
    review:
      summary: BRCA1 nucleoplasm localization from Reactome pathway annotation.
      action: ACCEPT
      reason: Nucleoplasm localization is well-established for BRCA1 DNA repair 
        functions.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-5685341
    review:
      summary: BRCA1 nucleoplasm localization from Reactome pathway annotation.
      action: ACCEPT
      reason: Nucleoplasm localization is well-established for BRCA1 DNA repair 
        functions.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-5685838
    review:
      summary: BRCA1 nucleoplasm localization from Reactome pathway annotation.
      action: ACCEPT
      reason: Nucleoplasm localization is well-established for BRCA1 DNA repair 
        functions.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-5685985
    review:
      summary: BRCA1 nucleoplasm localization from Reactome pathway annotation.
      action: ACCEPT
      reason: Nucleoplasm localization is well-established for BRCA1 DNA repair 
        functions.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-5685994
    review:
      summary: BRCA1 nucleoplasm localization from Reactome pathway annotation.
      action: ACCEPT
      reason: Nucleoplasm localization is well-established for BRCA1 DNA repair 
        functions.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-5686410
    review:
      summary: BRCA1 nucleoplasm localization from Reactome pathway annotation.
      action: ACCEPT
      reason: Nucleoplasm localization is well-established for BRCA1 DNA repair 
        functions.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-5686440
    review:
      summary: BRCA1 nucleoplasm localization from Reactome pathway annotation.
      action: ACCEPT
      reason: Nucleoplasm localization is well-established for BRCA1 DNA repair 
        functions.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-5686469
    review:
      summary: BRCA1 nucleoplasm localization from Reactome pathway annotation.
      action: ACCEPT
      reason: Nucleoplasm localization is well-established for BRCA1 DNA repair 
        functions.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-5686483
    review:
      summary: BRCA1 nucleoplasm localization from Reactome pathway annotation.
      action: ACCEPT
      reason: Nucleoplasm localization is well-established for BRCA1 DNA repair 
        functions.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-5686642
    review:
      summary: BRCA1 nucleoplasm localization from Reactome pathway annotation.
      action: ACCEPT
      reason: Nucleoplasm localization is well-established for BRCA1 DNA repair 
        functions.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-5686657
    review:
      summary: BRCA1 nucleoplasm localization from Reactome pathway annotation.
      action: ACCEPT
      reason: Nucleoplasm localization is well-established for BRCA1 DNA repair 
        functions.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-5686685
    review:
      summary: BRCA1 nucleoplasm localization from Reactome pathway annotation.
      action: ACCEPT
      reason: Nucleoplasm localization is well-established for BRCA1 DNA repair 
        functions.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-5693539
    review:
      summary: BRCA1 nucleoplasm localization from Reactome pathway annotation.
      action: ACCEPT
      reason: Nucleoplasm localization is well-established for BRCA1 DNA repair 
        functions.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-5693542
    review:
      summary: BRCA1 nucleoplasm localization from Reactome pathway annotation.
      action: ACCEPT
      reason: Nucleoplasm localization is well-established for BRCA1 DNA repair 
        functions.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-5693551
    review:
      summary: BRCA1 nucleoplasm localization from Reactome pathway annotation.
      action: ACCEPT
      reason: Nucleoplasm localization is well-established for BRCA1 DNA repair 
        functions.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-5693561
    review:
      summary: BRCA1 nucleoplasm localization from Reactome pathway annotation.
      action: ACCEPT
      reason: Nucleoplasm localization is well-established for BRCA1 DNA repair 
        functions.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-5693564
    review:
      summary: BRCA1 nucleoplasm localization from Reactome pathway annotation.
      action: ACCEPT
      reason: Nucleoplasm localization is well-established for BRCA1 DNA repair 
        functions.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-5693580
    review:
      summary: BRCA1 nucleoplasm localization from Reactome pathway annotation.
      action: ACCEPT
      reason: Nucleoplasm localization is well-established for BRCA1 DNA repair 
        functions.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-5693584
    review:
      summary: BRCA1 nucleoplasm localization from Reactome pathway annotation.
      action: ACCEPT
      reason: Nucleoplasm localization is well-established for BRCA1 DNA repair 
        functions.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-5693589
    review:
      summary: BRCA1 nucleoplasm localization from Reactome pathway annotation.
      action: ACCEPT
      reason: Nucleoplasm localization is well-established for BRCA1 DNA repair 
        functions.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-5693593
    review:
      summary: BRCA1 nucleoplasm localization from Reactome pathway annotation.
      action: ACCEPT
      reason: Nucleoplasm localization is well-established for BRCA1 DNA repair 
        functions.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-5693608
    review:
      summary: BRCA1 nucleoplasm localization from Reactome pathway annotation.
      action: ACCEPT
      reason: Nucleoplasm localization is well-established for BRCA1 DNA repair 
        functions.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-5693620
    review:
      summary: BRCA1 nucleoplasm localization from Reactome pathway annotation.
      action: ACCEPT
      reason: Nucleoplasm localization is well-established for BRCA1 DNA repair 
        functions.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-6799332
    review:
      summary: BRCA1 nucleoplasm localization from Reactome pathway annotation.
      action: ACCEPT
      reason: Nucleoplasm localization is well-established for BRCA1 DNA repair 
        functions.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-69891
    review:
      summary: BRCA1 nucleoplasm localization from Reactome pathway annotation.
      action: ACCEPT
      reason: Nucleoplasm localization is well-established for BRCA1 DNA repair 
        functions.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-9704330
    review:
      summary: BRCA1 nucleoplasm localization from Reactome pathway annotation.
      action: ACCEPT
      reason: Nucleoplasm localization is well-established for BRCA1 DNA repair 
        functions.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-9704408
    review:
      summary: BRCA1 nucleoplasm localization from Reactome pathway annotation.
      action: ACCEPT
      reason: Nucleoplasm localization is well-established for BRCA1 DNA repair 
        functions.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-9709571
    review:
      summary: BRCA1 nucleoplasm localization from Reactome pathway annotation.
      action: ACCEPT
      reason: Nucleoplasm localization is well-established for BRCA1 DNA repair 
        functions.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-9709601
    review:
      summary: BRCA1 nucleoplasm localization from Reactome pathway annotation.
      action: ACCEPT
      reason: Nucleoplasm localization is well-established for BRCA1 DNA repair 
        functions.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-9853389
    review:
      summary: BRCA1 nucleoplasm localization from Reactome pathway annotation.
      action: ACCEPT
      reason: Nucleoplasm localization is well-established for BRCA1 DNA repair 
        functions.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-2997709
    review:
      summary: BRCA1 nucleoplasm localization from Reactome pathway annotation.
      action: ACCEPT
      reason: Nucleoplasm localization is well-established for BRCA1 DNA repair 
        functions.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-2997616
    review:
      summary: BRCA1 nucleoplasm localization from Reactome pathway annotation.
      action: ACCEPT
      reason: Nucleoplasm localization is well-established for BRCA1 DNA repair 
        functions.
  - term:
      id: GO:0005634
      label: nucleus
    evidence_type: IDA
    original_reference_id: PMID:26833090
    review:
      summary: BRCA1 nuclear localization confirmed by direct assay.
      action: ACCEPT
      reason: Nuclear localization is fundamental to BRCA1 function in DNA 
        repair and transcriptional regulation. BRCA1 contains nuclear 
        localization sequences and IDA evidence is appropriate for this 
        annotation.
      supported_by:
        - reference_id: PMID:26833090
          supporting_text: 2016 Jan 28. Non-catalytic Roles for XPG with BRCA1 
            and BRCA2 in Homologous Recombination and Genome Stability.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-9701199
    review:
      summary: BRCA1 nucleoplasm localization from Reactome pathway annotation.
      action: ACCEPT
      reason: Nucleoplasm localization is well-established for BRCA1 DNA repair 
        functions.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-5683385
    review:
      summary: BRCA1 nucleoplasm localization from Reactome pathway annotation.
      action: ACCEPT
      reason: Nucleoplasm localization is well-established for BRCA1 DNA repair 
        functions.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-5691411
    review:
      summary: BRCA1 nucleoplasm localization from Reactome pathway annotation.
      action: ACCEPT
      reason: Nucleoplasm localization is well-established for BRCA1 DNA repair 
        functions.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-9701000
    review:
      summary: BRCA1 nucleoplasm localization from Reactome pathway annotation.
      action: ACCEPT
      reason: Nucleoplasm localization is well-established for BRCA1 DNA repair 
        functions.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-9707051
    review:
      summary: BRCA1 nucleoplasm localization from Reactome pathway annotation.
      action: ACCEPT
      reason: Nucleoplasm localization is well-established for BRCA1 DNA repair 
        functions.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-9663194
    review:
      summary: BRCA1 nucleoplasm localization from Reactome pathway annotation.
      action: ACCEPT
      reason: Nucleoplasm localization is well-established for BRCA1 DNA repair 
        functions.
  - term:
      id: GO:1990904
      label: ribonucleoprotein complex
    evidence_type: IDA
    original_reference_id: PMID:18809582
    review:
      summary: BRCA1 association with ribonucleoprotein complex requires 
        validation. While BRCA1 interacts with BRIP1/BACH1 which has RNA 
        helicase activity, the evidence for direct RNP complex localization 
        should be evaluated.
      action: UNDECIDED
      reason: Unable to access PMID:18809582 to verify the specific context of 
        this annotation. BRCA1 has been reported to associate with RNA-related 
        proteins but its presence in RNP complexes is not a core function.
      supported_by:
        - reference_id: PMID:18809582
          supporting_text: Sep 22. Nucleophosmin serves as a rate-limiting 
            nuclear export chaperone for the Mammalian ribosome.
  - term:
      id: GO:0032991
      label: protein-containing complex
    evidence_type: IDA
    original_reference_id: PMID:9774970
    review:
      summary: BRCA1 localization to a protein-containing complex is too 
        generic. BRCA1 forms specific complexes like BRCA1-BARD1, BRCA1-A, 
        BRCA1-B, and BRCA1-C.
      action: MODIFY
      reason: This term is too generic - BRCA1 forms well-characterized specific
        protein complexes. More informative annotations for BRCA1-BARD1, 
        BRCA1-A, BRCA1-B, and BRCA1-C complexes already exist.
      proposed_replacement_terms:
        - id: GO:0031436
          label: BRCA1-BARD1 complex
      supported_by:
        - reference_id: PMID:9774970
          supporting_text: Stable interaction between the products of the BRCA1 
            and BRCA2 tumor suppressor genes in mitotic and meiotic cells.
  - term:
      id: GO:0000800
      label: lateral element
    evidence_type: IDA
    original_reference_id: PMID:9774970
    review:
      summary: BRCA1 localization to lateral elements of the synaptonemal 
        complex during meiosis. This is consistent with its role in 
        recombination.
      action: KEEP_AS_NON_CORE
      reason: Lateral element localization is specific to meiotic cells and 
        represents a specialized localization of BRCA1 related to its 
        recombination function. This is a valid but context-specific annotation.
      supported_by:
        - reference_id: PMID:9774970
          supporting_text: Stable interaction between the products of the BRCA1 
            and BRCA2 tumor suppressor genes in mitotic and meiotic cells.
  - term:
      id: GO:0005634
      label: nucleus
    evidence_type: IDA
    original_reference_id: PMID:20160719
    review:
      summary: BRCA1 nuclear localization confirmed by direct assay.
      action: ACCEPT
      reason: Nuclear localization is fundamental to BRCA1 function in DNA 
        repair and transcriptional regulation. BRCA1 contains two nuclear 
        localization sequences in its central region.
      supported_by:
        - reference_id: PMID:20160719
          supporting_text: Feb 16. Identification of DBC1 as a transcriptional 
            repressor for BRCA1.
  - term:
      id: GO:0005737
      label: cytoplasm
    evidence_type: IDA
    original_reference_id: PMID:20160719
    review:
      summary: BRCA1 cytoplasmic localization detected by direct assay. While 
        BRCA1 is predominantly nuclear, cytoplasmic localization has been 
        observed.
      action: KEEP_AS_NON_CORE
      reason: BRCA1 is primarily nuclear but has been detected in cytoplasm. 
        This is not a core localization but represents a minor pool of the 
        protein and may be related to nuclear-cytoplasmic shuttling.
      supported_by:
        - reference_id: PMID:20160719
          supporting_text: Feb 16. Identification of DBC1 as a transcriptional 
            repressor for BRCA1.
  - term:
      id: GO:0071356
      label: cellular response to tumor necrosis factor
    evidence_type: IMP
    original_reference_id: PMID:23415688
    review:
      summary: BRCA1 involvement in cellular response to TNF. This is a 
        downstream effect rather than a core function.
      action: KEEP_AS_NON_CORE
      reason: While BRCA1 may influence TNF responses through its effects on 
        NF-kB signaling and cell survival pathways, this represents a secondary 
        consequence of its core functions rather than a direct role in TNF 
        signaling.
      supported_by:
        - reference_id: PMID:23415688
          supporting_text: BRCA1 is a novel target to improve endothelial 
            dysfunction and retard atherosclerosis.
  - term:
      id: GO:1902042
      label: negative regulation of extrinsic apoptotic signaling pathway via 
        death domain receptors
    evidence_type: IMP
    original_reference_id: PMID:23415688
    review:
      summary: BRCA1 role in regulating death receptor-mediated apoptosis. This 
        is a downstream effect related to its tumor suppressor function.
      action: MARK_AS_OVER_ANNOTATED
      reason: While BRCA1 loss may affect cell survival and death receptor 
        signaling, this is likely an indirect effect of its core functions in 
        DNA repair and genome stability rather than a direct mechanism. This 
        term is highly specific and may represent over-annotation.
      supported_by:
        - reference_id: PMID:23415688
          supporting_text: BRCA1 is a novel target to improve endothelial 
            dysfunction and retard atherosclerosis.
  - term:
      id: GO:2000378
      label: negative regulation of reactive oxygen species metabolic process
    evidence_type: IMP
    original_reference_id: PMID:23415688
    review:
      summary: BRCA1 involvement in ROS regulation. BRCA1 deficiency has been 
        linked to oxidative stress.
      action: MARK_AS_OVER_ANNOTATED
      reason: While BRCA1 loss may lead to increased ROS as a consequence of 
        genome instability and metabolic changes, direct regulation of ROS 
        metabolism is not a core function of BRCA1. This is likely an indirect 
        downstream effect.
      supported_by:
        - reference_id: PMID:23415688
          supporting_text: BRCA1 is a novel target to improve endothelial 
            dysfunction and retard atherosclerosis.
  - term:
      id: GO:0005634
      label: nucleus
    evidence_type: IDA
    original_reference_id: PMID:23855721
    review:
      summary: BRCA1 nuclear localization confirmed by direct assay.
      action: ACCEPT
      reason: Nuclear localization is fundamental to BRCA1 function in DNA 
        repair and transcriptional regulation.
      supported_by:
        - reference_id: PMID:23855721
          supporting_text: Localization of BRCA1 protein in breast cancer tissue
            and cell lines with mutations.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-5659781
    review:
      summary: BRCA1 nucleoplasm localization from Reactome pathway annotation.
      action: ACCEPT
      reason: Nucleoplasm localization is well-established for BRCA1 DNA repair 
        functions.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-6797712
    review:
      summary: BRCA1 nucleoplasm localization from Reactome pathway annotation.
      action: ACCEPT
      reason: Nucleoplasm localization is well-established for BRCA1 DNA repair 
        functions.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-9007605
    review:
      summary: BRCA1 nucleoplasm localization from Reactome pathway annotation.
      action: ACCEPT
      reason: Nucleoplasm localization is well-established for BRCA1 DNA repair 
        functions.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-9699163
    review:
      summary: BRCA1 nucleoplasm localization from Reactome pathway annotation.
      action: ACCEPT
      reason: Nucleoplasm localization is well-established for BRCA1 DNA repair 
        functions.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-9700998
    review:
      summary: BRCA1 nucleoplasm localization from Reactome pathway annotation.
      action: ACCEPT
      reason: Nucleoplasm localization is well-established for BRCA1 DNA repair 
        functions.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-9701003
    review:
      summary: BRCA1 nucleoplasm localization from Reactome pathway annotation.
      action: ACCEPT
      reason: Nucleoplasm localization is well-established for BRCA1 DNA repair 
        functions.
  - term:
      id: GO:0005654
      label: nucleoplasm
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-9926521
    review:
      summary: BRCA1 nucleoplasm localization from Reactome pathway annotation.
      action: ACCEPT
      reason: Nucleoplasm localization is well-established for BRCA1 DNA repair 
        functions.
  - term:
      id: GO:0005694
      label: chromosome
    evidence_type: ISS
    original_reference_id: GO_REF:0000024
    review:
      summary: BRCA1 association with chromosomes, consistent with its role in 
        DNA repair and chromatin functions.
      action: ACCEPT
      reason: BRCA1 localizes to chromatin and DNA damage sites on chromosomes 
        as part of its core DNA repair function. ISS evidence from sequence 
        similarity supports this localization.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: BRCA1 functions in chromatin structure maintenance
  - term:
      id: GO:0005886
      label: plasma membrane
    evidence_type: IDA
    original_reference_id: PMID:21282464
    review:
      summary: BRCA1 plasma membrane localization detected by direct assay. This
        is unexpected as BRCA1 is primarily a nuclear protein.
      action: UNDECIDED
      reason: Unable to access PMID:21282464 to verify this annotation. Plasma 
        membrane localization for BRCA1 is unusual and not consistent with its 
        known nuclear functions in DNA repair. This requires validation.
      supported_by:
        - reference_id: PMID:21282464
          supporting_text: Jan 31. A novel role for BRCA1 in regulating breast 
            cancer cell spreading and motility.
  - term:
      id: GO:0085020
      label: protein K6-linked ubiquitination
    evidence_type: IDA
    original_reference_id: PMID:12890688
    review:
      summary: BRCA1-BARD1 E3 ligase generates K6-linked ubiquitin chains. This 
        is a characteristic activity of the BRCA1-BARD1 complex.
      action: ACCEPT
      reason: K6-linked ubiquitination is a well-characterized enzymatic 
        activity of the BRCA1-BARD1 E3 ligase complex, distinguishing it from 
        other E3 ligases that typically generate K48 or K63 linkages.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: BRCA1 forms a heterodimeric RING-type E3 ubiquitin 
            ligase complex with BARD1 through their N-terminal RING domains
        - reference_id: PMID:12890688
          supporting_text: 2003 Jul 30. The BRCA1/BARD1 heterodimer assembles 
            polyubiquitin chains through an unconventional linkage involving 
            lysine residue K6 of ubiquitin.
  - term:
      id: GO:0085020
      label: protein K6-linked ubiquitination
    evidence_type: IDA
    original_reference_id: PMID:20351172
    review:
      summary: BRCA1-BARD1 E3 ligase generates K6-linked ubiquitin chains. 
        Additional evidence for this core enzymatic activity.
      action: ACCEPT
      reason: K6-linked ubiquitination is a well-characterized enzymatic 
        activity of the BRCA1-BARD1 E3 ligase complex.
      supported_by:
        - reference_id: PMID:20351172
          supporting_text: Mar 29. The UBXN1 protein associates with 
            autoubiquitinated forms of the BRCA1 tumor suppressor and inhibits 
            its enzymatic function.
  - term:
      id: GO:0031436
      label: BRCA1-BARD1 complex
    evidence_type: IDA
    original_reference_id: PMID:12890688
    review:
      summary: BRCA1 is a component of the BRCA1-BARD1 heterodimeric complex 
        that possesses E3 ubiquitin ligase activity.
      action: ACCEPT
      reason: The BRCA1-BARD1 complex is the essential functional unit for BRCA1
        E3 ligase activity. This is a core annotation.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: BRCA1 forms a heterodimeric RING-type E3 ubiquitin 
            ligase complex with BARD1 through their N-terminal RING domains
        - reference_id: PMID:12890688
          supporting_text: 2003 Jul 30. The BRCA1/BARD1 heterodimer assembles 
            polyubiquitin chains through an unconventional linkage involving 
            lysine residue K6 of ubiquitin.
  - term:
      id: GO:0031436
      label: BRCA1-BARD1 complex
    evidence_type: IDA
    original_reference_id: PMID:20351172
    review:
      summary: BRCA1 is a component of the BRCA1-BARD1 heterodimeric complex. 
        Additional evidence for this core complex.
      action: ACCEPT
      reason: The BRCA1-BARD1 complex is the essential functional unit for BRCA1
        E3 ligase activity. This is a core annotation.
      supported_by:
        - reference_id: PMID:20351172
          supporting_text: Mar 29. The UBXN1 protein associates with 
            autoubiquitinated forms of the BRCA1 tumor suppressor and inhibits 
            its enzymatic function.
  - term:
      id: GO:0051865
      label: protein autoubiquitination
    evidence_type: IDA
    original_reference_id: PMID:12890688
    review:
      summary: BRCA1-BARD1 complex undergoes autoubiquitination. This is a 
        characteristic property of E3 ubiquitin ligases.
      action: ACCEPT
      reason: Autoubiquitination is a common feature of E3 ligases and has been 
        demonstrated for the BRCA1-BARD1 complex. This is consistent with its E3
        ligase activity.
      supported_by:
        - reference_id: PMID:12890688
          supporting_text: 2003 Jul 30. The BRCA1/BARD1 heterodimer assembles 
            polyubiquitin chains through an unconventional linkage involving 
            lysine residue K6 of ubiquitin.
  - term:
      id: GO:0051865
      label: protein autoubiquitination
    evidence_type: IDA
    original_reference_id: PMID:20351172
    review:
      summary: BRCA1-BARD1 complex undergoes autoubiquitination. Additional 
        evidence for this E3 ligase property.
      action: ACCEPT
      reason: Autoubiquitination is a common feature of E3 ligases and has been 
        demonstrated for the BRCA1-BARD1 complex.
      supported_by:
        - reference_id: PMID:20351172
          supporting_text: Mar 29. The UBXN1 protein associates with 
            autoubiquitinated forms of the BRCA1 tumor suppressor and inhibits 
            its enzymatic function.
  - term:
      id: GO:0045944
      label: positive regulation of transcription by RNA polymerase II
    evidence_type: IDA
    original_reference_id: PMID:16331276
    review:
      summary: BRCA1 has transcriptional activation activity, particularly 
        through its C-terminal region.
      action: KEEP_AS_NON_CORE
      reason: While BRCA1 has documented transcriptional regulatory functions 
        and the C-terminal region can transactivate heterologous promoters, this
        is considered a secondary function compared to its core roles in DNA 
        repair and E3 ligase activity.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: The C-terminal region can transactivate heterologous 
            promoters
        - reference_id: PMID:16331276
          supporting_text: BRCA1 and FOXA1 proteins coregulate the expression of
            the cell cycle-dependent kinase inhibitor p27(Kip1).
  - term:
      id: GO:0031436
      label: BRCA1-BARD1 complex
    evidence_type: IDA
    original_reference_id: PMID:19117993
    review:
      summary: BRCA1 is a component of the BRCA1-BARD1 heterodimeric complex. 
        Additional evidence for this core complex.
      action: ACCEPT
      reason: The BRCA1-BARD1 complex is the essential functional unit for BRCA1
        E3 ligase activity. This is a core annotation.
      supported_by:
        - reference_id: PMID:19117993
          supporting_text: BRCA1-associated protein 1 interferes with 
            BRCA1/BARD1 RING heterodimer activity.
  - term:
      id: GO:0071681
      label: cellular response to indole-3-methanol
    evidence_type: IDA
    original_reference_id: PMID:10868478
    review:
      summary: BRCA1 involvement in cellular response to indole-3-methanol 
        (I3C), a dietary compound. This is a highly specific experimental 
        context.
      action: MARK_AS_OVER_ANNOTATED
      reason: While this may represent a valid experimental observation, 
        cellular response to a specific dietary compound is not a core function 
        of BRCA1. This is likely a downstream or indirect effect and represents 
        over-annotation.
      supported_by:
        - reference_id: PMID:10868478
          supporting_text: 'Suppression of breast cancer invasion and migration by
            indole-3-carbinol: associated with up-regulation of BRCA1 and E-cadherin/catenin
            complexes.'
  - term:
      id: GO:0005634
      label: nucleus
    evidence_type: IDA
    original_reference_id: PMID:17643121
    review:
      summary: BRCA1 nuclear localization confirmed by direct assay.
      action: ACCEPT
      reason: Nuclear localization is fundamental to BRCA1 function in DNA 
        repair and transcriptional regulation.
      supported_by:
        - reference_id: PMID:17643121
          supporting_text: Jul 22. CCDC98 targets BRCA1 to DNA damage sites.
  - term:
      id: GO:0070531
      label: BRCA1-A complex
    evidence_type: IDA
    original_reference_id: PMID:17525340
    review:
      summary: BRCA1 is a component of the BRCA1-A complex with RAP80 and 
        Abraxas for DNA damage recognition.
      action: ACCEPT
      reason: The BRCA1-A complex (containing RAP80, Abraxas, BRCC36, BRCC45) is
        a key BRCA1-containing complex involved in DNA damage response. This is 
        a core annotation.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: BRCA1-A Complex (RAP80/Abraxas)
        - reference_id: PMID:17525340
          supporting_text: Abraxas and RAP80 form a BRCA1 protein complex 
            required for the DNA damage response.
  - term:
      id: GO:0070531
      label: BRCA1-A complex
    evidence_type: IDA
    original_reference_id: PMID:17525341
    review:
      summary: BRCA1 is a component of the BRCA1-A complex. Additional evidence 
        for this core complex.
      action: ACCEPT
      reason: The BRCA1-A complex is a key BRCA1-containing complex involved in 
        DNA damage response. This is a core annotation.
      supported_by:
        - reference_id: PMID:17525341
          supporting_text: RAP80 targets BRCA1 to specific ubiquitin structures 
            at DNA damage sites.
  - term:
      id: GO:0070531
      label: BRCA1-A complex
    evidence_type: IDA
    original_reference_id: PMID:17525342
    review:
      summary: BRCA1 is a component of the BRCA1-A complex. Additional evidence 
        for this core complex.
      action: ACCEPT
      reason: The BRCA1-A complex is a key BRCA1-containing complex involved in 
        DNA damage response. This is a core annotation.
      supported_by:
        - reference_id: PMID:17525342
          supporting_text: Ubiquitin-binding protein RAP80 mediates 
            BRCA1-dependent DNA damage response.
  - term:
      id: GO:0070531
      label: BRCA1-A complex
    evidence_type: IDA
    original_reference_id: PMID:19261748
    review:
      summary: BRCA1 is a component of the BRCA1-A complex. Additional evidence 
        for this core complex.
      action: ACCEPT
      reason: The BRCA1-A complex is a key BRCA1-containing complex involved in 
        DNA damage response. This is a core annotation.
      supported_by:
        - reference_id: PMID:19261748
          supporting_text: MERIT40 facilitates BRCA1 localization and DNA damage
            repair.
  - term:
      id: GO:0070531
      label: BRCA1-A complex
    evidence_type: IDA
    original_reference_id: PMID:19261749
    review:
      summary: BRCA1 is a component of the BRCA1-A complex. Additional evidence 
        for this core complex.
      action: ACCEPT
      reason: The BRCA1-A complex is a key BRCA1-containing complex involved in 
        DNA damage response. This is a core annotation.
      supported_by:
        - reference_id: PMID:19261749
          supporting_text: NBA1, a new player in the Brca1 A complex, is 
            required for DNA damage resistance and checkpoint control.
  - term:
      id: GO:0031436
      label: BRCA1-BARD1 complex
    evidence_type: IDA
    original_reference_id: PMID:15265711
    review:
      summary: BRCA1 is a component of the BRCA1-BARD1 heterodimeric complex. 
        Additional evidence for this core complex.
      action: ACCEPT
      reason: The BRCA1-BARD1 complex is the essential functional unit for BRCA1
        E3 ligase activity. This is a core annotation.
      supported_by:
        - reference_id: PMID:15265711
          supporting_text: BARD1 regulates BRCA1 apoptotic function by a 
            mechanism involving nuclear retention.
  - term:
      id: GO:0000151
      label: ubiquitin ligase complex
    evidence_type: NAS
    original_reference_id: PMID:14976165
    review:
      summary: BRCA1 as part of a ubiquitin ligase complex. The term is somewhat
        generic but accurate.
      action: ACCEPT
      reason: BRCA1-BARD1 is indeed a ubiquitin ligase complex. While the more 
        specific term BRCA1-BARD1 complex exists, this general term is not 
        incorrect. NAS evidence is appropriate for this well-established 
        function.
      supported_by:
        - reference_id: PMID:14976165
          supporting_text: 'Feb 19. BRCA1 : BARD1 induces the formation of conjugated
            ubiquitin structures, dependent on K6 of ubiquitin, in cells during DNA
            replication and repair.'
  - term:
      id: GO:0000931
      label: gamma-tubulin ring complex
    evidence_type: NAS
    original_reference_id: PMID:12214252
    review:
      summary: BRCA1 association with gamma-tubulin ring complex at centrosomes.
        This is consistent with its centrosomal functions.
      action: ACCEPT
      reason: BRCA1 associates with gamma-tubulin at centrosomes and plays a 
        role in centrosome regulation. This is a validated localization.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: Associates with gamma-tubulin at mother centrioles in
            unduplicated centrosomes
        - reference_id: PMID:12214252
          supporting_text: Roles of BRCA1 in centrosome duplication.
  - term:
      id: GO:0046600
      label: negative regulation of centriole replication
    evidence_type: NAS
    original_reference_id: PMID:12214252
    review:
      summary: BRCA1 blocks centrosome reduplication, preventing formation of 
        multiple functional centrosomes.
      action: KEEP_AS_NON_CORE
      reason: BRCA1 has documented roles in centrosome regulation and blocks 
        centrosome reduplication. While this is a real function, it is secondary
        to the core DNA repair and E3 ligase functions.
      supported_by:
        - reference_id: file:human/BRCA1/BRCA1-deep-research.md
          supporting_text: Blocks centrosome reduplication, preventing formation
            of multiple functional centrosomes
        - reference_id: PMID:12214252
          supporting_text: Roles of BRCA1 in centrosome duplication.
references:
  - id: GO_REF:0000002
    title: Gene Ontology annotation through association of InterPro records with
      GO terms.
    findings: []
  - id: GO_REF:0000033
    title: Annotation inferences using phylogenetic trees
    findings: []
  - id: GO_REF:0000107
    title: Automatic transfer of experimentally verified manual GO annotation 
      data to orthologs using Ensembl Compara.
    findings: []
  - id: GO_REF:0000120
    title: Combined Automated Annotation using Multiple IEA Methods.
    findings: []
  - id: PMID:10477523
    title: Functional interaction of BRCA1-associated BARD1 with polyadenylation
      factor CstF-50.
    findings: []
  - id: PMID:10518542
    title: BRCA1-associated growth arrest is RB-dependent.
    findings: []
  - id: PMID:10855792
    title: VCP, a weak ATPase involved in multiple cellular events, interacts 
      physically with BRCA1 in the nucleus of living cells.
    findings: []
  - id: PMID:11090615
    title: Sequence-specific transcriptional corepressor function for BRCA1 
      through a novel zinc finger protein, ZBRK1.
    findings: []
  - id: PMID:11301010
    title: BACH1, a novel helicase-like protein, interacts directly with BRCA1 
      and contributes to its DNA repair function.
    findings: []
  - id: PMID:11739404
    title: BRCA1-induced large-scale chromatin unfolding and allele-specific 
      effects of cancer-predisposing mutations.
    findings: []
  - id: PMID:11751867
    title: The LIM domain protein LMO4 interacts with the cofactor CtIP and the 
      tumor suppressor BRCA1 and inhibits BRCA1 activity.
    findings: []
  - id: PMID:11836499
    title: BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon 
      DNA damage.
    findings: []
  - id: PMID:11877377
    title: SMC1 is a downstream effector in the ATM/NBS1 branch of the human 
      S-phase checkpoint.
    findings: []
  - id: PMID:12242698
    title: 'Highlight: BRCA1 and BRCA2 proteins in breast cancer.'
    findings: []
  - id: PMID:12354784
    title: BRCA1 interacts directly with the Fanconi anemia protein FANCA.
    findings: []
  - id: PMID:12419185
    title: NBS1 localizes to gamma-H2AX foci through interaction with the 
      FHA/BRCT domain.
    findings: []
  - id: PMID:12419249
    title: BRCA1 supports XIST RNA concentration on the inactive X chromosome.
    findings: []
  - id: PMID:12607005
    title: MDC1 is a mediator of the mammalian DNA damage checkpoint.
    findings: []
  - id: PMID:12890688
    title: The BRCA1/BARD1 heterodimer assembles polyubiquitin chains through an
      unconventional linkage involving lysine residue K6 of ubiquitin.
    findings: []
  - id: PMID:14550570
    title: BRCA1 interacts with FHL2 and enhances FHL2 transactivation function.
    findings: []
  - id: PMID:14576433
    title: The BRCT domain is a phospho-protein binding domain.
    findings: []
  - id: PMID:14654789
    title: A member of the Pyrin family, IFI16, is a novel BRCA1-associated 
      protein involved in the p53-mediated apoptosis pathway.
    findings: []
  - id: PMID:15107825
    title: BRCA1 cooperates with NUFIP and P-TEFb to activate transcription by 
      RNA polymerase II.
    findings: []
  - id: PMID:15125843
    title: 'Structure of the BRCT repeats of BRCA1 bound to a BACH1 phosphopeptide:
      implications for signaling.'
    findings: []
  - id: PMID:15133502
    title: Structure and mechanism of BRCA1 BRCT domain recognition of 
      phosphorylated BACH1 with implications for cancer.
    findings: []
  - id: PMID:15265711
    title: BARD1 regulates BRCA1 apoptotic function by a mechanism involving 
      nuclear retention.
    findings: []
  - id: PMID:15571721
    title: 'Characterization of segments from the central region of BRCA1: an intrinsically
      disordered scaffold for multiple protein-protein and protein-DNA interactions?'
    findings: []
  - id: PMID:15674350
    title: 'Structural determinants of the BRCA1 : estrogen receptor interaction.'
    findings: []
  - id: PMID:15965487
    title: BRCA1 participates in DNA decatenation.
    findings: []
  - id: PMID:16101277
    title: Structural basis for cell cycle checkpoint control by the BRCA1-CtIP 
      complex.
    findings: []
  - id: PMID:16326698
    title: BRCA1 affects lipid synthesis through its interaction with acetyl-CoA
      carboxylase.
    findings: []
  - id: PMID:16452482
    title: ATM activation by ionizing radiation requires BRCA1-associated BAAT1.
    findings: []
  - id: PMID:17334399
    title: Functional consequences of cyclin D1/BRCA1 interaction in breast 
      cancer cells.
    findings: []
  - id: PMID:17349954
    title: A critical role for the ubiquitin-conjugating enzyme Ubc13 in 
      initiating homologous recombination.
    findings: []
  - id: PMID:17511879
    title: The interaction of PP1 with BRCA1 and analysis of their expression in
      breast tumors.
    findings: []
  - id: PMID:17525332
    title: ATM and ATR substrate analysis reveals extensive protein networks 
      responsive to DNA damage.
    findings: []
  - id: PMID:17525340
    title: Abraxas and RAP80 form a BRCA1 protein complex required for the DNA 
      damage response.
    findings: []
  - id: PMID:17581638
    title: The FANCJ/MutLalpha interaction is required for correction of the 
      cross-link response in FA-J cells.
    findings: []
  - id: PMID:17643121
    title: CCDC98 targets BRCA1 to DNA damage sites.
    findings: []
  - id: PMID:17873885
    title: E2-BRCA1 RING interactions dictate synthesis of mono- or specific 
      polyubiquitin chain linkages.
    findings: []
  - id: PMID:18001824
    title: RNF8 ubiquitylates histones at DNA double-strand breaks and promotes 
      assembly of repair proteins.
    findings: []
  - id: PMID:18001825
    title: RNF8 transduces the DNA-damage signal via histone ubiquitylation and 
      checkpoint protein assembly.
    findings: []
  - id: PMID:18285836
    title: 'Pathogenicity of the BRCA1 missense variant M1775K is determined by the
      disruption of the BRCT phosphopeptide-binding pocket: a multi-modal approach.'
    findings: []
  - id: PMID:18716619
    title: CDK targets Sae2 to control DNA-end resection and homologous 
      recombination.
    findings: []
  - id: PMID:19117993
    title: BRCA1-associated protein 1 interferes with BRCA1/BARD1 RING 
      heterodimer activity.
    findings: []
  - id: PMID:19261748
    title: MERIT40 facilitates BRCA1 localization and DNA damage repair.
    findings: []
  - id: PMID:19369211
    title: PALB2 is an integral component of the BRCA complex required for 
      homologous recombination repair.
    findings: []
  - id: PMID:20016594
    title: The SUMO modification pathway is involved in the BRCA1 response to 
      genotoxic stress.
    findings: []
  - id: PMID:20016603
    title: Mammalian SUMO E3-ligases PIAS1 and PIAS4 promote responses to DNA 
      double-strand breaks.
    findings: []
  - id: PMID:20160719
    title: Identification of DBC1 as a transcriptional repressor for BRCA1.
    findings: []
  - id: PMID:20351172
    title: The UBXN1 protein associates with autoubiquitinated forms of the 
      BRCA1 tumor suppressor and inhibits its enzymatic function.
    findings: []
  - id: PMID:20820192
    title: BRCA1 affects global DNA methylation through regulation of DNMT1.
    findings: []
  - id: PMID:21102443
    title: Transcriptional regulation of BRCA1 expression by a metabolic switch.
    findings: []
  - id: PMID:21240188
    title: Interaction between the helicases genetically linked to Fanconi 
      anemia group J and Bloom's syndrome.
    findings: []
  - id: PMID:21407215
    title: Multifunctional transcription factor TFII-I is an activator of BRCA1 
      function.
    findings: []
  - id: PMID:21673012
    title: KIAA0101 interacts with BRCA1 and regulates centrosome number.
    findings: []
  - id: PMID:21951318
    title: Ligand-dependent differences in estrogen receptor beta-interacting 
      proteins identified in lung adenocarcinoma cells corresponds to estrogenic
      responses.
    findings: []
  - id: PMID:21988832
    title: Toward an understanding of the protein interaction network of the 
      human liver.
    findings: []
  - id: PMID:22110403
    title: Interplay between BRCA1 and RHAMM regulates epithelial apicobasal 
      polarization and may influence risk of breast cancer.
    findings: []
  - id: PMID:22193777
    title: ChAM, a novel motif that mediates PALB2 intrinsic chromatin binding 
      and facilitates DNA repair.
    findings: []
  - id: PMID:9662397
    title: BRCA1 protein is linked to the RNA polymerase II holoenzyme complex 
      via RNA helicase A.
    findings: []
  - id: Reactome:R-HSA-9701000
    title: BRCA1:BARD1 heterodimer autoubiquitinates
    findings: []
  - id: PMID:10549283
    title: Brca1 controls homology-directed DNA repair.
    findings: []
  - id: PMID:9789027
    title: BRCA1 is associated with the centrosome during mitosis.
    findings: []
  - id: GO_REF:0000003
    title: Gene Ontology annotation based on Enzyme Commission mapping
    findings: []
  - id: GO_REF:0000041
    title: Gene Ontology annotation based on UniPathway vocabulary mapping.
    findings: []
  - id: GO_REF:0000043
    title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword 
      mapping
    findings: []
  - id: PMID:10910365
    title: Functional link of BRCA1 and ataxia telangiectasia gene product in 
      DNA damage response.
    findings: []
  - id: PMID:12080089
    title: JunB potentiates function of BRCA1 activation domain 1 (AD1) through 
      a coiled-coil-mediated interaction.
    findings: []
  - id: PMID:12214252
    title: Roles of BRCA1 in centrosome duplication.
    findings: []
  - id: PMID:15159397
    title: BRCA1-BARD1 complexes are required for p53Ser-15 phosphorylation and 
      a G1/S arrest following ionizing radiation-induced DNA damage.
    findings: []
  - id: PMID:16288014
    title: BRCA1 and c-Myc associate to transcriptionally repress psoriasin, a 
      DNA damage-inducible gene.
    findings: []
  - id: PMID:16651405
    title: DNA damage-induced BARD1 phosphorylation is critical for the 
      inhibition of messenger RNA processing by BRCA1/BARD1 complex.
    findings: []
  - id: PMID:17505062
    title: Growth factor signaling pathways modulate BRCA1 repression of 
      estrogen receptor-alpha activity.
    findings: []
  - id: PMID:20656689
    title: Differential regulation of JAMM domain deubiquitinating enzyme 
      activity within the RAP80 complex.
    findings: []
  - id: PMID:22186889
    title: BRCA1 is an essential regulator of heart function and survival 
      following myocardial infarction.
    findings: []
  - id: PMID:22369660
    title: 'BRCA1 tumor suppressor network: focusing on its tail.'
    findings: []
  - id: PMID:22792074
    title: FANCJ/BACH1 acetylation at lysine 1249 regulates the DNA damage 
      response.
    findings: []
  - id: PMID:22884692
    title: TRIP12 and UBR5 suppress spreading of chromatin ubiquitylation at 
      damaged chromosomes.
    findings: []
  - id: PMID:23415688
    title: BRCA1 is a novel target to improve endothelial dysfunction and retard
      atherosclerosis.
    findings: []
  - id: PMID:23624935
    title: BRCA1 is a negative modulator of the PRC2 complex.
    findings: []
  - id: PMID:23680151
    title: Function of BRCA1 in the DNA damage response is mediated by 
      ADP-ribosylation.
    findings: []
  - id: PMID:24981860
    title: Human-chromatin-related protein interactions identify a demethylase 
      complex required for chromosome segregation.
    findings: []
  - id: PMID:26807646
    title: EXD2 promotes homologous recombination by facilitating DNA end 
      resection.
    findings: []
  - id: PMID:26833090
    title: Non-catalytic Roles for XPG with BRCA1 and BRCA2 in Homologous 
      Recombination and Genome Stability.
    findings: []
  - id: PMID:28319063
    title: Compromised BRCA1-PALB2 interaction is associated with breast cancer 
      risk.
    findings: []
  - id: PMID:28398198
    title: Functional and mutational landscapes of BRCA1 for homology-directed 
      repair and therapy resistance.
    findings: []
  - id: PMID:29656893
    title: DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of 
      NHEJ and PARP Inhibitor Sensitivity.
    findings: []
  - id: PMID:29899443
    title: Structural basis for regulation of human acetyl-CoA carboxylase.
    findings: []
  - id: PMID:30657944
    title: CtIP-BRCA1 complex and MRE11 maintain replication forks in the 
      presence of chain terminating nucleoside analogs.
    findings: []
  - id: PMID:31527615
    title: The RNA-mediated estrogen receptor α interactome of hormone-dependent
      human breast cancer cell nuclei.
    findings: []
  - id: PMID:33961781
    title: Dual proteome-scale networks reveal cell-specific remodeling of the 
      human interactome.
    findings: []
  - id: PMID:34552057
    title: ZGRF1 promotes end resection of DNA homologous recombination via 
      forming complex with BRCA1/EXO1.
    findings: []
  - id: PMID:34591612
    title: A protein interaction landscape of breast cancer.
    findings: []
  - id: PMID:35351360
    title: BRCA1/BARD1 is a nucleosome reader and writer.
    findings: []
  - id: PMID:8944023
    title: Identification of a RING protein that can interact in vivo with the 
      BRCA1 gene product.
    findings: []
  - id: PMID:9497340
    title: Identification of a novel cytoplasmic protein that specifically binds
      to nuclear localization signal motifs.
    findings: []
  - id: PMID:9528852
    title: 'BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger
      and enhances BRCA1-mediated cell growth suppression.'
    findings: []
  - id: PMID:9774970
    title: Stable interaction between the products of the BRCA1 and BRCA2 tumor 
      suppressor genes in mitotic and meiotic cells.
    findings: []
  - id: PMID:9811458
    title: Characterization of a carboxy-terminal BRCA1 interacting protein.
    findings: []
  - id: Reactome:R-HSA-5693606
    title: DNA Double Strand Break Response
    findings: []
  - id: GO_REF:0000024
    title: Manual transfer of experimentally-verified manual GO annotation data 
      to orthologs by curator judgment of sequence similarity.
    findings: []
  - id: GO_REF:0000052
    title: Gene Ontology annotation based on curation of immunofluorescence data
    findings: []
  - id: GO_REF:0000117
    title: Electronic Gene Ontology annotations created by ARBA machine learning
      models
    findings: []
  - id: PMID:10868478
    title: 'Suppression of breast cancer invasion and migration by indole-3-carbinol:
      associated with up-regulation of BRCA1 and E-cadherin/catenin complexes.'
    findings: []
  - id: PMID:11573085
    title: Structure of a BRCA1-BARD1 heterodimeric RING-RING complex.
    findings: []
  - id: PMID:14636569
    title: Regulation of BRCC, a holoenzyme complex containing BRCA1 and BRCA2, 
      by a signalosome-like subunit and its role in DNA repair.
    findings: []
  - id: PMID:14976165
    title: 'BRCA1 : BARD1 induces the formation of conjugated ubiquitin structures,
      dependent on K6 of ubiquitin, in cells during DNA replication and repair.'
    findings: []
  - id: PMID:16331276
    title: BRCA1 and FOXA1 proteins coregulate the expression of the cell 
      cycle-dependent kinase inhibitor p27(Kip1).
    findings: []
  - id: PMID:16391231
    title: Multifactorial contributions to an acute DNA damage response by 
      BRCA1/BARD1-containing complexes.
    findings: []
  - id: PMID:17525341
    title: RAP80 targets BRCA1 to specific ubiquitin structures at DNA damage 
      sites.
    findings: []
  - id: PMID:17525342
    title: Ubiquitin-binding protein RAP80 mediates BRCA1-dependent DNA damage 
      response.
    findings: []
  - id: PMID:18171670
    title: Cell cycle-dependent complex formation of BRCA1.CtIP.MRN is important
      for DNA double-strand break repair.
    findings: []
  - id: PMID:18809582
    title: Nucleophosmin serves as a rate-limiting nuclear export chaperone for 
      the Mammalian ribosome.
    findings: []
  - id: PMID:19261749
    title: NBA1, a new player in the Brca1 A complex, is required for DNA damage
      resistance and checkpoint control.
    findings: []
  - id: PMID:21282464
    title: A novel role for BRCA1 in regulating breast cancer cell spreading and
      motility.
    findings: []
  - id: PMID:23855721
    title: Localization of BRCA1 protein in breast cancer tissue and cell lines 
      with mutations.
    findings: []
  - id: PMID:29709199
    title: The MRE11-RAD50-NBS1 Complex Conducts the Orchestration of Damage 
      Signaling and Outcomes to Stress in DNA Replication and Repair.
    findings: []
  - id: PMID:9342365
    title: Cell cycle-dependent colocalization of BARD1 and BRCA1 proteins in 
      discrete nuclear domains.
    findings: []
  - id: Reactome:R-HSA-2997616
    title: PIAS1,4 SUMOylates BRCA1 with SUMO2,3
    findings: []
  - id: Reactome:R-HSA-2997709
    title: PIAS1,4 SUMOylates BRCA1 with SUMO1
    findings: []
  - id: Reactome:R-HSA-5659781
    title: BRCA1 forms a heterodimer with BARD1
    findings: []
  - id: Reactome:R-HSA-5683385
    title: Formation of BRCA1-A complex at DNA DSBs
    findings: []
  - id: Reactome:R-HSA-5683735
    title: CHEK2 is recruited to DNA DSBs
    findings: []
  - id: Reactome:R-HSA-5683801
    title: CHEK2 phosphorylates BRCA1
    findings: []
  - id: Reactome:R-HSA-5684052
    title: PIAS4 SUMOylates MDC1
    findings: []
  - id: Reactome:R-HSA-5684071
    title: RNF4 ubiquitinates MDC1
    findings: []
  - id: Reactome:R-HSA-5684108
    title: BRCA1 binds phosphorylated RBBP8
    findings: []
  - id: Reactome:R-HSA-5684875
    title: Binding of ATR:ATRIP to RPA at resected DNA DSBs
    findings: []
  - id: Reactome:R-HSA-5684882
    title: CHEK1 is recruited to resected DNA DSBs
    findings: []
  - id: Reactome:R-HSA-5684887
    title: Activation of CHEK1 at resected DNA DSBs
    findings: []
  - id: Reactome:R-HSA-5685011
    title: ATR activation at DNA DSBs
    findings: []
  - id: Reactome:R-HSA-5685156
    title: ATR phosphorylates RPA2
    findings: []
  - id: Reactome:R-HSA-5685341
    title: BCDX2 complex stabilizes RAD51 filament
    findings: []
  - id: Reactome:R-HSA-5685838
    title: CX3 complex binds D-loop structures
    findings: []
  - id: Reactome:R-HSA-5685985
    title: EXO1 or DNA2 in complex with BLM or WRN binds initially resected DNA 
      DSBs along with BRIP1 recruitment
    findings: []
  - id: Reactome:R-HSA-5685994
    title: Long-range resection of DNA DSBs by EXO1 or DNA2
    findings: []
  - id: Reactome:R-HSA-5686410
    title: BLM mediates dissolution of double Holliday junction
    findings: []
  - id: Reactome:R-HSA-5686440
    title: MUS81:EME1,EME2 cleaves D-loop
    findings: []
  - id: Reactome:R-HSA-5686469
    title: Resolution of D-loops cleaved by MUS81:EME1 or MUS81:EME2
    findings: []
  - id: Reactome:R-HSA-5686483
    title: Resolution of Holliday junctions cleaved by GEN1 or 
      SLX1A:SLX4:MUS81:EME1,(MUS81:EME2)
    findings: []
  - id: Reactome:R-HSA-5686642
    title: RAD52 promotes single strand annealing at resected DNA DSBs
    findings: []
  - id: Reactome:R-HSA-5686657
    title: ERCC1:XPF cleaves flaps generated by SSA
    findings: []
  - id: Reactome:R-HSA-5686685
    title: RIF1 and PAX1IP bind TP53BP1 at DNA DSBs
    findings: []
  - id: Reactome:R-HSA-5691411
    title: BRCA1-A complex deubiquitinates K63polyUb-histone H2A
    findings: []
  - id: Reactome:R-HSA-5693539
    title: Ligation of DNA and formation of Holliday structures following repair
      synthesis
    findings: []
  - id: Reactome:R-HSA-5693542
    title: Association of RPA complexes with ssDNA at resected DNA DSBs
    findings: []
  - id: Reactome:R-HSA-5693551
    title: Phosphorylation of BRCA1-A complex at multiple sites by ATM
    findings: []
  - id: Reactome:R-HSA-5693561
    title: RAD51 binds BRCA2 at resected DNA DSBs
    findings: []
  - id: Reactome:R-HSA-5693564
    title: Association of RAD51 with RAD52:DNA double-strand break ends
    findings: []
  - id: Reactome:R-HSA-5693580
    title: Association of RAD52 with the RPA complex at resected DNA DSBs
    findings: []
  - id: Reactome:R-HSA-5693584
    title: Cleavage of Holliday junctions by GEN1 or 
      SLX1A:SLX4:MUS81:EME1,(MUS81:EME2)
    findings: []
  - id: Reactome:R-HSA-5693589
    title: D-loop dissociation and strand annealing
    findings: []
  - id: Reactome:R-HSA-5693593
    title: D-loop extension by DNA polymerases
    findings: []
  - id: Reactome:R-HSA-5693608
    title: Initial resection of double-strand break ends
    findings: []
  - id: Reactome:R-HSA-5693620
    title: D-loop formation mediated by PALB2, BRCA2 and RAD51
    findings: []
  - id: Reactome:R-HSA-6797712
    title: CDK12 stimulates expression of DNA repair genes
    findings: []
  - id: Reactome:R-HSA-6799332
    title: ATR phosphorylates TP53
    findings: []
  - id: Reactome:R-HSA-69891
    title: Phosphorylation and activation of CHEK2 by ATM
    findings: []
  - id: Reactome:R-HSA-9007605
    title: BRCA1 gene expression is inhibited by E2F6
    findings: []
  - id: Reactome:R-HSA-9663194
    title: Some pathogenic BRCA1 mutants do not bind BARD1
    findings: []
  - id: Reactome:R-HSA-9699163
    title: Defective BARD1 does not bind BRCA1
    findings: []
  - id: Reactome:R-HSA-9700998
    title: BAP1 disrupts the BRCA1:BARD1 heterodimer
    findings: []
  - id: Reactome:R-HSA-9701003
    title: BAP1 binds BRCA1:BARD1 heterodimer
    findings: []
  - id: Reactome:R-HSA-9701199
    title: Defective D-loop formation mediated by PALB2, BRCA2 and RAD51 due to 
      loss-of-function of BRCA1 in PALB2 binding
    findings: []
  - id: Reactome:R-HSA-9704330
    title: Defective D-loop formation mediated by PALB2, BRCA2 and RAD51 due to 
      loss-of-function of PALB2 in BRCA1 binding
    findings: []
  - id: Reactome:R-HSA-9704408
    title: Defective D-loop formation mediated by PALB2, BRCA2 and RAD51 due to 
      loss-of-function of PALB2 in binding to BRCA2/RAD51/RAD51C
    findings: []
  - id: Reactome:R-HSA-9707051
    title: UBXN1 binds BRCA1:BARD1 heterodimer
    findings: []
  - id: Reactome:R-HSA-9709571
    title: BRCA2 mutants with BRC defects or a defect in the C-terminal RAD51 
      binding site do not bind RAD51
    findings: []
  - id: Reactome:R-HSA-9709601
    title: Defective recruitment of BRCA2 and RAD51 due to loss of BRCA2 
      function in PALB2 binding
    findings: []
  - id: Reactome:R-HSA-9853389
    title: FIGNL1 binds RAD51
    findings: []
  - id: Reactome:R-HSA-9926521
    title: MITF-M-dependent BRCA1 gene expression
    findings: []
  - id: file:human/BRCA1/BRCA1-deep-research-falcon.md
    title: Deep research on BRCA1 function
    findings: []
core_functions:
  - molecular_function:
      id: GO:0004842
      label: ubiquitin-protein transferase activity
    description: BRCA1-BARD1 heterodimer functions as RING-type E3 ubiquitin 
      ligase catalyzing K6-linked polyubiquitin chains essential for homologous 
      recombination repair. This enzymatic activity modifies histones and other 
      substrates to facilitate DNA repair and chromatin remodeling.
  - molecular_function:
      id: GO:0003684
      label: damaged DNA binding
    description: BRCA1 recognizes and binds damaged DNA at double-strand breaks 
      through its BRCT domains recognizing phosphorylated proteins and through 
      direct DNA interaction. This binding is essential for recruiting repair 
      machinery to sites of DNA damage.
  - molecular_function:
      id: GO:0002039
      label: p53 binding
    description: BRCA1 interacts with p53 tumor suppressor to coordinate DNA 
      damage response and apoptotic signaling. The central region of BRCA1 forms
      an intrinsically disordered scaffold for this and other protein 
      interactions.
status: COMPLETE

BRCA1

Gene Description

Existing Annotations Review

Core Functions

BRCA1-BARD1 heterodimer functions as RING-type E3 ubiquitin ligase catalyzing K6-linked polyubiquitin chains essential for homologous recombination repair. This enzymatic activity modifies histones and other substrates to facilitate DNA repair and chromatin remodeling.

BRCA1 recognizes and binds damaged DNA at double-strand breaks through its BRCT domains recognizing phosphorylated proteins and through direct DNA interaction. This binding is essential for recruiting repair machinery to sites of DNA damage.

BRCA1 interacts with p53 tumor suppressor to coordinate DNA damage response and apoptotic signaling. The central region of BRCA1 forms an intrinsically disordered scaffold for this and other protein interactions.

References

Deep Research

Falcon

Citations

Perplexity

The BRCA1 Protein: Structure, Function, and Mechanisms in Genomic Stability Maintenance

Structural Organization and Protein Architecture of BRCA1

Primary Enzymatic Function: E3 Ubiquitin Ligase Activity and Substrate Specificity

The BRCA1-BARD1 E3 Ubiquitin Ligase Complex and Nuclear Trafficking

BRCA1 and Homologous Recombination-Mediated DNA Double-Strand Break Repair

BRCA1 as an Antagonist of 53BP1 and Regulation of Repair Pathway Choice

BRCA1 as a Recombination Mediator and Facilitator of RAD51 Loading

Post-translational Modifications and Phosphorylation-Dependent Functions

Cell Cycle Checkpoint Control Functions of BRCA1

BRCA1 Localization and Nuclear Foci Formation

Transcriptional Regulation Functions and Target Gene Selection

Metabolic Sensing and Regulation of BRCA1 Expression

RNA Processing and mRNA Splicing Functions

Protection Against Oxidative DNA Damage

Chromatin Remodeling and Large-Scale Chromatin Decondensation

Protein-Protein Interaction Networks and Multiprotein Complex Assembly

Hereditary Breast and Ovarian Cancer Susceptibility

Conclusion and Integration of BRCA1 Functions

Citations

BRCA1 Deep Research Document

BRCA1 Deep Research Document

Gene Overview and Importance

Core Molecular Functions

1. E3 Ubiquitin Ligase Activity

2. Homologous Recombination-Mediated DNA Repair

3. Transcriptional Regulation

Key Biological Processes

1. DNA Damage Response and Cell Cycle Checkpoints

2. Centrosome Regulation and Mitotic Control

3. Chromatin Remodeling and Epigenetic Regulation

Protein Structure and Functional Domains

1. RING Domain (N-terminal)

2. Central Region (Exons 11-13)

3. BRCT Domain (C-terminal)

Major Protein Interactions and Complexes

1. BRCA1-BARD1 Complex

2. BRCA1-A Complex (RAP80/Abraxas)

3. BRCA1-B Complex (BACH1/BRIP1)

4. BRCA1-C Complex (CtIP/MRN)

5. BRCA1-D Complex (PALB2/BRCA2/RAD51)

Disease Associations

1. Hereditary Breast and Ovarian Cancer (HBOC)

2. Mutation Spectrum and Clinical Variants

Key Experimental Findings

1. Foundational HR Studies

2. Synthetic Lethality Discovery

3. Centrosome Association

4. E3 Ligase Function Validation

5. Replication Fork Protection

Core vs Peripheral Functions

Core Functions (Essential for Tumor Suppression)

Peripheral/Contextual Functions

Commonly Over-Annotated Aspects

1. General Protein Binding

2. Broad Transcriptional Terms

3. Development-Specific Over-Attribution

4. Non-Specific DNA Repair Terms

Clinical and Therapeutic Implications

1. PARP Inhibitor Therapy

2. Screening Recommendations

3. Treatment Response

Recent Research Directions (2023-2024)

Conclusion

📚 Additional Documentation

Notes

BRCA1 Gene Review Notes

2025-01-14 - Term Label Update

📄 View Raw YAML